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Abstract 
 
 The objective of this thesis was to replicate findings that isometric handgrip 
(IHG) training lowers resting blood pressure (BP), determine whether cardiovascular 
reactivity to a serial subtraction task (SST), IHG task (IHGT), and cold-pressor task 
(CPT) predict the post-IHG training hypotensive response in hypertensives, and 
investigate whether cardiovascular reactivity is attenuated following training. Resting BP 
and cardiovascular reactivity to a SST, IHGT, and CPT were determined prior-to and 
following 10-weeks of IHG training (n=12) or non-exercising control (n=12). Post-IHG 
training reductions in BP were observed (P<0.05), whereby reductions in systolic BP 
were related to pre-training cardiovascular reactivity to the SST (P<0.05) and IHGT 
(P<0.05), but not the CPT (P>0.05). Systolic BP reactivity to the SST and IHGT was 
significantly reduced in the IHG training group (P<0.05), compared to control. These 
results highlight promising clinical implications for hypertensives, and provide a tool to 
identify hypertensives who will respond to IHG training. 
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1.1 Hypertension 
1.1.1 Introduction 
Cardiovascular disease (CVD) is currently one of the leading causes of morbidity 
and mortality in Canadians (1), and represents the source of Canada’s largest economic 
burden, accounting for 15.2% of the total cost incurred by illnesses on Canada’s health 
care system (2). Globally, CVD remains the number one cause of death, representing 
30% of all mortality (3). Although several risk factors have been identified, the presence 
of chronically sustained elevations of systolic and/or diastolic blood pressure (BP), also 
known as hypertension (4), dramatically increases the risk of developing CVD (4;5). 
Hypertension afflicts nearly six million Canadians, representing 19% of the adult 
population (6). Furthermore, in Canadian individuals over 50-years of age, the prevalence 
of hypertension increases to greater than 50% (7). Worldwide, hypertension represents 
the leading risk factor for mortality, resulting in 7.1 million deaths per year (8), and has a 
prevalence of approximately one billion individuals, a number expected to increase to 1.5 
billion by 2025 (9). Specific long-term complications of chronically elevated resting BP 
include increased incidence and risk of coronary artery disease (CAD), peripheral 
vascular disease, stroke, renal failure, and both systolic and diastolic heart failure (10;11). 
Although considerable advancements in the identification and treatment of hypertension 
have been made, high BP and the coincident risk of hypertension-related CVD 
development remain prominent health concerns for individuals worldwide.  
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1.1.2 Arterial Blood Pressure Regulation 
 Before discussing the pathophysiology of hypertension, it is important to 
understand the basis of arterial BP, as well as the key regulatory mechanisms involved in 
sustaining BP in a healthy state. 
 The heart works as a pump to deliver blood to the various organs and tissues 
throughout the body via a continuous network of blood vessels called the circulatory 
system (12). These blood vessels can be categorized into three basic types: 1) arteries, 
which deliver blood to the tissues under high pressure, 2) capillaries, which allow for the 
diffusion of gases and other substances through their thin walls, and 3) veins, which 
return blood to the heart under low pressure (12). Furthermore, within the arterial and 
venous parts of the circulation, smaller branches deliver blood to (arterioles) and collect 
blood from (venules) the capillaries (12). Therefore, the circulatory system functions 
primarily as a transportation network, working to provide adequate blood flow and 
desired substances (i.e., oxygen, glucose, hormones) throughout the body in an attempt to 
meet the metabolic needs of the body’s organs and tissues (12).  
 The circulatory system consists of the pulmonic circulation and the systemic 
circulation. The pulmonic circulation carries blood from the right ventricle to the lungs 
via the pulmonary artery, and returns blood to the left atrium via the pulmonary vein. The 
pulmonic circulation serves to remove carbon dioxide from the blood, as well as to 
reoxygenate the blood through the diffusion of gases within the blood of the pulmonary 
capillaries and the alveoli. In contrast, the systemic circulation delivers blood from the 
left ventricle to the rest of the body via the aorta, and returns blood to the right atrium via 
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the superior and inferior venae cavae. The systemic circulation serves to provide 
oxygenated blood and nutrients to the organs and tissues throughout the body, while 
collecting carbon dioxide and waste products from these same areas. 
The flow of blood through a blood vessel within the systemic circulation is 
determined by two main factors: 1) the pressure gradient, or the pressure difference of the 
blood between the two ends of the vessel, and 2) the resistance to blood flow through the 
vessel (13). The blood flow through a vessel can thus be calculated via Ohm’s Law, 
which states that blood flow is equal to the pressure difference between the two ends of 
the vessel, divided by the resistance to flow (13). As such, blood flow is directly 
proportional to the pressure difference within the vessel, but inversely proportional to the 
resistance (13). This relationship between pressure, resistance, and blood flow within a 
blood vessel is further described by Poiseuille’s equation [F = (P1 – P2)πR4/8LN], where 
F is flow rate, P1 – P2 is the change in pressure between the two ends of the vessel, R is 
the radius of the vessel, L is the length of the vessel, and N is the viscosity of the blood 
(14). Poiseuille’s equation states that the flow of blood through a blood vessel varies 
directly with pressure differences, as well as to the fourth power of the radius of the 
vessel, and is inversely proportional to both the length of the vessel and the viscosity of 
the blood (14). Therefore, whether at rest or during exercise, blood must be pumped 
throughout the systemic circulation at pressures high enough to overcome the vascular 
resistance it endures throughout the arterial tree, in an attempt to adequately perfuse and 
meet the metabolic demands of all organs and tissues.   
Arterial BP is defined as the force exerted by the blood against any unit area of 
the vessel wall. Arterial BP is comprised of a systolic and a diastolic component, that 
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work together to provide a steady rate of blood flow to ensure the adequate perfusion of 
all organs and tissues throughout the body (12). Systolic BP represents the force exerted 
by the blood against the arterial walls during ventricular systole, or the contraction phase 
of the heart, and provides an estimate of the work of the heart during this period (12). As 
blood must flow from an area of high pressure to an area of low pressure, systolic BP 
must be greater than the resistance offered to it by the arterial side of the circulatory 
system, in order to ensure adequate blood supply (12). In individuals with normal levels 
of resting BP, systolic BP typically averages 120 mmHg (4;15). In contrast, diastolic BP 
represents the force exerted by the blood against the arterial walls during the relaxation 
phase of the heart, and provides an indication of peripheral resistance, or the ease to 
which blood flows through the arterioles and into the capillaries (12). During this 
relaxation phase of the cardiac cycle, BP decreases to approximately 80 mmHg (4;15). 
Arterial BP is the product of cardiac output (CO) and total peripheral resistance 
(TPR) (16). CO is the total amount of blood ejected from the left ventricle into the 
circulation in 1-minute, and is determined via the product of heart rate (HR), or the 
number of heart beats in 1-minute, and stroke volume (SV), or the volume of blood 
pumped from the ventricle in one heart beat (16). The other determinant of arterial BP, 
TPR, is defined as the sum of the resistance of all peripheral vasculature in the systemic 
circulation (16). A component of the vasculature within the systemic circulation is 
smooth muscle, and contraction of this smooth muscle decreases the lumen size of a 
blood vessel, a process known as vasoconstriction, while relaxation of this smooth 
muscle increases the lumen size of a blood vessel, a process known as vasodilation 
(17;18). As previously described, changes in the radius of a blood vessel have a fourfold 
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effect on the resistance to blood flow, and thus, vasodilation and vasoconstriction have a 
significant effect on TPR (17;18). Arterial BP, therefore, can be modified via increases or 
decreases in CO, and/or by increases or decreases in the vasodilation/vasoconstriction 
ratio in the systemic circulation, which causes changes in systemic peripheral resistance 
(TPR) (19;20). As such, regulatory systems relying on neural, local, and hormonal 
control mechanisms, many of which are influenced by constituents of the autonomic 
nervous system (ANS), work together to maintain arterial BP via effects on HR, SV, 
and/or TPR (21).  
The Autonomic Nervous System 
 As mentioned in section 1.1.2 Arterial Blood Pressure Regulation, many of the 
control mechanisms that work together to regulate BP are influenced by components of 
the ANS (19;21-23). The ANS is divided into two main branches: 1) the sympathetic 
nervous system (SNS), or the adrenergic system, and 2) the parasympathetic nervous 
system (PNS), or the cholinergic system (19;23). The SNS is the most important branch 
of the ANS for regulating BP and blood flow (19;22;24). Sympathetic vasomotor nerve 
fibres leave the spinal cord through the thoracic region and through the first one or two 
lumbar spinal nerves (19). They exert their influence on BP and blood flow through two 
main routes: 1) through sympathetic nerves that innervate the heart and internal viscera, 
and 2) by passing through the vasculature of the peripheral areas via spinal nerves (19). 
Sympathetic innervation of blood vessels allows sympathetic stimulation to increase 
resistance to blood flow, which subsequently raises BP (19;20;22). Furthermore, 
sympathetic stimulation augments heart activity, causing increases in HR and force of 
myocardial contraction, which lead to increases in both CO and BP (19;20;22). 
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 The parasympathetic branch of the ANS plays a more minor role in the regulation 
of BP and blood flow, primarily through its effects on and control of HR (19). 
Parasympathetic fibers leave the central nervous system (CNS) through cranial nerves III, 
VII, IX, and X, as well as through the spinal cord at the second and third and/or the first 
and fourth sacral nerves (19). Parasympathetic stimulation causes decreases in HR, as 
well as a slight reduction in force of myocardial contraction, causing subsequent 
reductions in both CO and BP (19;20). The following sections will summarize the neural, 
local, and hormonal control mechanisms involved in regulating arterial BP. 
Neural Regulation of Arterial Blood Pressure 
 Neural control of the cardiovascular system and arterial BP involves higher brain 
centers (i.e., central command), the cardiovascular control center, and peripheral afferents 
including arterial baroreceptors, chemoreceptors, and muscle afferent receptors (25-28). 
The primary neural regulatory mechanism of arterial BP control is established in the 
central area of the brain and is known as central command (20;29). In response to a 
cardiovascular stress, central command sends efferent signals to the cardiovascular 
control center, a loose connection of nerve cells located in the reticular formation of the 
brain stem (20;30). Stimulation of the cardiovascular control center by central command 
results in the alteration of sympathetic and parasympathetic activity (20;30;31). As 
mentioned above in section 1.1.2 Arterial Blood Pressure Regulation: The Autonomic 
Nervous System, SNS activity exerts a stimulatory effect in the body, causing increases 
in both HR and TPR, while PNS activity exerts a relaxation effect in the body, causing 
decreases in both HR and TPR (20).  
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 In addition, the cardiovascular control center receives impulses from the receptors 
located in the periphery (26). These receptors include arterial baroreceptors, 
chemoreceptors, and muscle afferent receptors (26;32). Arterial baroreceptors are stretch 
receptors located in the heart, major arteries (i.e., carotid sinus and aortic arch), and 
pulmonary vessels, that sense changes in BP over a wide range, from approximately 50 
mmHg to 150 mmHg (20;26;33). Arterial baroreceptors exert their influence on the 
cardiovascular control center, which causes changes in HR, cardiac contractility, and 
vascular resistance (26;33). Arterial baroreceptors operate by establishing an arterial BP 
set-point (26;33). If BP is increased and surpasses this set-point, the arterial baroreceptors 
transmit impulses to the cardiovascular control center, which causes reflex 
parasympathetic activation and sympathetic inhibition, leading to decreases in HR, 
cardiac contractility, vascular resistance, and venous return (33). This in turn, leads to a 
reduction in BP (33). In contrast, a decrease in BP causes a reduction in transmitted 
impulses from the arterial baroreceptors to the cardiovascular control center, which works 
to increase SNS activity, triggering reflex increases in HR, cardiac contractility, vascular 
resistance, and venous return, ultimately causing an increase in BP (33). Thus, the arterial 
baroreceptors provide powerful beat-to-beat regulation of arterial BP and minimize short-
term fluctuations in pressure through reflex BP and HR control (33). 
 A second example of short-term feedback regulation on the cardiovascular system 
is the chemoreceptor reflex (20). Chemoreceptors are located in the carotid and aortic 
bodies and respond to reductions in the partial pressure of oxygen of arterial blood, 
increased accumulation of hydrogen ions, and increased partial pressure of carbon 
dioxide, by transmitting impulses to the cardiovascular control center (20;32). The 
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cardiovascular control center responds to these impulses by inducing sympathetically 
mediated vasoconstriction in most vascular beds, as well as by increasing ventilation 
(20). This increased ventilation leads to increases in oxygen uptake in the blood, while 
the increased vasoconstriction serves to increase BP through an increase in systemic 
vascular resistance, thereby maintaining adequate tissue perfusion (20). 
 Lastly, there are two main muscle afferent receptors involved in the control of 
cardiovascular function: 1) Type III afferents (mechanoreceptors), which are sensitive to 
stretch and mechanical deformation, and 2) Type IV afferents (metaboreceptors), which 
are responsive to chemical stimuli and metabolic by-products such as lactic acid, 
diprotonated phosphate, potassium, bradykinin, serotonin, and adenosine (27). When 
stimulated, mechanoreceptors and metaboreceptors send impulses to the cardiovascular 
control center, which in turn alters ANS activity, resulting in increases in BP and HR 
(27;28). 
Local Regulation of Arterial Blood Pressure 
 Local regulation of arterial BP involves the local release of vasoactive substances 
that alter blood flow in response to increased metabolic needs, as well as lack of oxygen 
or other nutrients to the body’s organs and tissues (21;34). Vascular smooth muscle cells 
play an important role in the local regulation of BP by controlling vascular tone via 
vasodilation and vasoconstriction, thus altering blood flow and systemic vascular 
resistance throughout the body (18). The walls of the arteries consist of three layers: 1) 
the tunica adventitia (tunica externa), or the outer layer, composed of connective tissue, 
collagen, and elastic fibres, which allows the artery to stretch in an attempt to prevent 
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overextension, 2) the tunica media, or the middle layer, consisting of the vascular smooth 
muscle cells responsible for mediating vascular tone, and 3) the tunica intima (tunica 
interna), or the inner layer, which contains the endothelial cells of the endothelium, which 
acts as a physical barrier between the plasma and arterial wall, and plays a significant role 
in the regulation and maintenance of vascular tone (35). The vascular smooth muscle 
cells are controlled involuntarily, through the ANS, hormones, and many local vasoactive 
substances (18). Common vasoactive substances responsible for modulating the state of 
the vascular smooth muscle cells, and thus the regulation of BP and blood flow, include 
potassium (a by-product of muscular contraction), adenine derivatives (by-products of the 
hydrolysis of adenosine triphosphate during muscular contraction), and endothelium-
derived substances (i.e., nitric oxide and endothelin-1) (21;34;36). 
 Potassium, a by-product of muscular contraction, accumulates in the muscle 
during increased skeletal muscle activity (36;37). This increased potassium accumulation 
within the interstitial space stimulates the sodium-potassium pump in the vascular smooth 
muscle cells, and due to the unequal pumping of sodium and potassium (three sodium 
ions for every two potassium ions), causes hyperpolarization of the cell and a reduced 
calcium influx into the smooth muscle cells (37). This in turn, causes relaxation of the 
smooth muscle and a subsequent vasodilation of the arteriole, allowing for increased 
blood flow to meet the increased metabolic demands of the tissue (37).   
Furthermore, derivatives of adenine including adenosine, adenosine 
monophosphate, adenosine diphosphate, and adenosine triphosphate, are all potent 
vasodilatory substances (36). Adenosine triphosphate is an integral compound involved 
in the facilitation of muscular contraction, and the accumulation of by-products during its 
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catabolism signal an increased demand for blood flow in the exercising muscle (36). As 
such, when concentrations of these vasoactive substances accumulate, they cause 
relaxation of the smooth muscle cells, thereby inducing vasodilation in the vascular beds, 
and ultimately causing an increase in blood flow to the tissues (36). 
Finally, the endothelial cells of the endothelium synthesize several substances 
that, when released, can affect the degree of vasodilation and/or vasoconstriction in the 
arterial bed (38). The most potent of these vasodilatory substances is nitric oxide (35). 
Nitric oxide is produced by the endothelium, synthesized from L-arginine via the enzyme 
nitric oxide synthase (eNOS) (35;39). Nitric oxide is released from the endothelium in 
response to shear stress (i.e., due to increased blood flow) on the endothelial cells, as a 
result of the viscous drag of blood against the vascular walls, as well as in response to a 
number of stimuli including hypoxia, acetylcholine, bradykinin, and serotonin (35). Nitric 
oxide diffuses out of the endothelium and into the vascular smooth muscle cells, causing 
the activation of the cytosolic form of vascular smooth muscle guanylyl cyclase, which 
leads to an increased accumulation of cyclic guanine 3, 5, monophosphate (40;41). This 
in turn, activates cyclic guanine 3, 5, monophosphate-dependent protein kinase, which 
works to dephosphorylate the myosin light chain of the vascular smooth muscle, 
preventing contraction through the inhibition of myosin and actin binding (18;40). This 
therefore, promotes the relaxation of the vascular smooth muscle cells, allowing for the 
expansion of the vessel lumen and the subsequent vasodilation of the vessel (40). As a 
result, resistance within the vasculature is decreased and blood flow is increased (40).  
As mentioned, the endothelial cells of the endothelium can also mediate 
vasoconstriction through the release of vasoconstricting substances, the most potent of 
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which is endothelin (38;42). Of three endothelin isopeptides, endothelin-1 is the only 
isoform released constitutively from the endothelial cells, and plays an important role in 
mediating vascular tone via binding to one of several receptor subtypes in vascular 
smooth muscle (ETA) (42). Endothelin-1 is released by the endothelial cells in response 
to a variety of agents, including angiotensin II, catecholamines, cytokines, growth factors, 
hypoxia, and mechanical stress (i.e., shear stress) (43;44). When endothelin-1 binds to 
ETA in the vascular smooth muscle, a series of events occur which lead to 
vasoconstriction (42). The binding of endothelin-1 to ETA causes the activation of a G-
protein, which in turn stimulates the activation of phospholipase C (42). Hydrolysis of the 
membrane bound protein phosphatidylinositol by active phospholipase C generates 
inositol triphosphate and diacylglycerol (18;42). Inositol triphosphate then binds to a 
receptor on the sarcoplasmic reticulum and triggers the release of calcium from 
intracellular stores into the vascular smooth muscle cells, subsequently activating the 
calcium-calmodulin complex via the binding of calcium and calmodulin (18;42). The 
calcium-calmodulin interaction activates myosin light chain kinase, which stimulates the 
phosphorylation of the light chain of myosin within the vascular smooth muscle cells, 
allowing for myosin-actin cross-bridge formation and smooth muscle contraction (18). 
Contraction of the smooth muscle causes vasoconstriction of the vessel, and as a result, 
resistance within the vasculature is increased and blood flow is decreased (18;42). 
Endothelin-1 also acts to mediate vascular tone via a negative feedback mechanism, 
through the stimulation of ETB receptors, which triggers the release of nitric oxide (45). 
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Hormonal Regulation of Arterial Blood Pressure 
 Hormonal regulation of arterial BP involves the secretion of many hormones 
including catecholamines (released by the adrenal medulla), vasopressin (released by the 
pituitary gland), atrial natriuretic peptide (released by the heart), renin (released by the 
kidneys), and aldosterone (released by the adrenal cortex) (46). 
 As previously mentioned in section 1.1.2 Arterial Blood Pressure Regulation: 
The Autonomic Nervous System, the ANS has two major branches that work to regulate 
arterial BP: 1) the SNS (adrenergic system), or the stimulatory system, and 2) the PNS 
(cholinergic system), or the inhibitory system (20). The adrenergic system releases two 
catecholamines (neurotransmitters), epinephrine and norepinephrine, whereas the 
cholinergic system releases the neurotransmitter acetylcholine (20;46). 
In response to the stimulation of the SNS, the adrenal gland secretes both 
norepinephrine and epinephrine (46). Both norepinephrine and epinephrine work to 
regulate BP through influences on CO (via increases in HR and myocardial contractility) 
and systemic peripheral resistance (via vasoconstriction and vasodilation) (46). 
Norepinephrine is released by the adrenal medulla through sympathetic nerve endings 
located in the target tissue, as well as directly into the circulation, whereas epinephrine is 
released solely into the blood stream (46). Norepinephrine and epinephrine interact with 
two different types of post-synaptic receptors: 1) α-receptors, and 2) β-receptors (46). 
The α-receptors can be further subdivided into α1-receptors (located in most sympathetic 
target organs, excluding the heart), which cause vasoconstriction of blood vessels, and 
α2-receptors (located in the membranes of norepinephrine nerve ending terminals), which 
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function to regulate the inhibition of norepinephrine release from the nerve ending 
terminals (46). Furthermore, the β-receptors can also be further subdivided into those that 
exert a cardiac stimulatory effect (β1-receptors; located in the heart and coronary blood 
vessels, kidney, liver, and adipose tissue), which act to increase HR and force of 
myocardial contraction, and those found mostly in extra cardiac sites (β2-receptors; 
located in most sympathetic target organs and blood vessels supplying the heart), where 
they cause vasodilation of blood vessels (46). Norepinephrine and epinephrine affect the 
α1-receptors and α2-receptors, respectively, causing vasoconstriction, and thus lead to an 
increase in BP through an increase in systemic vascular resistance (23;46). Furthermore, 
epinephrine also interacts with the β2-receptors to promote vasodilation of blood vessels, 
leading to a decrease in BP via a reduction in systemic vascular resistance (23;46). 
 PNS neurons release the neurotransmitter acetylcholine, which then binds to 
muscarinic receptors (M2 receptors) located in the cardiac cell membrane, causing a 
subsequent decrease in myocardial contractility (23). Activation of M2 receptors by 
acetylcholine leads to the inhibition of adenylyl cyclase, which in turn inhibits increases 
in intracellular cyclic adenosine monophosphate (23). As a result, calcium channel 
phosphorylation is reduced and less calcium channels are opened, resulting in a decreased 
influx of calcium, thereby inhibiting the force of myocardial contraction (23). This 
reduction in myocardial contractility leads to a decreased CO, which ultimately causes a 
reduction in BP (23). The release of acetylcholine as a result of PNS stimulation also 
leads to a reduction in BP through a decrease in HR (23). The release of acetylcholine 
causes a consequent hyperpolarization of the sinoatrial node, elongating the time in 
which threshold potential is reached, and thus slowing the rate of depolarization (23). 
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This reduced rate of depolarization causes HR to decrease, and therefore leads to a 
reduction in BP (23). 
 The cardiac atrial cells of the heart release atrial natriuretic peptide in response to 
atrial wall stretch resulting from increased intravascular volume, which influences arterial 
BP through a reduction in TPR (47;48). Atrial natriuretic peptide increases intracellular 
cyclic guanine 3, 5, monophosphate concentrations, which then activates protein kinase 
GI (47). Protein kinase GI phosphorylation works to dephosphorylate the myosin light 
chain of the vascular smooth muscle, thereby preventing smooth muscle contraction via 
the inhibition of myosin and actin binding (18;47). This in turn causes vasodilation, 
which works to decrease systemic peripheral resistance and BP (47). Furthermore, atrial 
natriuretic hormone binds to the membrane receptor guanylate cyclase GC-A, located in 
both renal cells and the vasculature, and works by promoting diuresis and inhibiting the 
renin-angiotensin-aldosterone system, thereby modulating sodium and water retention by 
prompting the kidneys to excrete more water and sodium (47;48). Therefore, atrial 
natriuretic hormone causes a decrease in total blood volume and a reduction in BP 
(47;48). 
 Vasopressin, also known as antidiuretic hormone, is a powerful vasoconstrictor 
that is formed in the brain and transported down to the posterior pituitary gland where it 
is released into the blood (49). Vasopressin is released in response to an increase in 
plasma osmolarity and/or a decrease in BP (49). Vasopressin functions to regulate arterial 
BP in two main ways. First, vasopressin causes vasoconstriction through smooth muscle 
contraction, via the activation of phospholipase C and concomitant release of calcium 
from the sarcoplasmic reticulum (49). This leads to an increase in BP through an 
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elevation in TPR (49). Second, vasopressin acts on the kidney via the adenylyl cyclase-
coupled vasopressin receptor (V2-receptor) to regulate water excretion (50). Vasopressin 
reduces urinary water excretion by increasing the water permeability of the renal 
collecting duct, thereby promoting water resorption from the kidney (50). This increases 
blood volume, which causes an increase in BP (50). 
 The renin-angiotensin system is among the most important hormonal regulators of 
arterial BP, through its regulation of blood volume and influence on CO (16;51). Renin, a 
small protein enzyme released by the kidneys, is synthesized and stored in the 
juxtaglomerular cells of the kidneys in an inactive form called prorenin (52). In response 
to a decline in BP or blood volume, reactions within the kidneys occur and many of the 
prorenin molecules are converted to active renin by a trypsin-like activating enzyme (53). 
As a result, renin is released from the juxtaglomerular cells of the kidneys and circulates 
throughout the body (52). Renin then cleaves angiotensinogen to form angiotensin I 
(16;52). Although angiotensin I has minor vasoconstrictor properties, it is not enough to 
cause significant changes in the circulatory system (52). Angiotensin converting enzyme, 
mostly found on the membranes of endothelial, renal, and neuroepithelial cells, 
hydrolyzes the inactive angiotensin I into the biologically active angiotensin II (16;52). 
Angiotensin II has two main effects that lead to an elevation in BP. First, angiotensin II is 
a potent vasoconstrictor and thus increases TPR, which elevates BP and helps maintain 
adequate tissue perfusion (51;54). Angiotensin II-induced effects on TPR are mediated 
through the angiotensin II, type 1 receptors (AT1 receptors), which couples to a wide 
variety of signaling events, including phospholipase C, tyrosine kinases, and mitogen-
activated protein kinases (MAPKs; or extracellular signal-regulated protein kinase, ERK) 
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(54). The ERK signaling cascade consists of a 3-kinase module that includes an MAPK 
(ERK), which is activated via MAPK/ERK kinase (MEK), which in turn is activated via 
MEK kinase (MEKK) (54-56). MEK influences the concentration of calcium by 
modulating calcium influx and intracellular calcium mobilization (54). Calcium then 
works to cause actin-myosin interaction, cross-bridge cycling, and the subsequent 
contraction of the vascular smooth muscle cells (54;57). The contraction of the vascular 
smooth muscle cells induces vasoconstriction, which increases systemic vascular 
resistance and causes an elevation in BP (54). Second, angiotensin II acts directly on the 
kidneys and causes a reduction in the excretion of both sodium and water (51;52). This 
leads to an increased extracellular fluid volume, resulting in an increase in BP (51;52). 
Furthermore, the renin-angiotensin system works to regulate arterial BP indirectly. In 
addition to cleaving angiotensin I to angiotensin II, angiotensin converting enzyme 
metabolizes bradykinin, an active vasodilator and natriuretic substance, to an inactive 
form (bradykinin 1-7), thereby degrading its vasodilatory properties and thus contributing 
indirectly to a rise in BP (16;52). Angiotensin II also functions to stimulate the release of 
aldosterone via the adrenal cortex (16;52). Aldosterone increases sodium and water 
resorption, which leads to an increased blood volume and BP (16;52).  
1.1.3 Methods of Measuring Arterial Blood Pressure 
 The most accurate method of measuring resting BP (i.e., direct, intra-arterial 
measurement) is an invasive procedure, whereby a catheter is inserted into an artery, 
allowing for the continuous monitoring of arterial BP (58). However, the invasive nature 
of this BP measurement method renders it impractical for use in clinical settings (59;60). 
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As such, several indirect BP measurement techniques have been developed and validated, 
including auscultatory sphygmomanometry, oscillometry, and arterial tonometry (61). 
Auscultatory Sphygmomanometric Method  
 The gold standard indirect method of resting BP measurement used in clinical 
practice is the auscultatory sphygmomanometric technique (61-63). In this method, the 
brachial artery is occluded by a cuff placed around the upper arm that is inflated to a 
pressure greater than systolic BP, usually around 200 mmHg (62). As the cuff is 
gradually deflated, a stethoscope placed over the brachial artery enables the detection of 
auditory changes within the artery (62). As the pressure in the cuff drops below systolic 
BP, Korotkoff sounds can be heard (61-63). The sounds are thought to result from a 
combination of turbulent flow and oscillations of the arterial wall (62). Traditionally, the 
sounds have been classified as five phases: 1) clear tapping sounds corresponding to the 
appearance of a palpable pulse, 2) softer and longer sounds, 3) crisper and louder sounds, 
4) muffled and softer sounds, and 5) sounds disappear completely (62). The onset of 
Korotkoff sounds (i.e., Phase 1) represents systolic BP, while the disappearance of 
Korotkoff sounds (i.e., Phase 5) represents diastolic BP (61-63). The auscultatory 
sphygmomanometry method, using Korotkoff sounds, tends to give lower systolic BP 
and higher diastolic BP values (both by an average of approximately 8 mmHg) (64) 
compared to direct intra-arterial measurements (61-63), although they are highly 
correlated (65). Although the most commonly used method for resting BP measurement 
in clinical practice, it is not without inherent limitations. Prominent disadvantages of 
auscultatory sphygmomanometry include observer error (e.g., the reliance on auditory 
acuity of the observer for the detection of Korotkoff sounds), observer and measurement 
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bias (e.g., digit preference, where observers record a disproportionate number of readings 
ending in 5 or 0), the susceptibility of the technique to external noise, and the influence of 
cuff size and placement on resting BP measures (61-63). 
Oscillometric Method 
 Another form of indirect resting BP measurement is the oscillometric technique. 
As with auscultatory sphygmomanometry, this method involves the placement of a cuff 
around the upper arm which is inflated and subsequently deflated (61-63). This method, 
however, does not rely on auditory changes within the artery (61-63). Rather, it relies on 
oscillations within the cuff that occur as the cuff is gradually deflated (61-63). The 
oscillations begin at approximately systolic BP (rapid increase in oscillations) and cease 
below diastolic BP (rapid decrease in oscillations) (61-63). The point of maximal 
oscillation represents mean arterial BP (61-63). Systolic BP and diastolic BP are 
subsequently determined via an empirically derived algorithm (61-63). Lower values of 
systolic BP when using the oscillometric method tend to be found when compared with 
intra-arterial measures (66). Several investigations comparing the oscillometric method 
with intra-arterial and Korotkoff sound measurements, however, have reported good 
agreement between methods (67-69). Oscillometry has some distinct advantages over 
auscultatory sphygmomanometry, as it does not rely on human auditory acuity, it is less 
susceptible to external noise, and cuff placement is not as critical due to the fact that no 
transducer needs to be placed over the brachial artery (61-63). However, the oscillometric 
method has some disadvantages as well, as the amplitude of oscillations within the cuff 
depends on several factors other than arterial BP, such as the stiffness of the arteries (62). 
Therefore, in individuals with stiff arteries, mean arterial BP may be underestimated (62).  
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Arterial Tonometric Method 
 Arterial tonometry is another non-invasive method of resting BP measurement. 
As is the case with direct intra-arterial BP measurement, arterial tonometry allows for the 
continuous registration of the arterial pressure waveform (70). Arterial tonometry 
involves the placement of a pressure transducer on a superficial artery (i.e., radial artery), 
which is supported by a bony structure so that adequate applanation or flattening of the 
artery occurs (70). The flattened artery balances the pressure-induced stress on the 
arterial wall, causing arterial BP forces to act perpendicularly to wall tension (71). The 
intra-arterial forces are sensed by the pressure transducer and translated into arterial BP 
waveforms (71). Using an inflatable upper arm cuff, calibration of the continuous 
tonometric arterial BP waveforms using oscillometry is provided intermittently (71). 
Although this technique gives insight into the continuous (i.e., beat-to-beat) measurement 
of resting BP, it has some inherent limitations, including the location of BP measurement 
(i.e., radial artery versus the more common and standard brachial artery), the influence of 
the positioning of the pressure transducer, and the fact that calibration of the device 
requires external measurement (70-72). Furthermore, the accuracy of arterial tonometry 
has been found to be inferior to, although highly correlated with, intra-arterial methods of 
resting BP measurement (73). 
1.1.4 Pathophysiology of Hypertension 
 According to the Seventh Report of the Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of High Blood Pressure, normal resting BP is 
defined as a systolic BP < 120 mmHg and a diastolic BP < 80 mmHg (4;10). In contrast, 
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hypertension is defined as a systolic BP ≥ 140 mmHg, and/or a diastolic BP ≥ 90 mmHg 
(4;10). Hypertension is further subdivided into two stages of hypertension, whereby 
Stage I is defined as a systolic BP of 140 mmHg to 159 mmHg and/or a diastolic BP of 
90 mmHg to 99 mmHg, and Stage II is defined as a systolic BP of ≥ 160 mmHg and/or a 
diastolic BP ≥ 100 mmHg (4;10). As a result of new data on the lifetime risk of 
hypertension and the linking of previously defined normal resting BP with increased risk 
of cardiovascular complications, a new “prehypertension” classification has been 
introduced. Prehypertension is defined as a systolic BP of 120 mmHg to 139 mmHg, 
and/or a diastolic BP of 80 mmHg to 89 mmHg (4;10). This new designation is not a 
disease category; rather, it is intended to identify individuals at high risk of developing 
high BP, in whom early intervention could reduce this risk (4). The classification of 
resting BP is based on the average of two or more properly measured, seated resting BP 
readings on each of two or more visits (4). 
 There are two general classes of hypertension: 1) primary (essential) 
hypertension, and 2) secondary hypertension (4). Primary hypertension has no 
identifiable cause and represents 90% to 95% of all hypertension cases (4). Although the 
definitive cause of primary hypertension remains somewhat equivocal, significant 
advances have been made in understanding its pathogenesis. As mentioned previously in 
section 1.1.2 Arterial Blood Pressure Regulation, arterial BP is regulated through 
neural, local, and hormonal factors (21). Therefore, irregularities in one or more of these 
regulatory mechanisms may affect CO and/or TPR and lead to the development of 
primary hypertension (16). As such, numerous neural, hormonal, vascular, genetic, and 
21 
 
M.H.K Thesis – M. Badrov                                   Windsor – Applied Human Performance 
 
environmental factors have been hypothesized to play a role in the pathogenesis of 
hypertension (16).  
 Augmented SNS activity increases arterial BP and contributes to the development 
and maintenance of primary hypertension through its stimulatory effects on the heart, 
peripheral vasculature, and kidneys, thereby leading to increases in CO, systemic 
vascular resistance, and fluid retention (74;75). Numerous studies have reported that the 
SNS is often hyperactive in individuals with primary hypertension (16;76). For example, 
norepinephrine spillover studies, which provide evidence of norepinephrine release from 
the sympathetic nerve terminals, as well as studies looking at direct sympathetic outflow 
to muscle (muscle sympathetic nerve activity) (77;78), demonstrate that sympathetic 
stimulation is greater in hypertensive individuals compared to normotensive individuals 
of similar age, providing evidence that increased SNS activity may contribute to the 
development of primary hypertension (79). The mechanisms responsible for the increased 
SNS activity in hypertension are complex and have not been conclusively determined; 
however, it has been alleged that the resting arterial baroreceptor set-point for the control 
of arterial BP is reset to a higher level of BP in individuals with primary hypertension, 
leading to augmented resting sympathetic outflow (80). The consequences of this chronic 
SNS hyperactivity include vascular remodeling, left ventricular hypertrophy, greater 
release of norepinephrine from the adrenals, increased HR, and peripheral 
vasoconstriction, all of which lead to the subsequent increase in BP (16). Furthermore, 
the chronic increase in SNS activity, as well as aging, have been shown to mediate 
vascular hypertrophy and increased vascular stiffness, leading to reduced arterial 
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compliance (16;81). As a result of this reduced arterial compliance, TPR is increased and 
contributes to a chronic elevation of resting BP (16). 
 As previously mentioned in section 1.1.2 Arterial Blood Pressure Regulation: 
Hormonal Regulation of Arterial Blood Pressure, the renin-angiotensin system is a 
coordinated hormonal regulator that governs fluid and electrolyte balance and controls 
arterial BP (16;51;52). Abnormalities within the renin-angiotensin system have been 
implicated in the development of primary hypertension (16). There is evidence to suggest 
that plasma renin activity is increased in individuals with primary hypertension (16). This 
in turn, leads to greater concentrations of the vasoconstrictor angiotensin II, which causes 
stimulation of vascular smooth muscle contraction and hypertrophy, increased 
stimulation of SNS activity (facilitating norepinephrine release), suppressed PNS activity, 
stimulation of aldosterone synthesis, increases in renal vascular resistance, and increased 
sodium resorption, all of which contribute to the pathogenesis of primary hypertension 
(16;51;52). Furthermore, sodium retention occurs which raises total blood volume and 
CO, leading to an increase in resting BP (16;51;52). 
 Vascular factors such as persistent perturbations in the normal balance of 
vasoconstrictors and vasodilators have also been implicated in the development of 
primary hypertension (16;82-84). As mentioned in section 1.1.2 Arterial Blood Pressure 
Regulation: Local Regulation of Arterial Blood Pressure, the vascular endothelium is 
a monolayer of smooth muscle cells that plays an integral role in vascular homeostasis, 
via its effects and influence on arterial tone, fibrinolysis, cell growth, and inflammation 
(35;85). The endothelium works to regulate the complex vascular environment through 
the expression of many substances in response to a variety of mechanical and chemical 
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stimuli (35). Of these many factors, nitric oxide, a potent vasodilator, and endothelin-1, a 
potent vasoconstrictor, play a significant role (35). Therefore, alterations or impairments 
in endothelial function may have a significant effect on BP (16;82-84). For example, 
hypertension is associated with endothelial dysfunction (35;82-84). Endothelial 
dysfunction refers to altered or impaired vasoactive, anticoagulant, and anti-inflammatory 
properties of the vascular endothelium (35). This endothelial dysfunction associated with 
primary hypertension leads to an impairment of endothelium-dependent vasodilation as a 
result of reduced formation and/or bioavailability of the potent vasodilator nitric oxide, 
thereby leading to increases in TPR and resting BP (86). A reduction in nitric oxide 
bioavailability and activity may be caused by several factors including decreased eNOS 
expression, insufficient substrate (i.e., L-arginine) for eNOS, impaired eNOS activation, 
and/or increased oxidative stress/reactive oxygen species-induced rate of nitric oxide 
degradation (35). Furthermore, an overexpression of endothelin-I, an endothelium-
derived vasoconstrictor, is seen in individuals with primary hypertension and may play a 
role in the development of the disorder, through its effect on the augmentation of 
systemic vascular resistance (87). 
 Finally, genetics and environmental factors have been implicated in the 
development of primary hypertension (16). It has been estimated that approximately 30% 
to 60% of the variation in resting BP between individuals is attributed to the effects of 
genetic factors (16;88). Although hypertension has been suggested to result from genetic 
factors, it is thought that the effects of these gene variants on BP are rather weak, but may 
have a significant impact on the development of hypertension when they act together in 
the presence of environmental factors (16). The contribution of environmental factors to 
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the variation in resting BP between individuals has been estimated to be approximately 
20% (16). Environmental factors such as geography (i.e., rural areas have lower rates of 
hypertension than urban areas), high dietary intake of sodium, low dietary intake of 
calcium and potassium, physical inactivity, psychosocial stress, lower socioeconomic 
status, high alcohol consumption, cigarette smoking, and other poor lifestyle choices have 
been purported to have a significant effect on the development of primary hypertension 
(16;89). 
 In contrast to primary hypertension, the causes and mechanisms behind the 
development of secondary hypertension, which accounts for only 5% to 10% of all 
hypertension cases, are more well-known, and include known disorders such as 
Cushing’s syndrome, renovascular disease, primary aldosteronism, and/or 
hyperparathyroidism (4). 
1.1.5 Recommendations for the Treatment of Hypertension 
 The primary goal for treatment in individuals with hypertension and no other 
compelling secondary conditions is to decrease CVD-related morbidity and mortality by 
lowering systolic BP and diastolic BP to within the target range of < 140 mmHg and < 90 
mmHg, respectively (4). In individuals with prehypertension, the goal for treatment is to 
lower resting BP to within the normal range of systolic BP and diastolic BP of < 120 
mmHg and < 80 mmHg, respectively (4).  
Despite progress in the prevention, treatment, and control of high BP, 
hypertension remains a prominent health concern (4). Furthermore, an alarming statistic 
from the Framingham Heart Study suggests that the residual lifetime risk of developing 
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hypertension is 90% (90). As such, there is a concerted global effort towards the better 
understanding and implementation of successful strategies for the primary and secondary 
prevention and treatment of high BP (90). As there are minimal cost and side effects 
associated with lifestyle modifications, in addition to favourable interactions with other 
CVD risk factors, current treatment recommendations for the management of 
hypertension include the adoption of a healthy lifestyle, and should be recommended to 
all individuals diagnosed with hypertension, as well as to individuals identified as having 
prehypertension (4;10;90). Lifestyle modifications include: 1) attaining and maintaining a 
healthy body weight, 2) eating a low-fat, low-sodium diet rich in fruits, vegetables, low-
fat dairy products, calcium, and potassium, 3) limiting alcohol intake to two drinks per 
day for men and one drink per day for women, and 4) the initiation of an aerobic exercise 
training program, with resistance training as an adjunct (4). Lifestyle modifications 
reduce resting BP, prevent and/or delay the incidence of hypertension, enhance 
pharmacological treatment efficacy, and decrease CVD-related morbidity and mortality 
(4). 
Comprehensive prospective reviews provide convincing evidence to support the 
value of modest reductions in body weight as a beneficial treatment for the management 
of hypertension (4). For example, He and colleagues (91) investigated the effects of an 
18-month lifestyle modification intervention aimed at weight loss on resting BP and 
incidence of hypertension after a 6- to 8-year follow-up period. The weight loss 
intervention consisted primarily of group educational sessions, focusing on shopping, 
cooking, and food selection behaviours aimed at reducing caloric intake. The weight loss 
intervention also encompassed a strategy to achieve a moderate increase in caloric 
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expenditure, primarily via brisk-walking for 45-minutes, 4- to 5-days per week. The 
study examined the experience of 95 individuals with high-normal resting BP who had 
participated in Phase I of the Trials of Hypertension Prevention and found that after 18-
months, those assigned to the active intervention group (n = 53; age = 43.3 ± 5.5 years, 
mean ± standard deviation; baseline resting arterial BP = 122 ± 8/84 ± 3 mmHg) 
experienced a weight loss of 5.3 lbs, and that this was associated with a decrease in 
systolic BP and diastolic BP of 7 mmHg and 9 mmHg, respectively. In addition, after a 7-
year follow up period, incidence of hypertension was 18.9% in the weight loss group, 
compared to 40.5% in the control group. Moreover, Neter and colleagues (92) completed 
a recent meta-analysis of randomized controlled trials investigating the effects of weight 
reduction on resting BP. The meta-analysis examined a total of 4874 participants from 25 
trials (aged 37- to 66-years) and included both normotensive (n = 3328; baseline resting 
arterial BP = < 140/90 mmHg) and hypertensive (n = 1546; baseline resting arterial BP = 
≥ 140/90 mmHg) populations, utilizing a variety of different weight loss interventions 
aimed at energy restriction and/or increased physical activity. This meta-analysis 
revealed an overall net weight loss of 11.2 lbs, which was associated with reductions in 
both systolic BP and diastolic BP of approximately 4 mmHg and 4 mmHg, respectively. 
Most recently, a systematic review on the effects of weight reduction on resting BP, 
completed by Aucott and colleagues (93), concluded an approximate relationship of 1 
mmHg reduction in systolic BP for every 1 kg reduction in weight. Taken together, 
weight loss provides an effective strategy in the treatment and management of high BP.  
Reductions in resting BP have also been shown to occur in individuals who adopt 
the Dietary Approaches to Stop Hypertension eating plan, which is a diet low in saturated 
27 
 
M.H.K Thesis – M. Badrov                                   Windsor – Applied Human Performance 
 
and total fat, and rich in fruits, vegetables, and low-fat dairy products (94;95). 
Furthermore, reductions in resting BP have been reported in individuals who reduce 
dietary sodium intake (95). For example, Vollmer and colleagues (95) investigated the 
effects of reduced dietary sodium intake and the Dietary Approaches to Stop 
Hypertension eating plan on resting BP in participants (N = 412; age = 48.2 ± 10 years) 
with a systolic BP < 160 mmHg and a diastolic BP between 80 mmHg and 95 mmHg. 
Participants were randomly assigned to the Dietary Approaches to Stop Hypertension 
eating plan (n = 208) or a control diet (n = 204) for three consecutive 30-day periods, 
during which sodium intake varied for each period (low, medium, high). In all subgroups, 
the Dietary Approaches to Stop Hypertension eating plan and reduced sodium intake 
were associated with significant decreases in resting BP, while the Dietary Approaches to 
Stop Hypertension eating plan and lowest sodium intake was associated with the greatest 
reduction in both systolic BP and diastolic BP (12 mmHg and 6 mmHg, respectively). 
Furthermore, evidence for the benefits of the Dietary Approaches to Stop Hypertension 
diet in those with elevated resting BP was provided by Blumenthal and colleagues (96), 
who investigated the effects of the Dietary Approaches to Stop Hypertension eating plan 
alone (4-month intervention period) on resting BP in individuals with prehypertension or 
Stage I hypertension (N = 46; age = 51.8 ± 10 years; baseline resting arterial BP = 136 ± 
12/82 ± 9 mmHg). The 4-month Dietary Approaches to Stop Hypertension diet 
intervention reduced both systolic BP and diastolic BP by 11 mmHg and 8 mmHg, 
respectively. Furthermore, a recent meta-analysis completed by He and MacGregor (97) 
examined the effects of modest reductions in sodium intake on resting BP. A total of 17 
trials in hypertensive individuals (N = 734; aged 24- to 73-years; baseline resting arterial 
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BP = 150/93 mmHg) and 11 trials in normotensive individuals (N = 2220; aged 22- to 
67-years; baseline resting arterial BP = 127/78 mmHg) were included in the analysis. In 
the hypertensive individuals, the median net change in 24-hour urinary sodium was -78 
mmol (4.6 grams of salt per day), and this was associated with a reduction in systolic BP 
of 5 mmHg and diastolic BP of 3 mmHg. In the normotensive individuals, the median net 
change in 24-hour urinary sodium was -74 mmol (4.4 grams of salt per day), and this was 
associated with a reduction in systolic BP and diastolic BP of 2 mmHg and 1 mmHg, 
respectively. The above described findings provide convincing evidence for the positive 
effects of diet and sodium reduction on resting BP. 
Moderation of alcohol consumption has also been proven to be beneficial in the 
control and treatment of hypertension (4). In a meta-analysis of 15 randomized controlled 
trials (N = 2234; aged 27- to 57-years) investigating both hypertensive (n = 682; baseline 
resting arterial BP = ≥ 140/90 mmHg) and normotensive (n = 1552; baseline resting 
arterial BP = < 140/90 mmHg) individuals with a mean baseline alcohol consumption of 
three to six drinks per day, Xin and colleagues (98) reported that decreased consumption 
of alcohol (reduction in self-reported consumption of alcohol ranged from 16% to 100%) 
was associated with an average reduction in both systolic BP and diastolic BP of 3 
mmHg and 2 mmHg, respectively. Furthermore, a dose-response relationship was 
observed between the percentage alcohol reduction and overall decrease in resting BP, 
such that the greater the reduction in alcohol consumption, the greater the reduction in 
resting BP. 
Exercise training is also an integral component of the lifestyle modifications 
recommended for the treatment and management of hypertension. The effects of acute 
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exercise, as well as chronic exercise training, on resting BP, are discussed in detail in 
section 1.2 Exercise and Hypertension. 
Despite compelling evidence of the benefits of exercise and the known 
importance of engaging in regular physical activity, many individuals are not meeting 
current physical activity guidelines (99). Furthermore, exercise does not lower resting BP 
in approximately 25% of individuals with hypertension (100). As such, pharmacotherapy 
is often required in addition to lifestyle modifications to adequately control resting BP to 
optimal values (101). Commonly prescribed anti-hypertensive medications include 
diuretics, β-receptor blockers, α1-receptor blockers, calcium channel blockers, 
angiotensin converting enzyme inhibitors, angiotensin receptor blockers, centrally acting 
adrenergics, peripherally acting antiadrenergics, and direct vasodilators (4). 
Diuretics useful in the treatment of hypertension can be divided into three main 
groups: 1) loop diuretics, 2) thiazides, and 3) potassium sparing agents (4;102;103). A 
thiazide is the most common initial choice, often in combination with a potassium sparing 
agent (4;102;103). Loop diuretics are typically reserved for individuals with renal 
insufficiency or resistant hypertension (102;103). Thiazide diuretics promote the 
excretion of water and sodium, loop diuretics inhibit the resorption of sodium, and 
potassium sparing agents impede sodium resorption while decreasing potassium 
excretion (102;103). As such, all three classes of diuretics work to lower resting BP by 
promoting the excretion of water and sodium, thereby reducing plasma and extracellular 
fluid volume and leading to a decrease in CO (4;102;103). Within 6- to 8-weeks of use, 
plasma and extracellular fluid volume, as well as CO, return toward normal levels 
(102;103). At this point and beyond, the BP lowering effects of diuretics are achieved 
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through decreases in systemic peripheral resistance, possibly through potassium channel 
activation (104). 
β-receptor blockers are another commonly prescribed medication for the 
treatment of high BP. β-receptor blockers are classified into three main categories: 1) 
selective β-receptor blockers, 2) non-selective β-receptor blockers, and 3) β-receptor 
blockers with α-blocking activity (4). Selective β-receptor blockers reduce the work of 
the heart (i.e., decrease HR and force of cardiac contractility) and cause coronary artery 
dilation by blocking the stimulation of β1-receptors in cardiac smooth muscle, which in 
turn lowers CO and resting BP (4). Non-selective β-receptor blockers promote 
vasodilation through their influence on both β1- and β2-receptors, subsequently reducing 
TPR and resting BP (4). β-receptor blockers with α-blocking activity block both β1- and 
β2-receptors, as well as α1-receptors, which causes arterial and venous blood vessel 
vasodilation and reduced myocardial oxygen consumption, thus lowering resting BP 
(105). Similarly, α1-receptor blockers decrease resting BP through a decrease in TPR, via 
the promotion of vasodilation by binding to α1-receptors (105). 
Calcium channel blockers reduce vasoconstriction and promote vasodilation of 
the arteries in the peripheral vascular system by inhibiting the influx of calcium ions 
across smooth muscle cell membranes (106). Thus, systemic vascular resistance is 
reduced and leads to a reduction in resting BP (106). Furthermore, certain calcium 
channel blockers reduce HR by inhibiting calcium influx in conduction tissue, leading to 
reductions in CO and BP (106). 
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Angiotensin converting enzyme inhibitors work to lower resting BP by preventing 
the conversion of angiotensin I to angiotensin II, which, as previously mentioned in 
section 1.1.2 Arterial Blood Pressure Regulation: Hormonal Regulation of Arterial 
Blood Pressure, is a potent vasoconstrictor (51;52;107). Thus, angiotensin converting 
enzyme inhibitors cause a reduction in circulating angiotensin II, and therefore promote 
arterial and venous blood vessel vasodilation, which in turn reduces TPR and resting BP 
(106;107). Angiotensin receptor blockers produce similar outcomes to angiotensin 
converting enzyme inhibitors, as they block angiotensin II from binding to AT1 receptors. 
Furthermore, angiotensin receptor blockers inhibit the secretion of aldosterone, which 
causes a decrease in blood volume (107). Both of these effects cause a reduction in TPR, 
and ultimately a reduction in resting BP (107). 
Centrally acting adrenergics have a direct effect on α2- receptors in the 
sympathetic vasomotor center in the CNS, causing a reduction in SNS activity, and thus 
reducing systemic peripheral resistance and resting BP (4). Peripherally acting 
antiadrenergics also reduce BP through a reduction in TPR, via the blocking of α1-
receptors on the vascular smooth muscle and inhibition of vasoconstriction induced by 
the release of endogenous catecholamines (4). 
Finally, direct vasodilators act directly on the vascular smooth muscle of the 
arterioles and induce relaxation, which causes a reduction in TPR, and thus leads to 
decreases in resting BP (4). 
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1.2 Exercise and Hypertension  
 As mentioned in section 1.1.5 Recommendations for the Treatment of 
Hypertension, exercise training is an integral component in both the treatment and 
management of high BP. There is compelling evidence to suggest that physical activity 
has many important health benefits, including increased longevity (108-113). Evidence 
from epidemiological studies shows that physical inactivity is an independent risk factor 
for CAD (114), and that physical activity and physical fitness are inversely correlated 
with CVD-related morbidity and mortality (115). As such, the American College of 
Sports Medicine (ACSM) currently recommends that individuals with hypertension 
engage in 30- to 60-minutes per day of continuous or intermittent, moderate intensity 
(i.e., 40% to <60% maximal oxygen reserve), aerobic exercise (walking, jogging, cycling, 
etc.) on most, preferably all, days of the week (116). Resistance exercise training is 
recommended as an adjunct to aerobic exercise training, and current ACSM guidelines 
recommend that in individuals with hypertension, resistance exercise be performed 2- to 
3-days per week, incorporating at least one set of eight to 12 repetitions for eight to 10 
different exercises targeting the major muscle groups, at an intensity of 60% to 80% 1-
repetition maximum (116). Currently, there are no ACSM endorsed guidelines for 
isometric exercise training. The following sections will summarize the effects of acute 
and chronic exercise on BP.  
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1.2.1 Effects of Acute Exercise on Arterial Blood Pressure 
Acute Aerobic Exercise 
 At the onset of aerobic exercise, systolic BP increases in a linear manner and can 
reach values of  ≥ 200 mmHg during maximal-intensity exercise, in an effort to ensure 
adequate perfusion of the active muscle (117). This rise in systolic BP with high-intensity 
exercise is due to an increase in HR and a 4- to 6-fold increase in CO (117), achieved 
through a withdrawal in parasympathetic tone (increasing HR and cardiac contractility), 
an increase in sympathetic activity (increasing HR and cardiac contractility), and 
vasoconstriction of the venous vasculature (increasing venous return and SV) (117). 
Exercising muscles respond to this increase in systolic BP through the progressive 
vasodilation of blood vessels, resulting in a concomitant reduction in TPR (117). As a 
result of this reduction in TPR, diastolic BP changes minimally, and often decreases 
slightly during acute aerobic exercise (117). As exercise continues at the same intensity 
level, BP decreases from the peak values achieved early on during exercise (117), as a 
result of the redistribution of blood to the periphery for heat dissipation and the 
concurrent reduction in cardiac filling (118). 
 Following acute bouts of aerobic exercise, immediate and sustained reductions in 
BP, termed post-exercise hypotension (119), have been observed for up to 22-hours 
following the exercise session (120). Post-exercise hypotension has been found to occur 
in both normotensive (10;121-125) and hypertensive (10;126-130) individuals, and the 
drop in BP appears to be a function of pre-exercise values, whereby individuals with the 
greatest baseline BP values experience the greatest reduction in post-exercise BP 
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(10;119). In studies that have observed a reduction in BP immediately following aerobic 
exercise, average decreases in systolic BP and diastolic BP were approximately 8 mmHg 
and 9 mmHg, respectively, in normotensive populations, and 10 mmHg and 7 mmHg, 
respectively, in hypertensive populations (117). The magnitude of post-exercise 
hypotension reported in studies is dependent upon the method of BP monitoring (10). In 
studies where BP is taken in the laboratory setting using short-term auscultatory methods, 
average reductions in systolic BP of 15 mmHg and diastolic BP of 4 mmHg have been 
reported (10). In contrast, studies utilizing 24-hour ambulatory oscillatory BP monitoring 
methods, a more valid prognostic indicator of CVD-related morbidity and mortality 
(131), have reported average reductions in systolic BP and diastolic BP of 5 mmHg and 2 
mmHg, respectively (10). The mechanisms behind which post-exercise hypotension 
occurs following aerobic exercise remain equivocal, however, it is thought that the acute 
decrease in BP is due to reductions in peripheral resistance, via sympathetic inhibition 
(i.e., reduced sympathetic outflow, desensitized norepinephrine receptors) and/or altered 
vascular responsiveness (i.e., release of local vasodilatory substances induced by 
muscular contraction and increased muscle blood flow) following exercise (10;117). 
Acute Resistance Exercise 
 Resistance exercise, involving high-intensity lifts incorporating large muscle 
masses, induces sudden and simultaneous increases in systolic BP and diastolic BP of up 
to 400 mmHg and 200 mmHg, respectively (132). The magnitude of the BP response is 
dependent on the amount of work performed by the contracting muscle (132). The high 
intramuscular pressure associated with resistance exercise promotes the mechanical 
compression of the vasculature, leading to dramatic increases in systemic vascular 
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resistance, and ultimately, occlusion of blood flow to the contracting muscle (133). In an 
attempt to restore blood flow to the exercising muscles, a substantial increase occurs in 
SNS activity (increasing HR and force of myocardial contractility), causing CO to 
increase, ultimately resulting in an increase in BP (132;133). Other contributors to the 
increase in BP during acute resistance exercise are a rise in intrathoracic pressure via the 
Valsalva maneuver (forced expiration against a closed glottis) and the pressor response 
(132;133). In general, the magnitude of the hypertensive response to resistance exercise is 
related to both the intensity of the contraction and the amount of muscle mass activated 
(132;133). 
 There is some evidence to suggest that post-exercise hypotension occurs 
following an acute bout of resistance exercise; however, these findings are equivocal 
(10;117). For example, Hill and colleagues (134) investigated the effects of 11- to 18-
minutes of resistance exercise on post-exercise hypotension in young, normotensive 
individuals (N = 6; baseline resting arterial BP = 119 ± 4/86 ± 4 mmHg) and reported a 
statistically significant decrease in diastolic BP (approximately 11 mmHg) for up to 1-
hour post-exercise. Furthermore, Fisher (135) investigated the effects of an acute bout of 
resistance exercise on post-exercise BP in normotensive (n = 9; age = 45.3 ± 2.3 years; 
baseline resting arterial BP = 106 ± 3/70 ± 2 mmHg) and borderline hypertensive (n = 7; 
age = 47.6 ± 2.5 years; baseline resting arterial BP = 128 ± 4/83 ± 2 mmHg) individuals 
and found that systolic BP was lower (approximately 4 mmHg to 5 mmHg) at 60-minutes 
post-exercise than at any other time point. In contrast, however, a study conducted by 
O’Connor and colleagues (136) examined the effects of 30-minutes of resistance exercise 
on ambulatory BP for up to 2-hours post-exercise in young, female university students (N 
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= 14; age = 22.6 ± 3.9 years; baseline resting arterial BP = < 120/80 mmHg), and found 
no post-exercise hypotensive response. It has been stated that any observed reductions in 
BP following resistance exercise may simply be attributed to the sudden reperfusion of 
the previously occluded working muscle mass (117;132). 
Acute Isometric Exercise 
 Acute bouts of isometric exercise (sustained voluntary contraction of a muscle) 
result in the occlusion of blood flow to the working muscle via mechanical compression 
of the vasculature (137). This induces the pressor reflex, originating in sensory receptors 
which are sensitive to ischemic metabolites generated during the muscle contraction, and 
in an attempt to ensure adequate blood flow to the exercising muscle, increases SNS 
activity, which causes a resultant increase in HR and CO (137). BP is further augmented 
if the Valsalva maneuver is executed, as this leads to increased intrathoracic pressure 
(138).  
 The increase in BP as a result of acute isometric exercise is far greater than the BP 
needed to meet the metabolic costs of the exercise (139), and is dependent upon both the 
size of the contracting muscle mass and the duration of the isometric contraction (139). 
Increases in mean arterial BP of approximately 10 mmHg to 50 mmHg have been 
reported during an acute bout of isometric exercise (140;141). Furthermore, Davies and 
colleagues (142) reported increases in systolic BP and diastolic BP of 43 mmHg and 34 
mmHg, respectively, in individuals (N = 10; age = 22.0 ± 1.0 years; baseline resting 
arterial BP = 120 ± 3/65 ± 2 mmHg) performing isometric ankle plantar-flexion at 40% 
of maximal voluntary contraction (MVC) in conjunction with isometric handgrip (IHG) 
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exercise at 40% MVC. Wiley and colleagues (143) also investigated the acute changes in 
BP during a 2-minute IHG contraction at 30% MVC, using the dominant arm, in healthy, 
normotensive individuals (n = 8; aged 20- to 35-years; baseline resting arterial BP = 134 
± 1/87 ± 2 mmHg), and found mean increases in systolic BP of approximately 17 mmHg 
and diastolic BP of approximately 16 mmHg. In general, the HR and BP increases seen 
with acute isometric exercise exceed those of dynamic exercise when duration, intensity, 
and active muscle mass are similar (139).  
The effect of acute isometric exercise on post-exercise hypotension has been 
understudied and thus remains relatively unknown. However, a recent study conducted 
by Millar and colleagues (144) in healthy, older subjects (N = 18; age = 70.0 ± 5.0 years; 
baseline resting arterial BP = 125 ± 8/74 ± 4 mmHg), examined the effects of an acute 
bout of IHG exercise (four, 2-minute bilateral contractions (alternating hands) at 30% 
MVC, separated by 1-minute rest periods) on post-exercise BP and found a significant 
reduction in systolic BP of approximately 3 mmHg. 
1.2.2 Effects of Chronic Exercise on Arterial Blood Pressure 
Aerobic Exercise Training 
 Numerous thoroughly conducted meta-analyses of randomized controlled trials 
investigating the effects of aerobic exercise training on resting BP have been performed. 
An early meta-analysis conducted by Halbert and colleagues (114), comprised of 29 
randomized controlled trials involving 1533 hypertensive and normotensive individuals 
(aged 18- to 79-years) undergoing a minimum of 4-weeks of aerobic exercise training, 
found post-training reductions in systolic BP and diastolic BP of approximately 5 mmHg 
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and 3 mmHg, respectively. Another meta-analysis, conducted by Kelley and Kelley 
(145), involved 47 randomized controlled trials and 2543 participants (age = 47.4 ± 15.6 
years), and found significant reductions in systolic BP and diastolic BP in both 
hypertensive and normotensive participants. Hypertensive participants (baseline resting 
arterial BP = ≥ 140/90 mmHg) experienced post-training reductions in systolic BP of 6 
mmHg and diastolic BP of 5 mmHg, while normotensive participants (baseline resting 
arterial BP = < 140/90 mmHg) experienced post-training reductions in systolic BP and 
diastolic BP of 2 mmHg and 1 mmHg, respectively. More recently, a meta-analysis 
conducted by Whelton and colleagues (146) included 54 randomized controlled trials 
involving 2419 participants (aged 21- to 79-years; baseline resting arterial BP = 127/77 
mmHg), and concluded that aerobic exercise training was associated with a significant 
reduction in systolic BP of approximately 4 mmHg and diastolic BP of approximately 3 
mmHg in persons with and without hypertension. 
 Collectively, a number of meta-analyses support the effectiveness of aerobic 
exercise training in decreasing resting BP, despite encompassing a variety of training 
modalities (walking, running, cycling), frequencies (1- to 7-days per week), durations 
(30- to 60-minutes), intensities (30% to 90% of maximal oxygen reserve), and training 
intervention lengths (4- to 52-weeks) (10). Overall, hypertensive individuals exhibit 
average post-training reductions of approximately 7 mmHg and 6 mmHg for systolic BP 
and diastolic BP, respectively, whereas normotensive individuals show average post-
training reductions of approximately 3 mmHg and 2 mmHg for systolic BP and diastolic 
BP, respectively (10). It was concluded that the effects of aerobic exercise training on BP 
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reduction are minimally affected, if at all, by exercise frequency, intensity, mode, or 
duration (10;114;145;146).  
 The specific mechanisms underlying aerobic exercise training-induced reductions 
in resting BP remain speculative; however, it is thought that the primary mechanism 
through which resting BP is reduced following aerobic training is through a decrease in 
TPR, as chronic aerobic exercise training does not typically induce changes in CO (10). 
Modifications in neural and hormonal factors may lead to changes in BP following 
aerobic exercise training. As mentioned in section 1.1.2 Arterial Blood Pressure 
Regulation: Hormonal Regulation of Arterial Blood Pressure, sympathetic nerve 
activity and the subsequent release of norepinephrine mediates vasoconstriction and leads 
to increased vascular resistance (10). Aerobic training-induced reductions in basal SNS 
activity and circulating norepinephrine may attenuate vasoconstriction and therefore lead 
to reductions in resting BP (10;147;148). Other possible mechanisms underlying post-
aerobic training reductions in BP include structural adaptations, such as increased lumen 
diameter, as well as functional changes, such as desensitization of norepinephrine 
receptors (10), increased nitric oxide availability and release (a potent vasodilator) 
(10;149), and/or reduced endothelin-1 levels (a potent vasoconstrictor) (150). 
Furthermore, vascular changes such as improved endothelium-dependent vasodilation 
may be an important aerobic exercise training adaptation that leads to reductions in 
systemic peripheral resistance (10;151;152). As well, improvements in HR variability 
following aerobic exercise training, an index of autonomic modulation, suggest a 
reduction in sympathetic modulation and a concurrent increase in vagal modulation, and 
may therefore have an effect on aerobic training-induced reductions in BP (153). Finally, 
40 
 
M.H.K Thesis – M. Badrov                                   Windsor – Applied Human Performance 
 
genetics may also play a role in aerobic exercise training-induced reductions in resting 
BP (10).  
Resistance Exercise Training 
 Randomized controlled trials investigating the effects of resistance exercise 
training on resting BP have resulted in conflicting findings, and thus, the effects of 
resistance exercise training on resting BP remain equivocal (10). For example, a study 
conducted by Harris and Holly (154) investigated the effects of a 9-week circuit 
resistance exercise training program on resting BP in hypertensive individuals (N = 26; 
age = 32.7 ± 5.2 years; baseline resting arterial BP = 142 ± 8/91 ± 6 mmHg) and reported 
post-training reductions in diastolic BP of 5 mmHg. In contrast, Cononie and colleagues 
(155) investigated the effects of a thrice-weekly, 6-month circuit resistance training 
program in individuals with normal or slightly elevated resting BP (N = 56; age = 72.0 ± 
2.6 years; baseline resting arterial BP = 132 ± 16/78 ± 9 mmHg) and found no significant 
post-training changes in resting diastolic BP. Systolic BP also remained unaltered 
following training (155). 
 A recent meta-analysis (156) examining the effects of chronic resistance training 
on resting BP, however, reported average reductions in resting systolic BP and diastolic 
BP of 3 mmHg and 3 mmHg, respectively, in individuals with and without hypertension. 
This meta-analysis included 320 participants (age = 47.2 ± 20.9 years; baseline resting 
arterial BP = 125 ± 14/76 ± 10 mmHg) from 11 different studies that utilized a variety of 
resistance training regimens of varying lengths (6- to 30-weeks), frequencies (two to five 
sessions per week), sets per session (one to four sets), number of exercises performed per 
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session (six to 14 exercises), intensities (30% to 90% of 1-repetition maximum), and 
duration of exercise (20- to 60-minutes per session). The overall results of this study 
suggest that chronic resistance exercise training results in small, albeit beneficial, 
reductions in resting BP (156). For example, it has been shown that small reductions in 
systolic BP and diastolic BP, similar to values reported in this meta-analysis, have 
resulted in a decreased risk of stroke and CAD (157). 
 The specific mechanisms responsible for the reductions in resting BP following 
resistance exercise training remain elusive; however, they are thought to be similar to 
those seen with aerobic exercise training. As such, post-resistance exercise training 
reductions in resting BP are speculated to be mediated through vascular, structural, 
functional, and/or neurohumoral changes in TPR, as long-term resistance exercise 
training minimally alters CO (10).  
Isometric Exercise Training 
 Despite the known importance of regular physical activity, as outlined in sections 
1.2.2 Effects of Chronic Exercise on Arterial Blood Pressure: Aerobic Exercise 
Training and 1.2.2 Effects of Chronic Exercise on Arterial Blood Pressure: 
Resistance Exercise Training, many individuals are not meeting current physical 
activity guidelines (99;158;159). A 2011 Canadian Health Report highlights this 
disturbing trend in Canadian individuals, providing evidence that only 15% of adults 
(17% of men; 14% of women) are meeting current physical activity requirements (99). 
As such, and as mentioned previously in section 1.2.2 Recommendations for the 
Treatment of Hypertension, pharmacotherapy is often required in addition to exercise 
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training to adequately control resting BP to optimal values (101). However, due to poor 
effectiveness of, and/or poor adherence to anti-hypertensive medications, as well as to 
traditional exercise training regimens, many individuals are not successfully treated to 
target resting BP values (160;161). Furthermore, and of concern, research has 
demonstrated that approximately 50% of individuals medicated for hypertension may still 
maintain elevated levels of resting BP (162). 
 Thus, the ineffectiveness of currently recommended hypertension therapies has 
necessitated the need to investigate novel and complementary therapeutic modalities. 
Isometric exercise training has garnered little attention for its positive effects on resting 
BP despite a growing body of evidence demonstrating its benefits (163;164). Currently, 
there are no endorsed guidelines for isometric exercise training. Over the last decade, a 
novel form of isometric exercise training, IHG training, has demonstrated, through a 
number of small-scale investigations, to be a simple, time-efficient, and effective method 
of lowering resting BP in individuals with and without high BP (140;143;165-170). IHG 
training is a form of exercise where participants perform multiple, timed, constant 
contractions on a programmed handgrip dynamometer at a set percentage of their MVC 
(140;143;165-170). The use of IHG exercise as a tool to lower resting BP started out as 
serendipity in science. The General Dynamics F-16 Fighting Falcon was a jet fighter 
aircraft used as the main weapon for the United States Air Force. However, its extreme 
acceleration created significant G-forces that caused pilots to black out and/or experience 
vision loss as a result of lack of blood supply to the brain. As such, the United States Air 
Force instilled the help of Dr. Ronald Wiley, a noted cardiopulmonary physiologist, to 
find out how pilots could increase their BP and withstand these high G-forces. Dr. Ronald 
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Wiley designed a handgrip device that pilots could squeeze (i.e., isometric contraction) to 
increase their BP sufficiently to maintain adequate blood flow to the brain while flying. 
However, over time, Dr. Ronald Wiley observed that many pilots who used the handgrip 
device experienced a marked decrease in their resting BP (personal communication). 
 Current interest in IHG exercise as a means to lower resting BP is largely based 
upon a pioneering study that investigated the effect of whole-body isometric exercise 
training on resting BP. The study, conducted by Kiveloff and Huber (164), observed 
decreases in systolic BP of 4 mmHg to 28 mmHg and decreases in diastolic BP of 2 
mmHg to 14 mmHg in unmedicated hypertensives following 5- to 8-weeks of thrice 
weekly isometric exercise training consisting of 30-, 10-, and 6-second isometric 
contractions of the extremities, abdominal muscles, and buttocks. However, the lack of 
standardization and quantification of the exercise stimulus in their study precluded 
drawing conclusions about the efficacy of isometric exercise training (143). In 
accordance with these findings, Buck and Donner (163) provided further evidence of a 
beneficial effect of isometric exercise on resting BP. Observational data from their 
epidemiological study found that in a sample of 4273 men (aged 20- to 65-years; baseline 
resting diastolic BP = < 90 mmHg), moderate or heavy occupational isometric exercise 
was associated with a reduced incidence of hypertension. 
 In the first series of investigations utilizing handgrip dynamometers, Wiley and 
colleagues (143) completed two related studies in which they developed and investigated 
two IHG exercise protocols. In the first study, a randomized control trial, 17 participants 
(aged 20- to 35-years; resting baseline arterial BP = 134 ± 1/87 ± 2 mmHg) with high-
normal resting BP trained 3-days per week for 8-weeks, performing four, 2-minute 
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unilateral contractions with the dominant hand at 30% MVC, separated by 3-minute 
periods of rest. Training resulted in reductions in systolic BP of 13 mmHg and diastolic 
BP of 15 mmHg. In the second study, a prospective cohort study, borderline hypertensive 
individuals (n = 10; aged 29- to 52-years; baseline resting arterial BP = 127 ± 2/86 ± 2 
mmHg) trained 5-days per week for 5-weeks, performing four, 45-second bilateral 
contractions (alternating hands) at 50% MVC, separated by 1-minute rest periods. 
Following training, systolic BP and diastolic BP decreased by 10 mmHg and 9 mmHg, 
respectively, with resting BP returning to pre-study baseline values following 5-weeks of 
detraining.  
 Ray and Carrasco (140) provided further support for the effectiveness of IHG 
training in reducing resting BP in normotensive individuals (143). Ray and Carrasco, in a 
randomized control trial, implemented an IHG exercise protocol in which healthy, 
normotensive participants (n = 17; aged 19- to 35-years; baseline resting arterial BP = 
116 ± 3/67 ± 1 mmHg) completed four, 3-minute unilateral contractions with the 
dominant hand at 30% MVC, separated by 5-minute periods of rest, 4-days per week for 
5-weeks. IHG training resulted in significant reductions in mean arterial BP of 4 mmHg 
and diastolic BP of 5 mmHg. A decrease in systolic BP of 3 mmHg following IHG 
training was found, although this value was non-significant. Furthermore, McGowan and 
colleagues (165) also examined healthy, normotensive individuals (N = 11; age = 27.5 ± 
14.2 years; baseline resting arterial BP = 119 ± 7/65 ± 7 mmHg), and in a prospective 
cohort trial, demonstrated that IHG training was associated with a decrease in systolic BP 
of 5 mmHg. In this study, IHG exercise consisted of four, 2-minute unilateral 
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contractions with the non-dominant hand at 30% MVC, each separated by 4-minute 
periods of rest, and completed 3-days per week for 8-weeks.  
To date, the strongest evidence available for IHG training-induced reductions in 
resting BP are from an investigation completed by Millar and colleagues (167). To date, 
IHG research has focused on the use of relatively expensive digital handgrip devices as a 
training stimulus. The purpose of this study was to examine the potential hypotensive 
effects of IHG training using an inexpensive spring-loaded handgrip training device. This 
randomized controlled trial sampled unmedicated, normotensive participants (N = 49; age 
= 66.4 ± 1.0 years; baseline resting arterial BP = 122 ± 3/70 ± 1 mmHg). To match 
resistance levels with the established intensity levels used in past IHG training research 
(143;170), participants were given a spring handgrip trainer with a resistance level that 
approximated 30% to 40% MVC. Participants completed four, 2-minute bilateral 
contractions (alternating hands), separated by 1-minute of rest, 3-days per week for 8-
weeks. Following training, significant reductions were found in both resting systolic BP 
and diastolic BP of 10 mmHg and 3 mmHg, respectively. This study also yielded an 
important finding; women, who have been greatly under-represented in previous IHG 
literature, achieved greater post-training reductions in resting BP in comparison to men, a 
novel observation.  
The benefits of IHG in clinical populations was first explored by Taylor and 
colleagues (170), who, in a randomized control trial, investigated the effects of an 
extended training time (10-weeks) in a sample of older, hypertensive individuals (N = 
17), some of whom were on medication to treat their high BP. Participants randomized to 
the IHG training group (n = 9; age = 69.3 ± 6.0 years; baseline resting arterial BP = 156 ± 
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9/82 ± 9 mmHg) trained 3-days per week, performing four, 2-minute bilateral 
contractions (alternating hands) at 30% MVC, separated by 1-minute periods of rest. 
Training resulted in decreases in systolic BP of 19 mmHg, diastolic BP of 7 mmHg, and 
mean arterial BP of 11 mmHg. Similarly, a longitudinal cohort study conducted by Peters 
and colleagues (169) examined unmedicated, hypertensive individuals (N = 10; age = 
52.0 ± 5.0 years; baseline resting arterial BP = 146 ± 11/90 ± 7 mmHg) and the effects of 
a 3-day per week, 6-week IHG training program on resting BP. IHG exercise consisted of 
four, 45-second bilateral contractions (alternating hands) at 50% MVC, separated by 1-
minute periods of rest. Following IHG training, participants experienced a reduction in 
systolic BP of 13 mmHg. 
 Reductions in resting BP following IHG training in hypertensives were replicated 
by McGowan and colleagues (166) in a longitudinal cohort study involving medicated 
hypertensive participants (N = 17) who were randomized to either bilateral (n = 7; age = 
62.7 ± 4.2 years; baseline resting arterial BP = 134 ± 5/73 ± 3 mmHg) or unilateral (n = 
9; age = 66.1 ± 6.3 years; baseline resting arterial BP = 142 ± 4/80 ± 4 mmHg) IHG 
training. Participants randomized to the bilateral IHG training group trained 3-days per 
week for 8-weeks, performing four, 2-minute contractions (alternating hands) at 30% 
MVC, separated by 1-minute rest periods. Participants randomized to the unilateral IHG 
training group trained 3-days per week for 8-weeks, performing four, 2-minute unilateral 
contractions with their non-dominant hand at 30% MVC, separated by 4-minute periods 
of rest. Bilateral IHG training led to reductions in systolic BP of 15 mmHg, while 
unilateral IHG training led to reductions in systolic BP of 10 mmHg. To date, this is the 
only IHG training study to offer comparative data between bilateral and unilateral IHG 
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training protocols. Further research is required to determine if any differences exist in the 
magnitude of BP attenuation between the two protocols.  
More recently, Millar and colleagues (171) provided further evidence for a 
hypotensive effect following IHG training in a non-randomized cohort design, in which 
individuals medicated for high BP (n = 13; age = 65.0 ± 6.0 years; baseline resting 
arterial BP = 125 ± 12/78 ± 2 mmHg) trained 3-days per week for 8-weeks. IHG exercise 
consisted of four, 2-minute unilateral contractions of the non-dominant hand at 30% 
MVC, separated by 4-minute rest periods. IHG training resulted in a decrease in systolic 
BP of 5 mmHg and mean arterial BP of 3 mmHg. In contrast, a recent study conducted 
by Stiller-Moldovan and colleagues (172) did not find a reduction in resting BP following 
IHG training in medicated hypertensives. However, it is important to note that 
participants in this study were successfully treated with pharmacotherapy to within the 
normal range of resting BP (i.e., ≤ 120/80 mmHg). This randomized control trial sampled 
25 medicated hypertensive individuals, 13 of which (age = 60.0 ± 8.5 years; baseline 
resting arterial BP = 114 ± 13/61 ± 12 mmHg) trained 3-days per week for 8-weeks, 
performing four, 2-minute bilateral (alternating hands) contractions at 30% MVC, 
separated by 1-minute periods of rest. As mentioned, indices of resting BP were not 
significantly altered following IHG training in this well-managed sample of 
hypertensives. 
Additional evidence supporting the use of IHG exercise as a tool to reduce resting 
BP in hypertensive individuals was found in a summative analysis, performed by Millar 
and colleagues (173), of IHG training studies conducted by Taylor and colleagues (170) 
and McGowan and colleagues (174;175). Data from hypertensive individuals (N = 43; 
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age = 66.0 ± 1.0 years; baseline resting arterial BP = ≥ 130/80 mmHg), the majority of 
whom were medicated, were consolidated for analyses from three methodologically 
linked studies carried out over 4-years (170;174;175). All participants completed IHG 
training 3-days per week for 8- to 10-weeks. Participants completed either unilateral (n = 
27; using the non-dominant hand) or bilateral (n = 16; alternating hands) IHG training 
consisting of four, 2-minute contractions at 30% MVC, separated by 1-minute (bilateral) 
or 4-minute (unilateral) periods of rest. This multilevel analysis reported reductions in 
both systolic BP and diastolic BP of approximately 6 mmHg and 3 mmHg, respectively. 
The small-scale trials described above provide convincing evidence of the 
hypotensive effects of IHG training in both normotensive and hypertensive populations 
(140;143;165-170). A recent meta-analysis by Kelley and Kelley (176) reaffirms these 
findings. The meta-analysis included normotensive (n = 25; baseline resting arterial BP = 
122 ± 14/70 ± 7 mmHg), prehypertensive (n = 8; baseline resting arterial BP = 134 ± 3/87 
± 6 mmHg), and hypertensive individuals (n = 9; baseline resting arterial BP = 156 ± 
9/82 ±  9 mmHg), aged 20- to 80-years, (143;167;170) who completed 8- to 10-weeks of 
thrice-weekly IHG training consisting of four, 2-minute bilateral (alternating hands) or 
unilateral (dominant hand) contractions at 30% to 40% MVC, separated by 1- to 3-minute 
periods of rest. This meta-analysis concluded that IHG training is effective in reducing 
systolic BP and diastolic BP by 13 mmHg and 8 mmHg, respectively. These results 
demonstrate the high clinical significance that IHG training may have for patients with 
hypertension. 
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While studies on the effects of IHG training on resting BP have consistently 
demonstrated hypotensive effects (140;143;164-167;169-171;173-176), the mechanisms 
associated with these IHG training-induced reductions in resting BP remain equivocal. 
Hypertension is associated with dysfunction of vagal HR modulation (i.e., reduced HR 
variability) (177), reduced baroreflex function (178), increased sympathetic activation 
(77;78), vascular inflammation and endothelial dysfunction (35), resistance vessel 
remodeling (179), increased oxidative stress (180), and elevated reactive oxygen species 
(181). As such, hypothesized mechanisms have included improved endothelium-
dependent vasodilation, improvements in the modulation of the ANS, improved central 
arterial compliance, alterations in oxidative stress, and improved hormonal control. 
 Hypertension is associated with endothelial dysfunction (35), a condition 
characterized by the reduced formation and/or bioavailability of nitric oxide, a potent 
endothelium-derived vasodilator, which causes a subsequent impairment in endothelium-
dependent vasodilation (182-184). It has been hypothesized that increased systemic shear 
stress via the pressor response during IHG exercise may enhance the release of 
endothelium-derived nitric oxide and improve endothelium-dependent vasodilation, thus 
lowering resting BP via a decrease in systemic peripheral resistance (166). McGowan and 
colleagues (166), who reported reductions in systolic BP of 15 mmHg with bilateral IHG 
training and 10 mmHg with unilateral IHG training, investigated the effects of IHG 
training on endothelium-dependent vasodilation in medicated hypertensive individuals 
and found that bilateral IHG training improved brachial artery flow-mediated dilation in 
both arms, whereas unilateral IHG training only improved brachial artery flow-mediated 
dilation in the trained arm. These findings were replicated in a similar study conducted by 
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McGowan and colleagues (174) in the same population, where unilateral IHG training 
once again resulted in improved brachial artery flow-mediated dilation in the exercised 
limb only. Additionally, endothelium-independent vasodilation remained unchanged, 
suggesting that training-induced local improvements in endothelium-dependent 
vasodilation are not due to underlying changes in the forearm vasculature (174). A 
similar study in normotensive individuals, in which IHG training led to reductions in 
systolic BP of 5 mmHg, found no significant changes in brachial artery flow-mediated 
dilation following 8-weeks of unilateral IHG training (165). Therefore, as training-
induced improvements in endothelium-dependent vasodilation were confined to the 
forearm of the IHG exercised arms only in hypertensives, and remained unchanged in 
normotensives despite reductions in resting BP, a systemic improvement in endothelial 
dysfunction is not likely a mechanism by which IHG training lowers resting BP. To date 
however, examination of changes in central vascular function as a result of IHG exercise 
has not been completed.  
 As hypertension is associated with an increase in sympathetic activation (77;78) 
and a resultant shift in sympathovagal balance, reductions in BP following IHG training 
may result from favourable changes in autonomic modulation. Taylor and colleagues 
(170), who reported reductions in systolic BP, diastolic BP, and mean arterial BP of 19 
mmHg, 7 mmHg, and 11 mmHg, respectively, assessed HR variability and BP variability 
via power spectral analysis to detect changes in ANS modulation. Analysis of HR 
variability revealed an increased high frequency area and a trend towards a decrease in 
the low frequency to high frequency ratio, while analysis of BP variability revealed a 
decreased low frequency area and an increased high frequency area, providing evidence 
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of improved vagal activity and a concurrent reduction in sympathetic modulation 
following 10-weeks of IHG training in older, hypertensive individuals. IHG training-
induced alterations in resting BP may result from modifications in the baroreflex control 
of HR, potentially via downregulation of the aortic baroreflex (185). IHG training may 
also interact with the ANS to reduce central sympathetic outflow and norepinephrine 
release. Evidence exists to suggest that sympathetic outflow to the working muscle 
(muscle sympathetic nerve activity) is attenuated during bouts of IHG exercise following 
dynamic forearm training (186), perhaps due to changes in the muscle metaboreflex 
and/or mechanoreflex (147;186). Kamiya and colleagues (187) demonstrated that acute 
IHG exercise is associated with metaboreflex-mediated resetting of the baroreflex and 
increased sensitivity of the vascular sympathetic outflow arm of the baroreflex. Aerobic 
exercise training has been shown to attenuate baroreflex control of forearm vascular 
resistance (185), and thus, repetitive exposure to the IHG stimulus and the consequent 
resetting of the baroreflex may stimulate adaptations at rest. Ray and Carrasco (140) 
measured muscle sympathetic nerve activity and observed no significant changes 
following IHG training. However, it is important to note that this study investigated 
young, healthy normotensive individuals, a population with low baseline muscle 
sympathetic nerve activity. In contrast, in older individuals with hypertension, Taylor and 
colleagues (170), as noted above, found post-IHG training reductions in BP variability, 
an indirect marker of vascular sympathetic modulation. Nonetheless, improved 
neurovascular control of BP via alterations in autonomic modulation (i.e., improved vagal 
modulation of HR and its reflex control; reduced sympathetic activation) may explain the 
reductions in resting BP following IHG training. 
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Aerobic exercise training increases central arterial compliance in individuals with 
CVD, as well as in individuals who are at risk for disease development (188). As such, 
the potential exists for IHG training to improve central arterial compliance, thus 
augmenting baroreceptor sensitivity, and ultimately lowering TPR and resting BP. To 
date, no studies have investigated the effects of IHG training on central arterial 
compliance. 
Chronic elevations in resting systolic BP and diastolic BP are associated with 
increased oxidative stress (180) and elevated levels of reactive oxygen species (181), 
which are thought to play a role in vascular damage and the pathophysiology of 
hypertension (189). Furthermore, increased oxidative stress causes sympatho-excitation, 
endothelial dysfunction, and the remodeling of resistance vessels, all of which are 
common in individuals with hypertension (35;77). To date, only one IHG training study 
has investigated the effects of IHG training on markers of oxidative stress (169). As 
mentioned previously, Peters and colleagues (169) reported a decrease in systolic BP of 
13 mmHg following IHG training, and this was accompanied by improvements in resting 
whole blood glutathione to oxidized glutathione ratios (+ 61%), as well as a significant 
reduction in exercise-induced reactive oxygen species (− 266%). Reactive oxygen species 
reacts with nitric oxide to form peroxinitrate, which reduces the bioavailability of nitric 
oxide (190;191). Therefore, reduced oxidative stress may lower resting BP via a 
reduction in TPR, as a result of improved endothelium-dependent vasodilation and 
reduced sympathetic outflow. As such, increased antioxidant production may be a 
potential mechanism in the observed hypotensive effects of IHG training. 
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 Reductions in circulating catecholamines and/or the sensitivity of norepinephrine 
receptors, and/or changes in the renin-angiotensin system may also contribute to the 
observed reductions in resting BP following IHG training. As norepinephrine inhibits 
vagal modulation of sinoatrial node discharge, a reduction in cardiac norepinephrine may 
elicit augmented reflex vagal modulation of HR via the withdrawal of this inhibition 
(192). 
There have been several hypothesized mechanisms implicated in the training-
induced hypotensive effects of IHG training including improvements in endothelium-
dependent vasodilation, improvements in the modulation of the ANS, improved central 
arterial compliance, beneficial alterations in oxidative stress, and improved hormonal 
control. However, to date, only a small number of studies have investigated potential 
mechanisms responsible for the reductions in resting BP. 
While a reduction in systemic vascular resistance (TPR) through the above-
described mechanisms is a probable contributor to the reductions in resting BP following 
IHG training, alterations in CO as a result of IHG training cannot be ruled out as a 
potential mechanism. Currently, the effects of IHG training on CO are unknown; 
however, resting HR has not been shown to decrease following IHG training. Further 
highlighting the difficulty in ascertaining the mechanisms responsible for modest 
reductions in resting BP, Wiles and colleagues (193) reported no significant changes in 
CO, SV, or TPR following isometric leg training, even though reductions in systolic BP 
and diastolic BP were found.  
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While there are many hypothesized mechanisms, it may be that small alterations 
in multiple pathways are responsible for the reduction in resting BP following IHG 
training. Furthermore, specific mechanisms responsible for the change may be related to 
the individual pathology of each patient. As such, further research is needed to 
conclusively determine the exact mechanisms responsible for the reductions in resting BP 
following IHG training. 
1.2.3 Universality of Isometric Handgrip Training Response 
Although numerous small-scale investigations provide support for the efficacy of 
IHG training in reducing resting BP in both individuals with and without hypertension, 
the effect is not consistent across participants within or between IHG training studies 
(140;143;165-170;174-176). For example, some individuals experience large and 
dramatic decreases in resting BP, whereas others show little or no change (173). As such, 
Millar and colleagues (168) investigated data from three previously conducted IHG 
training studies and used hierarchical linear modeling to investigate inter-individual 
differences in IHG training effects (i.e., reductions in resting BP), as reflected by 
differences in trajectories of BP change within individuals over time. Results of this 
hierarchical linear modeling analysis indicated that the trajectories, or slopes, of BP 
change over the 8-week IHG training period were not uniform across participants, 
indicating a lack of consistency in the stimulus response to IHG exercise training. They 
demonstrated a significant correlation between high baseline systolic BP and greater 
attenuations in resting systolic BP following IHG training (r = − 0.67). Furthermore, 
there is evidence to suggest that approximately 30% of individuals do not respond to IHG 
exercise training with a reduction in resting BP, an observation that may be related to the 
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use of anti-hypertensive medications (165;166;174). The large inter-individual variability 
in IHG training responses is consistent with those observed with more traditional forms 
of exercise training, in which it has been found that marked individual differences exist in 
the responsiveness to exercise training that may be related to specific pathological and 
genetic profiles (194). 
1.3 Cardiovascular Stress Reactivity and Hypertension  
1.3.1 Cardiovascular Stress Reactivity 
 One area of study investigating the inter-individual variability observed with IHG 
training is that involving cardiovascular stress reactivity. Cardiovascular stress reactivity 
is the responses of cardiovascular measures, such as systolic BP, diastolic BP, and HR, 
elicited by the body in response to physical and/or mental stressors (195). The 
cardiovascular response to these stressors is typically quantified in a laboratory setting, 
where the difference between measurements of the peak BP and HR obtained during an 
individual’s exposure to the stress task and a preceding baseline measurement are used 
(195). Cardiovascular stress reactivity testing has shown high inter-individual variability 
in the cardiovascular responses evoked from stress task exposure that are thought to be a 
consequence of the type of stress, as well as individual genetics and pathology (196). 
Cardiovascular stress reactivity to tasks such as cold-pressor, mental arithmetic (serial 
subtraction), and isometric exercise have been used in two prominent areas: 1) predicting 
future values of resting BP and risk of hypertension (197;198), and 2) predicting the 
effectiveness of IHG training (i.e., reductions in resting BP) (199).  
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Cold-Pressor Task 
 The cold-pressor task has been used extensively in cardiovascular reactivity 
research to assess the function of the sympathetic branch of the cardiovascular system, by 
observing the cardiovascular responses (i.e., systolic BP, diastolic BP, and HR response) 
during immersion of a peripheral limb (i.e., hand or foot) in cold water (200). Although 
several protocols exist for the cold-pressor task, it most commonly requires participants 
to immerse a peripheral limb (i.e., hand or foot) in a cold water bath (~ 4 ± 1°C) for a 
period of 2- to 10-minutes (199). The body’s reaction to this task elicits increases in 
systolic BP and diastolic BP, as well as HR (197;201-204). For example, Kline and 
colleagues (203) sampled normotensive individuals (N = 154; aged 17- to 25-years; 
baseline resting arterial BP = < 120/80 mmHg) who underwent a cold-pressor task in 
which they immersed their left foot in a 4°C mixture of ice and water for 100-seconds, 
and found task-induced increases in systolic BP of 20 ± 10 mmHg, diastolic BP of 16 ± 8 
mmHg, and HR of 14 ± 12 beats per minute. Furthermore, Greene and colleagues (205) 
investigated the cardiovascular responses to a cold-pressor task in normotensive (n = 10; 
age = 35.7 ± 11.5 years; baseline resting arterial BP = 122 ± 13/73 ± 9 mmHg) and 
hypertensive (n = 8; age = 44.1 ± 5.4 years; baseline resting arterial BP = 172 ± 23/102 ± 
12 mmHg) individuals. The cold-pressor task required participants to immerse their hand 
in 4°C water for a period of 60-seconds. The task elicited increases in systolic BP and 
diastolic BP of approximately 23 mmHg and 20 mmHg, respectively, in the normotensive 
individuals, and approximately 32 mmHg and 18 mmHg, respectively, in the 
hypertensive individuals. More recently, Millar and colleagues (199) studied the 
cardiovascular responses (i.e., systolic BP, diastolic BP, and HR response) to a 2-minute 
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cold-pressor task (4 ± 1°C) using the right hand, in a group of older, normotensive 
individuals (N = 17; age = 66.0 ± 2.0 years; baseline resting arterial BP = 125 ± 4/69 ± 1 
mmHg), and found significant task-induced increases in systolic BP (28 ± 3 mmHg), 
diastolic BP (17 ± 2 mmHg), and HR (10 ± 1 beats per minute). The cold-pressor task is 
defined as a vascular-mediated arterial BP response (198;199;203;204). That is, the 
increased BP seen in response to the cold-pressor task is primarily due to the fact that it 
induces an α-adrenergic vasoconstriction, and involves both central neural and peripheral 
reflex arc modulations (198;199;203;204). Therefore, the increased BP during the cold-
pressor task is achieved mainly via increased systemic vascular resistance, and is thus, in 
a generalized sense, classified as a vascular-mediated arterial BP response 
(198;199;203;204). 
Serial-Subtraction Task 
The serial subtraction task, or mental arithmetic, is another common laboratory 
stressor used in cardiovascular stress reactivity research. The serial subtraction task most 
commonly requires individuals to mentally subtract a 2-digit number from a series of 
displayed 4-digit numbers, and respond with their answers aloud prior to the appearance 
of the next number (199). As with the cold-pressor task, the body’s reaction to this task 
elicits increases in systolic BP, diastolic BP, and HR (197;201-204). For example, a study 
by Spalding and colleagues (206) examined the systolic BP, diastolic BP, and HR 
response to a mental arithmetic task that required participants (N = 45; age = 22.2 ± 2.8 
years; baseline resting arterial BP = 119 ± 5/75 ± 5 mmHg) to answer 10, 2- and 3-digit 
multiplication and division problems, displayed every 20-seconds. They found increases 
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in systolic BP (15 ± 1 mmHg), diastolic BP (3 ± 1 mmHg), and HR (17 ± 1 beats per 
minute) as a result of the task. Furthermore, a study conducted by Nyberg and colleagues 
(207) examined the cardiovascular stress reactivity to a mental arithmetic task in 
hypertensive individuals (N = 10; age = 45.0 ± 15.1 years; baseline resting arterial BP = 
≥ 140/90 mmHg). Participants were required to subtract the number 17 from a series of 
displayed 4-digit numbers as quickly as possible for 5-minutes. Mental arithmetic was 
associated with heightened systolic BP reactivity (4% to 8% increase), diastolic BP 
reactivity (10% to 12% increase), and HR reactivity (5% to 10% increase). More 
recently, Millar and colleagues (199) examined cardiovascular reactivity to a serial 
subtraction task, which required individuals (N = 17; age = 66.0 ± 2.0 years; baseline 
resting arterial BP = 125 ± 4/69 ± 1 mmHg) to subtract a 2-digit number from 25, 4-digit 
numbers, and found significant task-induced increases in systolic BP (22 ± 3 mmHg), 
diastolic BP (16 ± 2 mmHg), and HR (19 ± 2 beats per minute). In contrast to the cold-
pressor task, the serial subtraction task is classified as a myocardial-mediated arterial BP 
stress response (198;199;203;204). The increased BP seen with the serial subtraction task 
is primarily caused by increases in CO (i.e., increased HR) via central neural modulations 
of the β-adrenergic system, without a change in systemic vascular resistance, suggesting 
that the augmented cardiovascular response is primarily myocardial in nature 
(198;199;203;204). 
Isometric Exercise 
 As with the cold-pressor task and serial subtraction or mental arithmetic tasks, 
isometric exercise is another common laboratory stressor used in cardiovascular 
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reactivity research that has shown to elicit increases in BP (both systolic BP and diastolic 
BP) and HR (197;201-204). For example, Shapiro and colleagues (208) examined 
systolic BP and diastolic BP reactivity to an IHG task involving two successive 1-minute 
contractions with the right hand at 20% MVC, in a population of healthy college students 
(N = 209; age = 20.7 ± 2.5 years; baseline resting arterial BP = 118 ± 11/70 ± 8 mmHg), 
and found increases in systolic BP of 10 ± 9 mmHg and diastolic BP of 9 ± 8 mmHg. 
Furthermore, Drummond and colleagues (209) examined the cardiovascular responses to 
a unilateral lower-limb isometric exercise (isometrically contracted right foot against an 
inflated cuff at 70% MVC) in hypertensive individuals (N = 18; age = 25.0 years; 
baseline resting arterial BP = 131/89 mmHg). Isometric exercise was associated with 
increases in systolic BP of approximately 12 mmHg, diastolic BP of approximately 9 
mmHg, and HR of approximately 11 beats per minute. The mechanism behind the 
cardiovascular response seen with isometric exercise mimics that of the serial subtraction 
task, as task-induced increases in BP are mediated via an increase in CO (i.e., increased 
HR), with little or no change in systemic vascular resistance (210).  
1.3.2 Temporal Stability of Cardiovascular Reactivity to Laboratory Stressors 
As mentioned above in section 1.3.1 Cardiovascular Stress Reactivity, 
laboratory testing of cardiovascular responses to common laboratory stressors, such as 
the cold-pressor task, serial subtraction task, and isometric exercise, has emerged as a 
definitive research field examining the supposed role of stress, as well as cardiovascular 
stress reactivity to these behavioural stimuli, in the etiology of CVD and CVD-related 
morbidity and mortality (211). Furthermore, and more recently, laboratory testing of 
cardiovascular responses to cardiovascular stress reactivity tasks have been investigated 
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to better understand the association between cardiovascular stress reactivity and the 
hypotensive effects of IHG training. A major hypothesis of this cardiovascular stress 
reactivity research is that stress tasks should elicit a characteristically individual response 
(i.e., systolic BP, diastolic BP, and HR response), differing in magnitude in relation to 
others, dependent on the mechanism of action (211). In addition, a further assumption of 
this hypothesis is the fact that cardiovascular reactivity to stress tasks should be stable 
over time and across conditions, in populations without pathological changes (211).  
Within the context of the laboratory setting, recent investigations support the 
notion that individual differences in the magnitude of BP and HR response (i.e., 
cardiovascular reactivity) are stable over time and across task conditions, supporting the 
view that cardiovascular reactivity is a stable psychophysiological trait, determined by 
genetics and pathology (202). A number of studies have investigated the temporal 
stability of inter-individual differences in cardiovascular reactivity to common laboratory 
stressors over periods of several weeks and several months, and up to several years (212-
217). The collective evidence from these studies indicates that individuals’ systolic BP 
and HR reactivity to laboratory stressors remain stable over time, as indicated by 
significant test-retest correlations, whereas diastolic BP responses are less stable over 
time, as evidenced by non-significant correlations (212-217).  
Furthermore, a study conducted by Sherwood and colleagues (211) examined the 
test-retest, or temporal stability of cardiovascular stress reactivity over a 10-year period 
to a common laboratory stressor (cold-pressor task) in healthy, young adult men (N = 55; 
aged 18- to 22-years at baseline; follow-up age = 29.0 ± 1.4; baseline resting arterial BP 
= 125 ± 10/66 ± 7 mmHg; follow-up resting arterial BP = 123 ± 9/77 ± 8 mmHg). For the 
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cold-pressor task, participants were required to immerse their foot in a cold water (4°C) 
bath for 90-seconds. The cold-pressor task was conducted in the same manner at baseline 
and follow-up testing. Cold-pressor task reactivity at baseline testing was characterized 
by significant increases in both systolic BP (20 ± 10 mmHg) and diastolic BP (16 ± 11 
mmHg), as well as HR (12 ± 11 beats per minute). At the 10-year follow-up testing, cold-
pressor task reactivity was comparable in both magnitude and pattern to the responses at 
baseline testing. Systolic BP (18 ± 13 mmHg), diastolic BP (13 ± 11 mmHg), and HR (11 
± 11 beats per minute) were all significantly increased during the cold-pressor task to 
similar levels seen at baseline. Furthermore, test-retest correlations for systolic BP and 
HR responses were highly significant, and interindividual variability in the magnitudes of 
systolic BP and HR response were comparable at baseline and follow-up testing. 
Therefore, as the cold-pressor task response was preserved, essentially unchanged, in all 
measured cardiovascular variables (i.e., systolic BP, diastolic BP, and HR) at the 10-year 
follow-up period, the study suggests that individual differences in cardiovascular 
reactivity to laboratory stressors remain stable over long periods of time, which is 
consistent with the view that cardiovascular reactivity is a stable psychophysiological 
trait (195). 
Although cardiovascular responses to laboratory stressors are thought to be a 
relatively stable trait (195;211-217), the extent to which an individual’s characteristic 
emotional state serves as a confounding influence on their cardiovascular reactivity has 
been questioned. As such, several researchers in the field of cardiovascular stress 
reactivity and hypertension have used the Trait versions of Spielberger’s State-Trait 
Anger Scale (218) and State-Trait Anxiety Inventory Form Y (219) to account for any 
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potential confounding influence of trait anger and/or trait anxiety on the cardiovascular 
responses to laboratory stressors. For example, Dishman and colleagues (204) examined 
the effects of trait anger and trait anxiety on cardiovascular responses to two laboratory 
stressors (cold-pressor task and mental arithmetic task) in normotensive and hypertensive 
individuals (N = 28; aged 19- to 39-years; resting arterial BP = < 160/90 mmHg). For the 
cold-pressor task, participants were required to immerse their right hand in an ice water 
(2 ± 1°C) bath for a period of 2-minutes. The mental arithmetic task required participants 
to orally perform serial subtraction of the number 13 from a new 4-digit number given at 
1-minute intervals during a 5-minute session. Spielberger’s State-Trait Anger Scale (218) 
and State-Trait Anxiety Inventory Form Y (219) were administered prior to the 
completion of both laboratory stress tasks. Participants’ levels of trait anger (16.4 ± 3.4) 
and trait anxiety (34 ± 8.5) were found to be within the range of population norms for 
their age (males: 19.9 ± 5.8, 32.5 ± 8.6; females: 20.0 ± 5.2, 35.7 ± 8.5), and 
cardiovascular reactivity was found to be similar to levels found in previous study. 
During the cold-pressor task, systolic BP (24 ± 3 mmHg) and diastolic BP (21 ± 2 
mmHg) were significantly increased. These responses were seen with the mental 
arithmetic task as well, as systolic BP (21 ± 3 mmHg) and diastolic BP (12 ± 2 mmHg) 
were increased. Additionally, the effects of acute stress (i.e., state anxiety) and chronic 
stress (i.e., trait anxiety) on cardiovascular reactivity measures were examined in 
hypertensive individuals by Steptoe and colleagues (220). Hypertensive male participants 
(N = 12; age = 42.3 ± 2.7 years; baseline resting arterial BP = 146 ± 13/95 ± 12 mmHg) 
completed the State-Trait Anxiety Inventory Form Y (219), prior to the performance of a 
laboratory stressor (stroop test). The stroop test required participants to name first the 
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colour, and then the word, of a sequence of colours and words that were presented via 
slides, and resulted in average increases in systolic BP of approximately 23 mmHg and 
diastolic BP of approximately 13 mmHg. Analysis of state anxiety and trait anxiety 
revealed no relationship between State-Trait Anxiety Inventory Form Y (219) test scores 
and systolic BP or diastolic BP reactivity. These collective results suggest that when 
levels of state anger, state anxiety, and trait anxiety (in both normotensive and 
hypertensive populations), as measured via the Trait versions of Spielberger’s State-Trait 
Anger Scale (218) and State-Trait Anxiety Inventory Form Y (219), are within the 
established population norms, individual cardiovascular reactivity is reflective of their 
true pattern of cardiovascular response. 
Furthermore, Young and colleagues (221) used data from the longitudinal 
population-based study of BP and CVD in Tecumseh, Michigan, in which data was 
collected on cardiovascular reactivity to two common laboratory stressors (mental 
arithmetic and IHG exercise) and trait anxiety in 832 adults aged 19- to 41-years. Young 
and colleagues completed cross-sectional analyses to determine the relationship between 
state and trait anxiety and the cardiovascular responses (i.e., systolic BP, diastolic BP, 
and HR responses) to mental arithmetic and IHG exercise. The mental arithmetic task 
required subjects to serially subtract a 2-digit number from a 4-digit number for a 5-
minute period, while the IHG exercise required subjects to generate an isometric 
contraction at 30% of maximal effort for 5-minutes. State and trait anxiety measures were 
attained in the same testing session as the cardiovascular stress reactivity measures. 
These measures were obtained using the State-Trait Personality Index, form X-2, which 
contains 10 items on state anxiety and 10 items on trait anxiety, and provides reliable and 
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brief scales for anxiety in research settings. For the data analyses, categories for state and 
trait anxiety were constructed based on the normal distribution in the population. All 
participants with anxiety ratings greater than one standard deviation above the mean were 
classified as “high anxiety” (n = 140; baseline resting arterial BP = 118 ± 1/73 ± 1 
mmHg), those with anxiety rating less than one standard deviation from the mean were 
classified as “low anxiety” (n = 79; baseline resting arterial BP = 119 ± 2/73 ± 1 mmHg), 
while those with anxiety ratings within one standard deviation of the mean were 
classified as “medium anxiety” (n = 613; baseline resting arterial BP = 120 ± 1/74 ± 1 
mmHg). Results indicated that baseline measures of systolic BP, diastolic BP, and HR 
did not differ between any of the three anxiety groups. Furthermore, with the mental 
arithmetic, there was no difference in systolic BP or diastolic BP reactivity between the 
three anxiety groups. Systolic BP increased to similar levels in the low anxiety (10 ± 1 
mmHg), medium anxiety (8 ± 1 mmHg), and high anxiety (8 ± 1 mmHg) groups. 
Similarly, diastolic BP increased to comparable levels in the low anxiety (7 ± 1 mmHg), 
medium anxiety (7 mmHg), and high anxiety (6 ± 1 mmHg) groups. With the IHG 
exercise task, systolic BP was essentially increased to the same levels in all three anxiety 
groups (low anxiety: 12 ± 1 mmHg; medium anxiety: 9 ± 1 mmHg; high anxiety: 7 ± 1 
mmHg); however, the effect of state anxiety on systolic BP reactivity did reach 
significant levels. As with the mental arithmetic task, diastolic BP reactivity was not 
different between anxiety groups, as diastolic BP was increased to similar levels in the 
low anxiety (9 ± 1 mmHg), medium anxiety (7 ± 1 mmHg), and high anxiety (8 ± 1 
mmHg) groups. In conclusion, and in agreement with a number of previous studies 
examining the relationship between anxiety and cardiovascular reactivity to laboratory 
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stressors (212-217;220;222-224), it appears that high anxiety levels are not associated 
with heightened cardiovascular reactivity to laboratory stressors. 
1.3.3 Cardiovascular Stress Reactivity and Future Risk of Hypertension 
 As mentioned above in section 1.3.1 Cardiovascular Stress Reactivity, 
cardiovascular stress reactivity to tasks such as cold-pressor, mental arithmetic (serial-
subtraction), and isometric exercise have been used in two prominent areas: 1) predicting 
future values of resting BP and risk of hypertension (197;198), and 2) predicting the 
effectiveness of IHG training (i.e., reductions in resting BP) (199). 
 The fact that individuals show marked variability in their cardiovascular 
responses to behavioural and cardiovascular stressors prompted speculation that 
individual differences in cardiovascular reactivity may confer increased risk for disease 
(195). The link between cardiovascular reactivity and hypertension began in the early 
1960s, when it was found that laboratory stressors evoked stereotypically large 
cardiovascular responses in individuals with hypertension, as well as in normotensive 
offspring of hypertensive individuals (225;226). While prospective studies examining the 
link between cardiovascular reactivity and future risk of hypertension have resulted in 
conflicting reports (227), investigations encompassing follow-up periods of greater than 
5-years have shown a strong association between greater cardiovascular reactivity and 
future risk of hypertension (197;228-233). Matthews and colleagues (231) tested whether 
systolic BP and diastolic BP reactivity to three tasks (cold-pressor, star tracing, and video 
game) predicted incident hypertension in young adults over the course of a 13-year 
follow-up period. In participants who developed hypertension, results indicated that the 
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greater the BP response to each of the three stress tasks, the earlier hypertension 
occurred. Most recently, Flaa and colleagues (198) published an 18-year longitudinal 
study that examined the relationship between individual differences in cardiovascular 
reactivity and development of hypertension. At entry, BP and HR were measured in 80 
healthy men at rest (age = 19.3 ± 0.4 years; baseline resting arterial BP = 126 ± 20/70 ± 
17 mmHg), during a mental arithmetic test, and during a cold-pressor task. After 18-years 
of follow-up (age = 37.3 ± 1.0 years; follow-up resting arterial BP = 131 ± 16/89 ± 10 
mmHg), resting BP was measured. Results indicated that systolic BP and diastolic BP at 
follow-up were significantly predicted by systolic BP and diastolic BP during both the 
mental arithmetic and cold-pressor task at baseline. The effects were more marked with 
the cardiovascular reactivity to the mental arithmetic than the cold-pressor task. Both 
tasks elicit marked pressor responses; however, as mentioned above in sections 1.3.1 
Cardiovascular Stress Reactivity: Serial Subtraction Task and 1.3.1 Cardiovascular 
Stress Reactivity: Cold-Pressor Task, mental arithmetic elicits a β-adrenergic response 
and causes an increase in CO, whereas the cold-pressor task induces an α-adrenergic 
vasoconstriction response, leading to increases in systemic peripheral resistance 
(196;198;198). This supports the notion that the catecholamine responses to 
psychological stress drive a hyperkinetic hemodynamic profile that contributes to 
hypertension risk (196). As sympathetic stimulation is known to be a trophic factor for 
vascular hypertrophy, hyperreactors who have frequent surges in sympathetic activity 
may develop sustained increases in TPR, which leads to the development of hypertension 
(198). 
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1.3.4 Cardiovascular Stress Reactivity and Isometric Handgrip Training 
 As mentioned in section 1.3.1 Cardiovascular Stress Reactivity, a more recent 
area of study involving cardiovascular stress reactivity is that involving cardiovascular 
responses to stress tasks and the prediction of the effectiveness of IHG exercise training 
(i.e., reductions in resting BP). Given that sustained isometric exercise represents a 
psychophysiological stressor (i.e., moderated by biological/physiological and 
behavioural/psychological processes) (199), the inter-individual differences in IHG 
training-induced reductions in resting BP may suggest that central neuroregulatory 
mechanisms representing individual differences in responsiveness to  cardiovascular 
stress may play a role in IHG training-induced hypotensive effects (199). 
 Although in its early stages of investigation, there is evidence to suggest that 
cardiovascular reactivity responses to psychological stress successfully predict the 
effectiveness of IHG exercise training (i.e., reductions in resting BP) in older, 
normotensive individuals (199). A study conducted by Millar and colleagues (199) 
examined cardiovascular stress reactivity responses to cardiovascular stressors (serial 
subtraction task and cold-pressor task) as predictors of the hypotensive effects of IHG 
training in older, normotensive individuals. Participants (N = 17; age = 66.0 ± 2.0 years; 
baseline resting arterial BP = 125 ± 4/69 ± 1 mmHg) were required to complete IHG 
training (four, 2-minute bilateral contractions (alternating hands) at 30% MVC, separated 
by 1-minute rest periods) 3-days per week for 8-weeks, followed by a 6-month detraining 
period (i.e., no IHG exercise). Following the 6-month detraining period, all participants 
underwent a testing session to monitor BP and HR responses during a 2-minute cold-
pressor task and a serial subtraction task. The cold-pressor task involved participants 
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immersing their right hands (up to the wrist) in a cold water bath (4 ± 1°C) for a period of 
2-minutes. The cold-pressor task elicited significant increases in systolic BP (28 ± 3 
mmHg), diastolic BP (17 ± 2 mmHg), and HR (10 ± 1 beats per minute). For the serial 
subtraction task, participants were presented with a sequence of 25, 4-digit numbers. 
Each number was displayed for 5-seconds, and participants were required to subtract the 
number 13 from the displayed numbers and say their answers aloud, prior to the 
appearance of the next number. The serial subtraction task elicited increases in systolic 
BP (22 ± 3 mmHg), diastolic BP (16 ± 2 mmHg), and HR (19 ± 2 beats per minute). IHG 
training-induced reductions in resting BP were strongly and inversely correlated with the 
cardiovascular responses to the serial subtraction task, but not the cold-pressor task, such 
that the greater the BP and HR increase in response to the serial subtraction task, the 
greater the post-IHG training reduction in resting BP. Taken together, this work suggests 
that the cardiovascular response to a serial subtraction task is predictive of a post-IHG 
training hypotensive response in older, normotensive individuals. These findings, if 
replicated in individuals with hypertension (i.e., resting BP ≥ 140/90 mmHg), would have 
important clinical implications for individuals living with high BP, in whom 
hypertension-related CVD risk is greatly elevated, and who do not have their resting BP 
successfully controlled to target values through lifestyle modifications and/or the use of 
pharmacotherapy (162). 
1.4 Summary of Background 
 In summary, hypertension is estimated to affect approximately 26% of the global 
population and is one of the most prevalent risk factors for the development of CVD, 
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significantly increasing the risk of all-cause mortality (3). Mainstream treatment 
guidelines for the primary and secondary prevention of hypertension include lifestyle 
modifications and/or pharmacotherapy; however, data suggests that current therapies for 
hypertension result in poor rates of BP control (160;162). Thus, the expansion of 
currently available hypertension therapies is required to increase the number of 
successfully treated individuals. IHG training represents an effective and time-efficient 
form of exercise that reduces resting BP in individuals with and without high BP. IHG 
training effects have, however, been shown to exhibit inter-individual variability, and 
given that sustained isometric exercise represents a psychophysiological stressor, 
cardiovascular stress reactivity testing may provide insight into the inter-individual 
variability observed with IHG training. Cardiovascular stress reactivity testing has been 
most commonly used to predict future risk of hypertension; however, a more recent 
application of cardiovascular stress reactivity testing involves IHG training, in which it 
was found that cardiovascular reactivity to a serial subtraction task may be predictive of a 
post-IHG training hypotensive response. This is an important finding, as it may help 
identify hypertensives who will respond to IHG training with a reduction in resting BP, 
thus increasing the number of successfully treated individuals. The rationale for the 
present study is based upon these experimental findings. It is hoped that the results of this 
research will provide preliminary support for the use of a serial subtraction task and/or a 
2-minute IHG contraction as a simple and efficacious tool to identify individuals with 
hypertension who will respond to IHG training with a reduction in resting BP, thus 
providing health care professionals an alternative, yet effective, tool for the treatment of 
hypertension in this high-risk population. 
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1.5 Thesis Objectives  
 The objective of the current study was to replicate previous findings that IHG 
training decreases resting BP in individuals with hypertension, as well as to prospectively 
test the hypotheses that: 1) cardiovascular stress reactivity responses to a serial 
subtraction task and IHG task, but not a cold-pressor task, are predictive of a post-IHG 
training hypotensive response, and 2) IHG training attenuates cardiovascular reactivity to 
psychophysiological stressors. 
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2.1 Introduction 
 Hypertension is highly prevalent worldwide and represents a major risk factor for 
all-cause and cardiovascular disease (CVD)-related morbidity and mortality (1). Current 
treatment strategies for hypertension include lifestyle modifications, such as diet and 
exercise training, as well as the use of anti-hypertensive medications (1;2). However, 
poor effectiveness and/or adherence to traditional lifestyle modifications and anti-
hypertensive therapies has resulted in inadequate rates of blood pressure (BP) control 
(3;4). A growing body of research suggests that a novel form of exercise training, 
isometric handgrip (IHG) training, is a time-efficient and effective method of lowering 
resting BP in individuals with hypertension, including those receiving pharmacotherapy 
to treat their high BP (5-9).  
 Consistent with observations from aerobic exercise training (10), IHG training 
demonstrates a high inter-individual variability in training responsiveness (i.e., reductions 
in resting BP) (6). Typically, individuals with higher pre-training BP values experience 
greater reductions following training (6). Furthermore, lower IHG training responder 
rates are seen in individuals medicated for high BP (5;11;12), an observation thought to 
be the result of overlapping mechanisms responsible for BP lowering effects.  
 It has been postulated that one way to probe inter-individual differences in 
cardiovascular regulation is to assess the acute cardiovascular responses to 
psychophysiological stressors (i.e., cardiovascular reactivity). To date, numerous large-
scale studies have reported that high cardiovascular reactivity is associated with the 
future development of hypertension and CVD (13;14), although this observation is not 
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universal (15;16). Furthermore, attenuation of cardiovascular reactivity to 
psychophysiological stressors has been implicated as a mechanism by which exercise 
training lowers CVD-related morbidity and mortality (17).   
 The utility of cardiovascular reactivity testing to probe the variability in exercise 
training responses is largely unexplored. In the only published study of IHG training and 
cardiovascular reactivity, cardiovascular reactivity to a serial subtraction task (SST), but 
not a cold-pressor task (CPT), successfully predicted retrospective effectiveness of IHG 
training in reducing resting BP in older, normotensive individuals (18). These findings, if 
replicated in individuals with hypertension (medicated and/or non-medicated), may help 
identify those who will respond to IHG training with a reduction in resting BP. In 
addition, given the potential link between heightened cardiovascular reactivity and future 
risk of hypertension (13;14), managing cardiovascular stress reactivity may be important 
in the prevention and management of hypertension and CVD. Aerobic exercise studies 
have reported reductions in cardiovascular reactivity following training interventions 
(19;20); however, at this time, the effects of IHG training on cardiovascular stress 
reactivity are unknown.   
 The purpose of the current study was to replicate previous findings that IHG 
training decreases resting BP in individuals with hypertension, as well as to prospectively 
test the hypotheses that: 1) cardiovascular stress reactivity responses to a SST and IHG 
task (IHGT), but not a CPT, are predictive of a post-IHG training hypotensive response, 
and 2) IHG training attenuates cardiovascular reactivity to psychophysiological stressors.  
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2.2 Methods 
Participants 
 Twenty-four hypertensive men (n = 13) and women (n = 11) aged 51- to 74-years 
were recruited from Windsor, Ontario, Canada. Participants had a resting systolic BP of ≥ 
140 mmHg, and/or a resting diastolic BP of ≥ 90 mmHg, and/or were receiving 
pharmacotherapy (for a period ≥ 4-months) to treat their high BP (83% of participants). 
Participants were excluded if they were normotensive, had diabetes, a paced rhythm at 
rest, frequent premature beats, heart failure, and/or had a physical limitation preventing 
them from performing IHG exercise. The University of Windsor Research Ethics Board 
approved the investigation, and all participants provided written informed consent prior 
to participation. 
Study Design 
 Upon establishment of eligibility, participants were familiarized to all testing 
procedures and randomized to an IHG training group (n = 12) or a non-exercising control 
group (n = 12). Following group assignment, all participants underwent three baseline 
testing sessions to assess resting BP and HR, as well as cardiovascular reactivity (systolic 
BP, diastolic BP, and HR response) to a SST, IHGT, and CPT. Participants completed 
one stress task at each testing session, with order of task randomized for each participant. 
All three testing sessions were repeated following 10-weeks of IHG training, or no 
training for the control group, and were conducted within 1-week of IHG training 
completion. 
108 
 
M.H.K Thesis – M. Badrov                                   Windsor – Applied Human Performance 
 
 
IHG Training Protocol 
 Participants randomized to the IHG training group trained 3-days per week for 10-
weeks, with the aid of a programmed handgrip dynamometer (ZonaPLUS; Zona Health, 
Boise, Idaho, USA). Training consisted of four, 2-minute bilateral contractions at 30% of 
maximal voluntary contraction (MVC), separated by 1-minute rest periods. One training 
session per week took place under the supervision of an exercise trainer in the Physical 
Activity and Cardiovascular Research Laboratory at the University of Windsor, while the 
remaining two sessions were completed in the participants’ home. Participants were 
provided detailed written instructions on how to complete the IHG exercise to ensure 
proper at-home training and completed training log books, in which they recorded the 
date of exercise completion, MVC scores for each training session, and the final 
compliance score (i.e., percentage of time the participant maintained 30% MVC). In all 
cases, compliance scores were ≥ 90%.  
 In comparison, non-exercising control participants underwent a 10-week non-
intervention period. To establish similar face-time with study investigators, participants 
in the non-exercising control group visited the laboratory once per week to have their 
resting BP measured (Dinamap Carescape v100, Critikon, Tampa, Florida, USA); these 
data were not used for analysis. 
 All participants in both groups were given a log book to record any changes in 
exercise, diet, and medication, and this was discussed with participants at each laboratory 
visit to ensure these potentially confounding factors remained unchanged throughout the 
10-week intervention period.  
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Experimental Protocol 
 All testing was conducted in a quiet, temperature-controlled laboratory (20-24°C) 
following a light meal, a 24-hour abstinence from vigorous exercise and alcohol, and a 
12-hour abstinence from caffeine. Participants were asked to void their bladder prior to 
the start of all testing sessions to minimize the effects of bladder distension on resting BP 
(21). All testing days were conducted within 2-hours of initial testing time of day, and 
time of medication ingestion was standardized. 
Resting Blood Pressure 
 Resting BP was measured in the brachial artery of the participants’ dominant arm 
using automated brachial oscillometry (Dinamap Carescape v100, Critikon, Tampa, 
Florida, USA), following 10-minutes of seated rest (22). Participants rested with their 
dominant arm supported at heart level and the BP cuff was placed approximately 2.5 cm 
proximal to the antecubital fossa (22). Four BP and HR measures were obtained by the 
same trained investigator following the 10-minute rest period, each separated by 2-
minutes, and the latter three measures were averaged and used in the final analysis. 
Cardiovascular Reactivity 
 During the completion of each stress task, systolic BP and diastolic BP were 
collected every minute (i.e., at minute one and minute two) using brachial artery 
oscillometry (Dinamap Carescape v100, Critikon, Tampa, Florida, USA). HR was 
collected continuously via single-lead electrocardiography. Data collection was 
completed using PowerLab acquisition equipment (PowerLab 8/30; ADInstruments Inc., 
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Colorado Springs, Colorado, USA) and LabChart software (LabChart v7.3.2, 
ADInstruments Inc., Colorado Springs, Colorado, USA). To account for the potential 
confounding influence of state- and trait-anxiety on cardiovascular reactivity responses, 
participants completed a State-Trait Anxiety Inventory Form Y prior to all testing days 
(23). 
Serial Subtraction Task 
 Participants were presented a sequence of 25, four-digit numbers on a computer 
monitor. Each number was displayed for 5-seconds. Participants were instructed to 
mentally subtract the number 13 from each number and say their answer aloud, prior to 
the appearance of the next number. At post-testing, participants were presented with a 
different sequence of 25 numbers, and were instructed to subtract the number 17 from 
each number presented. The number of correct and incorrect answers was recorded. 
Isometric Handgrip Task 
 Participants completed a single 2-minute IHG contraction at 30% MVC, using 
their non-dominant hand, on a programmed handgrip dynamometer (IBX H-101, MD 
Systems, Inc., Westerville, Ohio, USA). Participant compliance scores (i.e., percentage of 
time the participant maintained 30% MVC) were ≥ 92%. The IHGT protocol was 
identical at both pre- and post-testing. 
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Cold-Pressor Task 
 Participants immersed their right hand (up to the wrist) in a temperature-
controlled cold water bath (4 ± 1ºC) for 2-minutes. All participants completed the 2-
minute protocol. The CPT was identical at both pre- and post-testing. 
Statistical Analysis 
 The current study was powered to detect a change in resting BP and 
cardiovascular stress reactivity following IHG training. Based on mean values and 
standard deviations of resting BP and cardiovascular reactivity in hypertensive 
individuals following IHG training, with an assigned α of 0.05 and β of 0.2, a maximum 
of 12 participants per group (IHG training group, n = 12; non-exercising control group, n 
= 12) was deemed sufficient. To evaluate changes in resting systolic BP, diastolic BP, 
mean arterial BP [Diastolic BP + 1/3(Systolic BP – Diastolic BP)], pulse pressure 
[systolic BP – diastolic BP], and HR following IHG training, in comparison to the non-
exercising control group, two-way analysis of variances (group x time) were used and 
Tukey’s post-hoc procedures were completed to evaluate specific differences between 
means, where applicable. 
 Cardiovascular reactivity (systolic BP, diastolic BP, and HR responses) to the 
SST, IHGT, and CPT was calculated as the difference between the peak stress task-
induced values and the mean baseline resting values. Dependent and independent t-tests 
were used to examine whether cardiovascular reactivity differed from baseline levels and 
between stressors. To determine the relationship between cardiovascular reactivity and 
IHG training effects in the IHG training group, Pearson correlation coefficients between 
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the cardiovascular reactivity values and residualized IHG systolic BP change were 
assessed. As pre-intervention resting BP and the magnitude of BP reduction following 
IHG training have shown correlated effects (6), residualized change scores for systolic 
BP were used, and were obtained by regressing pre-post intervention changes in systolic 
BP on pre-intervention systolic BP. Changes in resting systolic BP following IHG 
training were used because of the magnitude of the reduction. 
 To determine whether cardiovascular reactivity to the SST, IHGT, and CPT was 
reduced following IHG training, in comparison to the non-exercising control group, two-
way analysis of variances (group x time) were used and Tukey’s post-hoc procedures 
were completed to evaluate specific differences between means, where appropriate. All 
data were analyzed using STATISTICA (Version 10.0; StatSoft, Inc., Tulsa, Oklahoma, 
USA) software, and statistical significance was set at P ≤ 0.05. Results are mean ± SD, 
unless otherwise specified.  
2.3 Results   
 Participant baseline characteristics are displayed in Table 1. All baseline 
participant characteristics were similar between the IHG training and non-exercising 
control groups (all P > 0.05). Adherence to the IHG training prescription was 100%. All 
participants in the IHG training group completed 30 IHG exercise sessions over the 10-
week intervention period. There were no reported changes in exercise, diet, and 
medication throughout the investigation in both the IHG training and non-exercising 
control groups. 
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Table 1. Baseline characteristics of the participants 
Characteristics 
 
IHG Training 
(n = 12) 
 
 
Control 
(n = 12) 
 
 
Sex (n) 
   Males 
   Females 
Age (years)   
Height (cm)  
Weight (kg)  
BMI (kg/m2) 
Resting SBP (mmHg)  
Resting DBP (mmHg) 
Resting MAP (mmHg) 
Resting PP (mmHg) 
Resting HR (beats·min-1) 
State-Anxiety (score /80) 
Trait-Anxiety (score /80) 
Medication classification (n) 
   ACE inhibitor 
   β-blocker 
   Calcium channel blocker 
   Diuretic 
   ACE inhibitor + β-blocker 
   ACE inhibitor + calcium channel blocker 
   ACE inhibitor + diuretic 
 
 
 
6 
6 
65 ± 7 
169 ± 9 
77 ± 13 
27 ± 4 
129 ± 16 
72 ± 9 
91 ± 11 
 58 ± 11  
68 ± 11 
29 ± 5 
30 ± 4 
 
4 
0 
1 
1 
1 
1 
2 
 
 
7 
5 
63 ± 9 
168 ± 10 
83 ± 18 
29 ± 6 
130 ± 17 
73 ± 12 
92 ± 13 
57 ± 10 
67 ± 7 
27 ± 5 
29 ± 5 
 
4 
1 
1 
0 
1 
1 
2 
SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial blood pressure; 
PP, pulse pressure; HR, heart rate; ACE, angiotensin converting enzyme. Values are mean ± SD. 
 
Effects of Isometric Handgrip Training on Resting Blood Pressure, Heart Rate, and 
Anxiety 
 IHG training resulted in significant reductions in resting systolic BP, diastolic BP, 
mean arterial BP, and pulse pressure (Figure 1). Specifically, systolic BP decreased in the 
IHG training group (129 ± 16 mmHg to 121 ± 16 mmHg, P < 0.001) compared to the 
control group (130 ± 17 mmHg to 131 ± 18 mmHg). Diastolic BP also decreased in the 
IHG training group (72 ± 9 mmHg to 67 ± 8 mmHg, P < 0.05) compared to the control 
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group (73 ± 12 mmHg to 74 ± 14 mmHg). Furthermore, IHG training decreased mean 
arterial BP (91 ± 11 mmHg to 85 ± 10 mmHg, P < 0.001) compared to the control group 
(92 ± 13 mmHg to 92 ± 13 mmHg), while pulse pressure also decreased in the IHG 
training group (58 ± 11 mmHg to 54 ± 11 mmHg, P < 0.01) compared to the control 
group (57 ± 10 mmHg to 58 ± 8 mmHg). In contrast, resting HR remained unchanged (P 
> 0.05) in both the IHG training group (68 ± 11 beats·min-1 to 68 ± 11 beats·min-1) and 
control group (67 ± 8 beats·min-1 to 68 ± 7 beats·min-1). Measures of state- and trait-
anxiety remained unchanged in both the IHG training and control groups (all P > 0.05).   
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Fig 1. Effects of 10-weeks of isometric handgrip (IHG) training on (a) systolic blood pressure, (b) 
diastolic blood pressure, (c) mean arterial blood pressure, and (d) pulse pressure. Values are mean 
± SE. *Significantly different from pre- (P < 0.05). 
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Cardiovascular Reactivity as a Predictor of Isometric Handgrip Training 
Effectiveness  
 Cardiovascular stress reactivity responses at baseline to the SST, IHGT, and CPT 
and the relationship to IHG training effects are displayed in Table 2. Specifically, in the 
IHG training group, baseline systolic BP (Figure 2a), diastolic BP, and HR reactivity to 
the SST, as well as baseline systolic BP (Figure 2b) and HR reactivity to the IHGT were 
significantly associated with IHG training-induced residualized reductions in systolic BP 
(all P < 0.05), while baseline systolic BP (Figure 2c), diastolic BP, and HR reactivity to 
the CPT showed no associations (P > 0.05). In contrast, no associations between baseline 
cardiovascular stress reactivity to the SST, IHGT, and CPT and residualized changes in 
systolic BP were found in the control group (all P > 0.05). State- and trait-anxiety were 
not significantly related to any of the cardiovascular reactivity responses to the SST, 
IHGT, or CPT in both the IHG training group and control group (all P > 0.05). 
Table 2. Baseline cardiovascular stress reactivity and the relationship to isometric handgrip 
training adaptations 
 
 ΔSBP  (mmHg) r P 
ΔDBP 
(mmHg) r P 
ΔHR  
(bpm) r P 
 
IHG  
   SST 
 
 
27 ± 13* 
 
 
− 0.82 
 
 
0.001
 
 
11 ± 8* 
 
 
− 0.68
 
 
0.016
 
 
14 ± 6* 
 
 
− 0.63
 
 
0.029
   IHGT 35 ± 16* − 0.62 0.033 16 ± 8* − 0.52 0.083 15 ± 7* − 0.78 0.003
   CPT 
Control 
   SST 
   IHGT 
   CPT 
 
31 ± 19* 
 
24 ± 8* 
32 ± 13* 
26 ± 8* 
0.37 
 
− 0.21 
0.37 
0.17 
0.232 
 
0.516 
0.241 
0.607
15 ± 8* 
 
13 ± 3* 
14 ± 3* 
14 ± 4* 
0.34 
 
− 0.26 
− 0.40 
− 0.31 
 
0.279 
 
0.419 
0.196 
0.327
5 ± 4*† 
 
16 ± 5* 
15 ± 5* 
9 ± 4*† 
− 0.03 
 
− 0.13 
− 0.00 
− 0.46 
 
0.923 
 
0.691 
0.999 
0.134
SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; SST, serial 
subtraction task; IHGT, isometric handgrip task; CPT, cold-pressor task. Values are mean ± SD. 
*Significant difference compared to baseline resting, P < 0.001. †Significant difference between 
stress tasks, P < 0.001.  
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Fig 2. Correlation analysis of systolic blood pressure (BP) reactivity to (a) serial subtraction task 
(SST), (b) isometric handgrip task (IHGT), and (c) cold-pressor task (CPT) and residualized 
changes in systolic blood pressure following 10-weeks of isometric handgrip (IHG) training. 
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Effects of Isometric Handgrip Training on Cardiovascular Reactivity 
Following IHG training, systolic BP reactivity to the SST and IHGT was 
significantly reduced in the IHG training group (P < 0.05) compared to the control group. 
Conversely, diastolic BP and HR reactivity to the SST and IHGT, as well as the 
cardiovascular reactivity to the CPT remained unchanged in both the IHG training group 
and control group (all P > 0.05). This data is presented in Table 3. 
Table 3. Cardiovascular reactivity responses pre- and post-isometric handgrip training 
 
IHG Training  
Pre-                  Post- 
Control  
 Pre-                  Post- 
     
Serial Subtraction Task     
   ΔSBP (mmHg) 27 ± 13 20 ± 8* 24 ± 8 25 ± 10 
   ΔDBP (mmHg) 11 ± 8 9 ± 5 13 ± 3 13 ± 4 
   ΔHR (bpm) 14 ± 6 12 ± 6 16 ± 5 15 ± 6 
 
Isometric Handgrip Task 
    
   ΔSBP (mmHg) 35 ± 16 27 ± 9* 32 ± 13 34 ± 14 
   ΔDBP (mmHg) 16 ± 8 14 ± 6 14 ± 3 11 ± 5 
   ΔHR (bpm) 
 
Cold-Pressor Task 
   ΔSBP (mmHg) 
   ΔDBP (mmHg) 
   ΔHR (bpm) 
15 ± 7 
 
 
31 ± 19 
15 ± 8 
5 ± 4 
12 ± 9 
 
 
27 ± 13 
14 ± 4 
5 ± 3 
15 ± 5 
 
 
26 ± 8 
14 ± 4 
9 ± 4 
15 ± 5 
 
 
24 ± 6 
11 ± 5 
9 ± 5 
          
SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate. Values are mean ± 
SD. *Significant difference compared to pre-, P < 0.05. 
 
 
2.4 Discussion 
 
 This randomized-controlled trial is the first prospective study to demonstrate that, 
in individuals with hypertension, cardiovascular reactivity responses to a SST and IHGT 
are significantly related to reductions in systolic BP following 10-weeks of IHG training. 
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Furthermore, this study demonstrated that systolic BP reactivity to both a SST and IHGT 
are attenuated following IHG training. Taken together, these findings highlight the 
promising clinical implications that IHG training may have for individuals with high BP, 
and may also provide a tool to identify hypertensive individuals who will respond to IHG 
training with reductions in resting BP.  
Effects of Isometric Handgrip Training on Resting Blood Pressure 
 The significant reductions in resting systolic BP (8 mmHg), diastolic BP (5 
mmHg), and mean arterial BP (6 mmHg) found in the present study highlight the 
robustness of the IHG training effect and are confirmatory to previous work in medicated 
and non-medicated hypertensives (5-9). An important extension of the existing work is 
our novel finding that 10-weeks of IHG training significantly decreases pulse pressure (4 
mmHg). This is a key finding, as pulse pressure has been shown to be a major 
determinant of CVD risk and all-cause mortality (24). The results of this study thus 
provide further convincing evidence for the effectiveness of IHG training in reducing 
resting BP in individuals with hypertension, even in patients who are currently managed 
with pharmacotherapy. The clinical implication of these findings is that IHG training may 
offer a viable adjunct therapy to more traditional forms of exercise training and/or 
pharmacotherapy in the treatment and management of high BP. Furthermore, the 
simplicity, portability, and reduced time-commitment (i.e., 12-minutes per day, 3-days 
per week) of IHG training may lead to greater adherence versus more traditional forms of 
anti-hypertensive therapy. This is evidenced by the current results of this study, in which 
participants in the IHG training group exhibited 100% adherence to the IHG training 
prescription and ≥ 90% compliance with the specific IHG exercise protocol.  
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Cardiovascular Reactivity as a Predictor of Isometric Handgrip Training 
Effectiveness 
 IHG training has been shown to exhibit inter-individual variability in the BP 
adaptations following training (6), which may be related to cardiovascular stress 
reactivity responses (18). This is the first study to note in a prospective design, that 
cardiovascular reactivity to a SST and IHGT, but not a CPT, is significantly correlated 
with IHG training-induced reductions in resting systolic BP. These findings are 
confirmatory to Millar et al (18), who in a retrospective design, found significant 
correlations between the cardiovascular reactivity to a SST and IHG training adaptations 
in older, normotensive individuals. We provide an important novel finding in that the 
cardiovascular reactivity to an IHGT is also significantly associated with the BP lowering 
effects of IHG training. Taken together, our results suggest that the cardiovascular 
responses to a SST and IHGT are predictive of a post-IHG training hypotensive response 
in individuals with high BP. Highlighting this relationship provides key clinical 
implications, as it may provide a simple, effective, and portable tool to identify 
individuals with hypertension who will benefit from IHG training with a reduction in 
resting BP.   
Effects of Isometric Handgrip Training on Cardiovascular Reactivity 
 Attenuation of cardiovascular reactivity to psychophysiological stressors has been 
demonstrated following 6- to 24-weeks of aerobic exercise training in individuals with 
hypertension (19;20). Our findings provide the first evidence that IHG training also 
reduces cardiovascular reactivity to psychophysiological stressors in individuals with 
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high BP. Following 10-weeks of IHG training, systolic BP reactivity to both the SST and 
IHGT was reduced in the IHG training group, while remaining unchanged in the non-
exercising control group. In contrast, cardiovascular reactivity to the CPT was not 
attenuated following IHG training. It is important to note that only systolic BP reactivity 
to the SST and IHGT was reduced following IHG training, and not diastolic BP and HR 
reactivity, likely due to the smaller magnitude of reduction following training in 
comparison to the larger change in systolic BP. The clinical significance of reduced 
systolic BP reactivity to a SST and IHGT remains unclear. However, as evidence 
suggests that increased cardiovascular reactivity to psychophysiological stressors is 
associated with greater risk of hypertension (13;14), and as the additive effects of 
episodically high stress responses has been implicated in the development of high BP 
(25), this finding may be especially important. Our results provide evidence for a possible 
protective effect of IHG training through a reduction in cardiovascular stress reactivity. 
Future study examining attenuation of cardiovascular reactivity following IHG training, 
with an extended follow-up period, is warranted to determine the clinical benefits of this 
reduction in cardiovascular reactivity. 
 The results of the current investigation are novel and note-worthy; we do 
acknowledge certain limitations. Most participants in the study were medicated for 
hypertension, medication type was diverse between participants, and some anti-
hypertensive medications have been shown to confound stress reactivity (26). To best 
account for the effects of anti-hypertensive medications on cardiovascular reactivity, all 
medications were strictly monitored throughout the study period, all testing procedures 
were conducted at a standardized time from medication ingestion, and all medications 
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had been maintained for a period of greater than 4-months prior to the study. However, 
this could also be considered a strength of the investigation, as this is more reflective of 
individuals with hypertension in the general population.  
2.5 Perspectives 
 This study noted significant reductions in resting BP following 10-weeks of IHG 
training in older, hypertensive individuals, which were strongly correlated to pre-training 
cardiovascular reactivity responses to a SST and IHGT. IHG training also produced 
significant attenuations in systolic BP reactivity to the SST and IHGT. Our findings 
provide additional support for the use of IHG training as a complementary therapy in the 
treatment and management of high BP. Furthermore, we offer support for the use of a 
SST and/or IHGT as a simple tool to identify individuals who stand to benefit from IHG 
training. This is especially important, as it may increase the number of successfully 
controlled and/or treated individuals.  
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Participant Characteristics 
ID Group Age (years) Sex 
Height
(cm) 
Weight
(kg) 
BMI 
(kg/m2) Medication 
1 IHG  72 Male 167.64 70.31 25.02 ACE, CCB 
2 IHG  64 Female 157.48 62.60 25.24 CCB 
3 IHG  72 Female 160.02 70.76 27.63 ACE 
4 IHG  58 Female 162.56 83.91 31.75 Diuretic 
5 IHG  63 Female 167.64 61.69 21.95 ACE, Diuretic 
6 IHG  63 Male 180.34 78.02 23.99 ACE 
7 IHG  72 Male 182.88 83.91 25.09 ACE, BB 
8 IHG  60 Female 154.94 67.13 27.96 ACE 
9 IHG  51 Male 172.72 92.99 31.17 ACE, Diuretic 
10 IHG  67 Male 177.80 72.57 22.96 ACE 
11 IHG  75 Male 172.72 76.20 25.54 N/A 
12 IHG  59 Female 172.72 106.14 35.58 N/A 
13 Control 55 Female 165.10 120.20 44.10 BB 
14 Control 55 Male 177.80 77.11 24.39 N/A 
15 Control 73 Male 180.34 73.94 22.73 CCB 
16 Control 60 Female 175.26 100.24 32.64 ACE 
17 Control 67 Female 157.48 63.50 25.61 ACE, Diuretic 
18 Control 68 Female 152.40 69.40 29.88 ACE 
19 Control 71 Female 152.40 61.23 26.37 ACE, CCB 
20 Control 77 Male 175.26 79.38 25.84 ACE, Diuretic 
21 Control 60 Male 167.64 106.59 37.93 ACE 
22 Control 66 Male 170.18 69.85 24.12 ACE 
23 Control 52 Male 175.26 83.91 27.32 N/A 
24 Control 51 Male 170.18 91.17 31.48 ACE, BB 
BMI, body mass index; IHG, isometric handgrip; ACE, angiotensin converting enzyme; 
CCB, calcium channel blocker; BB, beta blocker 
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Resting Systolic Blood Pressure Data 
ID Group 
Pre-IHG 
Training SBP 
Post-IHG 
Training SBP 
(mmHg) (mmHg) 
1 IHG  144 145 
2 IHG  125 116 
3 IHG  121 112 
4 IHG  118 115 
5 IHG  106 97 
6 IHG  130 121 
7 IHG  124 120 
8 IHG  105 96 
9 IHG  134 123 
10 IHG  135 127 
11 IHG  150 139 
12 IHG  157 144 
13 Control 135 138 
14 Control 146 148 
15 Control 125 125 
16 Control 105 106 
17 Control 114 115 
18 Control 100 97 
19 Control 125 131 
20 Control 132 134 
21 Control 137 132 
22 Control 146 148 
23 Control 153 153 
24 Control 144 147 
IHG, isometric handgrip; SBP, systolic blood pressure 
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Resting Diastolic Blood Pressure Data 
ID Group 
Pre-IHG 
Training DBP 
Post-IHG 
Training DBP 
(mmHg) (mmHg) 
1 IHG  71 79 
2 IHG  61 57 
3 IHG  75 72 
4 IHG  75 71 
5 IHG  60 56 
6 IHG  79 71 
7 IHG  72 68 
8 IHG  55 53 
9 IHG  76 69 
10 IHG  70 63 
11 IHG  75 69 
12 IHG  88 80 
13 Control 63 66 
14 Control 84 84 
15 Control 68 68 
16 Control 61 63 
17 Control 65 57 
18 Control 62 53 
19 Control 71 74 
20 Control 63 69 
21 Control 73 74 
22 Control 86 86 
23 Control 92 94 
24 Control 92 95 
IHG, isometric handgrip; DBP, diastolic blood pressure 
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Resting Mean Arterial Blood Pressure Data 
ID Group 
Pre-IHG 
Training MAP 
Post-IHG 
Training MAP 
(mmHg) (mmHg) 
1 IHG  96 101 
2 IHG  83 77 
3 IHG  90 85 
4 IHG  89 85 
5 IHG  75 70 
6 IHG  96 88 
7 IHG  89 85 
8 IHG  72 67 
9 IHG  95 87 
10 IHG  92 84 
11 IHG  100 92 
12 IHG  111 101 
13 Control 87 87 
14 Control 105 105 
15 Control 87 87 
16 Control 76 76 
17 Control 82 81 
18 Control 75 75 
19 Control 89 89 
20 Control 86 86 
21 Control 94 95 
22 Control 107 106 
23 Control 112 112 
24 Control 109 110 
IHG, isometric handgrip; MAP, mean arterial blood pressure 
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Resting Pulse Pressure Data 
ID Group 
Pre-IHG 
Training PP 
Post-IHG 
Training PP 
(mmHg) (mmHg) 
1 IHG  72 66 
2 IHG  64 59 
3 IHG  46 40 
4 IHG  43 45 
5 IHG  46 41 
6 IHG  51 50 
7 IHG  53 52 
8 IHG  50 43 
9 IHG  58 54 
10 IHG  65 63 
11 IHG  75 70 
12 IHG  68 64 
13 Control 71 71 
14 Control 62 64 
15 Control 57 57 
16 Control 44 42 
17 Control 49 58 
18 Control 38 44 
19 Control 54 57 
20 Control 69 65 
21 Control 64 58 
22 Control 60 62 
23 Control 60 59 
24 Control 52 52 
IHG, isometric handgrip; PP, pulse pressure 
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Resting Heart Rate Data 
ID Group 
Pre-IHG 
Training HR 
Post-IHG 
Training (HR) 
(bpm) (bpm) 
1 IHG  48 65 
2 IHG  74 65 
3 IHG  74 80 
4 IHG  74 73 
5 IHG  72 75 
6 IHG  65 63 
7 IHG  75 74 
8 IHG  54 47 
9 IHG  71 67 
10 IHG  49 51 
11 IHG  84 83 
12 IHG  73 73 
13 Control 69 69 
14 Control 66 69 
15 Control 54 56 
16 Control 56 57 
17 Control 71 72 
18 Control 65 68 
19 Control 70 68 
20 Control 71 69 
21 Control 67 66 
22 Control 65 68 
23 Control 82 84 
24 Control 62 67 
IHG, isometric handgrip; HR, heart rate; bpm, beats per minute 
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Pre-IHG Training Serial Subtraction Task Reactivity 
ID Group 
Resting Resting Resting Minute One Minute Two 
SBP 
(mmHg) 
DBP 
(mmHg)
HR 
(bpm)
SBP
(mmHg) 
DBP
(mmHg) 
HR
(bpm) 
SBP 
(mmHg) 
DBP
(mmHg) 
HR
(bpm) 
1 IHG  133 68 48 137 67 47 137 69 46 
2 IHG  132 65 74 159 71 83 151 73 84 
3 IHG  124 76 73 169 82 70 144 91 72 
4 IHG  117 76 72 119 78 76 132 77 74 
5 IHG  102 58 80 130 66 82 139 59 85 
6 IHG  132 79 60 156 98 78 155 95 70 
7 IHG  134 71 75 138 79 88 141 77 80 
8 IHG  101 52 56 132 69 66 128 72 68 
9 IHG  134 75 69 181 101 81 176 89 83 
10 IHG  142 75 54 153 81 57 167 75 72 
11 IHG  150 75 81 180 91 100 176 90 96 
12 IHG  156 87 70 186 95 92 170 91 86 
13 Control 133 65 70 157 69 78 163 78 84 
14 Control 146 85 66 171 94 79 173 96 82 
15 Control 123 68 54 140 78 64 141 79 63 
16 Control 105 61 57 130 75 68 133 76 69 
17 Control 114 63 70 125 68 83 124 65 80 
18 Control 100 61 65 137 72 83 141 70 85 
19 Control 127 72 66 141 84 77 146 80 77 
20 Control 130 65 70 151 77 88 153 81 91 
21 Control 136 78 65 155 90 76 156 90 79 
22 Control 140 86 63 150 91 85 155 99 80 
23 Control 152 92 80 186 101 96 184 104 99 
24 Control 145 92 60 170 100 79 166 101 81 
IHG, isometric handgrip; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
HR, heart rate; bpm, beats per minute 
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Pre-IHG Training Isometric Handgrip Task Reactivity 
ID Group 
Resting Resting Resting Minute One Minute Two 
SBP 
(mmHg) 
DBP 
(mmHg)
HR 
(bpm)
SBP
(mmHg) 
DBP
(mmHg) 
HR 
(bpm) 
SBP 
(mmHg) 
DBP
(mmHg) 
HR
(bpm) 
1 IHG  141 72 48 159 81 50 158 80 50 
2 IHG  121 57 72 129 71 96 148 80 84 
3 IHG  124 80 75 160 82 72 121 74 72 
4 IHG  120 74 74 140 82 72 140 80 74 
5 IHG  109 61 68 127 65 89 151 75 71 
6 IHG  131 83 65 157 103 84 150 96 81 
7 IHG  113 68 73 130 72 90 133 78 75 
8 IHG  112 61 51 140 71 56 118 58 52 
9 IHG  132 80 72 191 102 84 205 81 81 
10 IHG  132 69 46 151 75 57 157 89 62 
11 IHG  151 74 84 185 99 105 176 86 101
12 IHG  158 90 74 202 115 97 191 106 96 
13 Control 134 61 70 156 72 84 161 73 85 
14 Control 147 83 67 182 96 78 179 95 79 
15 Control 127 69 55 143 81 66 157 76 65 
16 Control 105 61 55 134 76 81 156 77 80 
17 Control 115 65 72 127 69 84 130 71 85 
18 Control 101 63 65 142 73 86 141 75 84 
19 Control 122 72 70 172 85 80 140 83 71 
20 Control 131 60 71 156 68 81 150 75 88 
21 Control 137 74 67 156 91 77 158 90 78 
22 Control 147 87 69 156 99 81 160 101 86 
23 Control 150 92 82 183 101 96 184 100 95 
24 Control 143 90 61 166 101 80 188 103 76 
IHG, isometric handgrip; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
HR, heart rate; bpm, beats per minute 
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Pre-IHG Training Cold-Pressor Task Reactivity 
ID Group 
Resting Resting Resting Minute One Minute Two 
SBP 
(mmHg) 
DBP 
(mmHg)
HR 
(bpm)
SBP 
(mmHg) 
DBP
(mmHg) 
HR 
(bpm) 
SBP 
(mmHg) 
DBP
(mmHg) 
HR
(bpm) 
1 IHG  157 74 49 190 106 51 202 99 50 
2 IHG  122 62 77 140 69 72 140 72 78 
3 IHG  115 70 75 152 85 70 154 85 74 
4 IHG  116 74 77 180 89 77 147 80 76 
5 IHG  107 60 67 132 73 65 102 71 68 
6 IHG  127 76 69 150 96 78 141 90 76 
7 IHG  126 75 76 138 81 89 151 82 80 
8 IHG  102 53 55 103 54 52 106 56 53 
9 IHG  136 73 73 143 84 80 138 91 76 
10 IHG  132 68 47 140 79 51 143 74 50 
11 IHG  150 77 86 210 98 92 190 94 93 
12 IHG  157 87 76 196 109 81 190 91 80 
13 Control 136 64 68 157 76 71 156 78 72 
14 Control 147 84 66 163 91 70 165 88 71 
15 Control 126 68 54 156 85 57 154 84 60 
16 Control 105 61 56 135 71 61 135 74 63 
17 Control 114 67 71 136 69 80 132 65 76 
18 Control 100 62 66 131 65 74 130 62 76 
19 Control 126 68 74 150 84 79 150 80 84 
20 Control 135 64 72 155 80 81 154 76 80 
21 Control 139 68 71 157 90 79 156 90 88 
22 Control 151 86 63 180 95 76 171 100 79 
23 Control 156 93 84 176 101 91 179 100 92 
24 Control 144 94 65 160 105 70 191 106 70 
IHG, isometric handgrip; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
HR, heart rate; bpm, beats per minute 
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Post-IHG Training Serial Subtraction Task Reactivity 
ID Group 
Resting Resting Resting Minute One Minute Two 
SBP 
(mmHg) 
DBP 
(mmHg)
HR 
(bpm)
SBP 
(mmHg) 
DBP
(mmHg) 
HR 
(bpm) 
SBP 
(mmHg) 
DBP
(mmHg) 
HR
(bpm) 
1 IHG  139 79 62 135 79 64 144 78 65 
2 IHG  116 59 63 135 68 78 133 71 74 
3 IHG  116 75 80 144 81 87 137 74 80 
4 IHG  116 70 73 131 75 76 112 70 71 
5 IHG  102 58 75 125 77 80 131 69 76 
6 IHG  121 71 58 131 75 76 138 79 74 
7 IHG  120 70 77 129 79 86 128 78 88 
8 IHG  99 55 48 133 67 62 108 64 58 
9 IHG  121 72 67 128 81 79 138 86 80 
10 IHG  127 63 51 146 68 65 137 67 67 
11 IHG  138 70 79 161 84 96 162 83 90 
12 IHG  144 80 72 170 90 94 166 88 91 
13 Control 137 62 69 165 79 81 166 78 82 
14 Control 150 84 69 174 95 78 176 97 84 
15 Control 124 68 54 143 79 66 140 80 61 
16 Control 105 65 58 134 76 71 130 77 72 
17 Control 112 57 72 127 70 84 125 61 80 
18 Control 95 52 70 143 74 83 141 70 82 
19 Control 130 71 70 143 81 76 147 82 70 
20 Control 134 69 69 155 78 93 150 76 92 
21 Control 135 72 67 154 85 78 150 86 79 
22 Control 153 84 70 160 92 82 171 90 83 
23 Control 153 90 86 187 103 91 191 108 100
24 Control 147 91 68 171 99 77 155 98 98 
IHG, isometric handgrip; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
HR, heart rate; bpm, beats per minute 
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Post-IHG Training Isometric Handgrip Task Reactivity 
ID Group 
Resting Resting Resting Minute One Minute Two 
SBP 
(mmHg) 
DBP 
(mmHg)
HR 
(bpm)
SBP 
(mmHg) 
DBP
(mmHg) 
HR 
(bpm) 
SBP 
(mmHg) 
DBP
(mmHg) 
HR
(bpm) 
1 IHG  159 88 77 170 90 80 183 94 80 
2 IHG  115 59 63 111 74 69 136 75 76 
3 IHG  108 70 79 139 89 78 138 93 82 
4 IHG  115 72 74 137 77 78 136 78 78 
5 IHG  96 56 80 116 65 77 115 64 81 
6 IHG  121 71 64 138 85 84 135 86 80 
7 IHG  120 67 74 140 75 88 135 76 79 
8 IHG  92 51 49 133 67 61 130 66 53 
9 IHG  126 68 67 153 86 76 156 85 78 
10 IHG  127 63 53 147 75 66 141 78 67 
11 IHG  138 67 84 156 86 101 153 81 98 
12 IHG  144 82 74 179 102 100 181 101 106
13 Control 137 69 68 163 78 81 161 76 82 
14 Control 148 83 71 182 92 78 176 94 79 
15 Control 125 68 57 142 70 68 177 80 61 
16 Control 107 63 59 139 66 80 130 75 79 
17 Control 118 59 75 131 72 84 130 70 83 
18 Control 97 51 68 145 70 85 136 72 86 
19 Control 132 75 64 192 80 81 160 87 76 
20 Control 132 66 70 157 68 85 150 66 86 
21 Control 133 77 66 160 94 78 155 70 85 
22 Control 146 87 64 166 100 87 159 99 85 
23 Control 155 94 87 182 99 86 184 99 98 
24 Control 148 98 67 165 102 77 189 100 75 
IHG, isometric handgrip; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
HR, heart rate; bpm, beats per minute 
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Post-IHG Training Cold-Pressor Task Reactivity 
ID Group 
Resting Resting Resting Minute One Minute Two 
SBP 
(mmHg) 
DBP 
(mmHg)
HR 
(bpm)
SBP 
(mmHg) 
DBP
(mmHg) 
HR 
(bpm) 
SBP 
(mmHg) 
DBP
(mmHg) 
HR
(bpm) 
1 IHG  136 69 55 153 86 56 155 76 55 
2 IHG  117 53 67 133 61 61 131 61 71 
3 IHG  111 70 80 145 82 84 144 81 81 
4 IHG  115 70 71 165 86 74 165 86 74 
5 IHG  92 54 70 116 63 70 119 67 74 
6 IHG  121 71 66 136 85 76 130 84 71 
7 IHG  120 66 70 155 80 78 149 80 75 
8 IHG  96 53 44 120 64 46 124 53 46 
9 IHG  122 69 67 136 82 65 117 81 68 
10 IHG  127 64 49 133 70 55 131 68 51 
11 IHG  139 70 85 180 86 92 176 84 90 
12 IHG  144 78 72 179 100 78 181 101 79 
13 Control 139 67 70 154 79 74 156 78 71 
14 Control 148 86 68 166 92 73 167 90 72 
15 Control 126 67 58 156 86 58 158 80 65 
16 Control 105 62 54 136 70 62 130 74 64 
17 Control 115 56 70 140 68 81 139 65 76 
18 Control 99 55 67 126 70 70 125 62 71 
19 Control 132 75 70 149 79 80 155 81 83 
20 Control 136 71 67 150 81 76 161 80 77 
21 Control 129 74 65 160 86 79 148 95 87 
22 Control 145 87 71 170 94 77 171 93 77 
23 Control 152 96 81 177 100 93 176 99 92 
24 Control 146 96 67 140 103 71 155 102 70 
IHG, isometric handgrip; SBP, systolic blood pressure; DBP, diastolic blood pressure; 
HR, heart rate; bpm, beats per minute 
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Serial Subtraction Task Systolic Blood Pressure Reactivity Data 
ID Group 
Pre-IHG Training  
SBP Reactivity 
Post-IHG Training 
SBP Reactivity 
(Δ mmHg) (Δ mmHg) 
1 IHG  4 5 
2 IHG  27 19 
3 IHG  45 28 
4 IHG  15 15 
5 IHG  37 29 
6 IHG  24 17 
7 IHG  7 9 
8 IHG  31 34 
9 IHG  47 17 
10 IHG  25 19 
11 IHG  30 24 
12 IHG  30 26 
13 Control 30 29 
14 Control 27 26 
15 Control 18 19 
16 Control 28 29 
17 Control 11 15 
18 Control 41 48 
19 Control 19 17 
20 Control 23 21 
21 Control 20 19 
22 Control 15 18 
23 Control 34 38 
24 Control 25 24 
IHG, isometric handgrip; SBP, systolic blood pressure 
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Serial Subtraction Task Diastolic Blood Pressure Reactivity Data 
ID Group 
Pre-IHG Training 
DBP Reactivity 
Post-IHG Training 
DBP Reactivity 
(Δ mmHg) (Δ mmHg) 
1 IHG  1 0 
2 IHG  8 9 
3 IHG  15 6 
4 IHG  2 5 
5 IHG  8 19 
6 IHG  19 8 
7 IHG  8 9 
8 IHG  20 12 
9 IHG  26 14 
10 IHG  6 5 
11 IHG  16 14 
12 IHG  8 10 
13 Control 13 17 
14 Control 11 13 
15 Control 11 12 
16 Control 15 12 
17 Control 14 13 
18 Control 21 22 
19 Control 12 11 
20 Control 16 9 
21 Control 12 14 
22 Control 13 8 
23 Control 12 18 
24 Control 9 8 
IHG, isometric handgrip; DBP, diastolic blood pressure 
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Serial Subtraction Task Heart Rate Reactivity Data 
ID Group 
Pre-IHG Training 
HR Reactivity 
Post-IHG Training 
HR Reactivity 
(Δ bpm) (Δ bpm) 
1 IHG  2 3 
2 IHG  10 15 
3 IHG  22 7 
4 IHG  12 3 
5 IHG  6 5 
6 IHG  18 18 
7 IHG  13 11 
8 IHG  12 14 
9 IHG  14 13 
10 IHG  18 16 
11 IHG  19 17 
12 IHG  22 22 
13 Control 14 13 
14 Control 16 15 
15 Control 9 12 
16 Control 12 14 
17 Control 13 12 
18 Control 20 13 
19 Control 11 6 
20 Control 21 24 
21 Control 14 12 
22 Control 22 13 
23 Control 19 14 
24 Control 21 30 
IHG, isometric handgrip; HR, heart rate; bpm, beats per minute 
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Isometric Handgrip Task Systolic Blood Pressure Reactivity Data 
ID Group 
Pre-IHG Training 
SBP Reactivity 
Post-IHG Training 
SBP Reactivity 
(Δ mmHg) (Δ mmHg) 
1 IHG  18 24 
2 IHG  47 41 
3 IHG  36 31 
4 IHG  20 22 
5 IHG  42 20 
6 IHG  26 17 
7 IHG  20 20 
8 IHG  28 41 
9 IHG  73 30 
10 IHG  25 20 
11 IHG  34 18 
12 IHG  44 37 
13 Control 27 26 
14 Control 35 32 
15 Control 30 34 
16 Control 51 52 
17 Control 15 13 
18 Control 41 48 
19 Control 50 60 
20 Control 25 25 
21 Control 21 27 
22 Control 13 20 
23 Control 34 29 
24 Control 45 41 
IHG, isometric handgrip; SBP, systolic blood pressure 
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Isometric Handgrip Task Diastolic Blood Pressure Reactivity Data 
ID Group 
Pre-IHG Training 
DBP Reactivity 
Post-IHG Training 
DBP Reactivity 
(Δ mmHg) (Δ mmHg) 
1 IHG  9 6 
2 IHG  23 16 
3 IHG  2 23 
4 IHG  8 6 
5 IHG  14 9 
6 IHG  20 15 
7 IHG  10 9 
8 IHG  10 16 
9 IHG  21 18 
10 IHG  20 15 
11 IHG  25 19 
12 IHG  25 20 
13 Control 12 9 
14 Control 13 11 
15 Control 12 12 
16 Control 16 12 
17 Control 16 13 
18 Control 22 21 
19 Control 13 12 
20 Control 15 2 
21 Control 17 17 
22 Control 14 13 
23 Control 9 5 
24 Control 13 4 
IHG, isometric handgrip; DBP, diastolic blood pressure 
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Isometric Handgrip Task Heart Rate Reactivity Data 
ID Group 
Pre-IHG Training 
HR Reactivity 
Post-IHG Training 
HR Reactivity 
(Δ bpm) (Δ bpm) 
1 IHG  2 3 
2 IHG  18 13 
3 IHG  20 3 
4 IHG  4 4 
5 IHG  21 1 
6 IHG  19 20 
7 IHG  17 14 
8 IHG  15 12 
9 IHG  9 11 
10 IHG  16 14 
11 IHG  21 17 
12 IHG  23 32 
13 Control 15 14 
14 Control 12 8 
15 Control 11 11 
16 Control 26 21 
17 Control 13 9 
18 Control 21 18 
19 Control 10 17 
20 Control 17 16 
21 Control 11 19 
22 Control 17 23 
23 Control 14 11 
24 Control 19 10 
IHG, isometric handgrip; HR, heart rate; bpm, beats per minute 
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Cold-Pressor Task Systolic Blood Pressure Reactivity Data 
ID Group 
Pre-IHG Training 
SBP Reactivity 
Post-IHG Training 
SBP Reactivity 
(Δ mmHg) (Δ mmHg) 
1 IHG  45 19 
2 IHG  28 16 
3 IHG  39 34 
4 IHG  64 50 
5 IHG  25 27 
6 IHG  23 15 
7 IHG  25 35 
8 IHG  4 28 
9 IHG  7 14 
10 IHG  9 6 
11 IHG  60 41 
12 IHG  39 37 
13 Control 21 17 
14 Control 18 19 
15 Control 30 32 
16 Control 30 31 
17 Control 22 25 
18 Control 31 27 
19 Control 24 23 
20 Control 20 25 
21 Control 18 31 
22 Control 29 26 
23 Control 23 25 
24 Control 47 9 
IHG, isometric handgrip; SBP, systolic blood pressure 
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Cold-Pressor Task Diastolic Blood Pressure Reactivity Data 
ID Group 
Pre-IHG Training 
DBP Reactivity 
Post-IHG Training 
DBP Reactivity 
(Δ mmHg) (Δ mmHg) 
1 IHG  32 17 
2 IHG  10 8 
3 IHG  15 12 
4 IHG  15 16 
5 IHG  11 13 
6 IHG  20 14 
7 IHG  7 14 
8 IHG  3 11 
9 IHG  18 13 
10 IHG  7 6 
11 IHG  21 16 
12 IHG  22 23 
13 Control 14 12 
14 Control 7 6 
15 Control 17 19 
16 Control 13 12 
17 Control 12 12 
18 Control 14 15 
19 Control 16 6 
20 Control 16 10 
21 Control 22 21 
22 Control 14 7 
23 Control 8 4 
24 Control 12 7 
IHG, isometric handgrip; DBP, diastolic blood pressure 
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Cold-Pressor Task Heart Rate Reactivity Data 
ID Group 
Pre-IHG Training 
HR Reactivity 
Post-IHG Training 
HR Reactivity 
(Δ bpm) (Δ bpm) 
1 IHG  2 1 
2 IHG  1 4 
3 IHG  1 4 
4 IHG  2 3 
5 IHG  1 4 
6 IHG  9 10 
7 IHG  13 8 
8 IHG  2 2 
9 IHG  7 1 
10 IHG  4 6 
11 IHG  7 7 
12 IHG  5 7 
13 Control 4 4 
14 Control 5 5 
15 Control 6 7 
16 Control 7 10 
17 Control 9 11 
18 Control 10 4 
19 Control 10 13 
20 Control 9 10 
21 Control 17 22 
22 Control 16 6 
23 Control 8 12 
24 Control 5 4 
IHG, isometric handgrip; HR, heart rate; bpm, beats per minute 
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State-Trait Anxiety Inventory for Adults Form Y-1 (State Anxiety) Data 
ID Group 
Pre-IHG Training STAI-S Post-IHG Training STAI-S 
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3 
1 IHG  27 27 20 30 26 21 
2 IHG  21 20 23 25 21 21 
3 IHG  44 42 40 45 30 30 
4 IHG  30 28 28 29 27 27 
5 IHG  37 21 26 33 20 20 
6 IHG  22 22 22 21 21 21 
7 IHG  32 30 30 20 20 20 
8 IHG  39 32 32 25 24 24 
9 IHG  27 27 27 21 21 21 
10 IHG  30 29 29 28 28 28 
11 IHG  25 25 25 26 24 24 
12 IHG  20 20 20 20 20 20 
13 Control 30 30 30 31 31 31 
14 Control 28 29 29 29 29 29 
15 Control 32 32 31 33 31 31 
16 Control 30 29 29 27 32 32 
17 Control 31 29 30 25 25 25 
18 Control 29 27 27 26 26 26 
19 Control 35 32 32 36 32 35 
20 Control 41 36 38 37 36 36 
21 Control 36 32 35 33 34 34 
22 Control 21 21 21 20 20 20 
23 Control 28 25 25 26 26 25 
24 Control 25 21 21 24 27 21 
IHG, isometric handgrip; STAI-S, state anxiety 
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State-Trait Anxiety Inventory for Adults Form Y-1 (Trait Anxiety) Data 
ID Group 
Pre-IHG Training STAI-T Post-IHG Training STAI-T 
Day 1 Day 2 Day 3 Day 1 Day 2 Day 3 
1 IHG  25 32 33 28 35 29 
2 IHG  32 28 27 24 23 23 
3 IHG  37 39 39 45 40 40 
4 IHG  33 34 34 35 33 33 
5 IHG  25 23 26 24 26 26 
6 IHG  28 22 22 22 22 22 
7 IHG  29 31 31 20 20 20 
8 IHG  27 27 27 23 26 26 
9 IHG  25 25 25 25 25 25 
10 IHG  32 32 32 33 33 33 
11 IHG  26 27 27 27 28 28 
12 IHG  25 24 26 25 26 27 
13 Control 33 33 33 33 33 33 
14 Control 29 30 30 30 30 30 
15 Control 35 36 35 36 32 32 
16 Control 33 35 35 33 27 27 
17 Control 35 34 33 33 33 33 
18 Control 30 31 31 32 32 32 
19 Control 36 35 35 35 35 33 
20 Control 36 36 36 35 36 36 
21 Control 35 35 33 32 35 35 
22 Control 22 22 22 20 22 22 
23 Control 25 30 30 26 27 29 
24 Control 26 27 27 26 25 25 
IHG, isometric handgrip; STAI-T, trait anxiety 
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State-Trait Anxiety Inventory for Adults Form Y-1 (State Anxiety) Data 
ID Group Pre-IHG Training STAI-S Post-IHG Training STAI-S
1 IHG  25 26 
2 IHG  21 22 
3 IHG  42 35 
4 IHG  29 28 
5 IHG  28 24 
6 IHG  22 21 
7 IHG  31 20 
8 IHG  34 24 
9 IHG  27 21 
10 IHG  29 28 
11 IHG  25 25 
12 IHG  20 20 
13 Control 30 31 
14 Control 29 29 
15 Control 32 32 
16 Control 29 30 
17 Control 30 25 
18 Control 28 26 
19 Control 33 34 
20 Control 38 36 
21 Control 34 34 
22 Control 21 20 
23 Control 26 26 
24 Control 22 24 
IHG, isometric handgrip; STAI-S, state anxiety 
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State-Trait Anxiety Inventory for Adults Form Y-1 (Trait Anxiety) Data 
ID Group Pre-IHG Training STAI-T Post-IHG Training STAI-T 
1 IHG  30 31 
2 IHG  29 23 
3 IHG  38 42 
4 IHG  34 34 
5 IHG  25 25 
6 IHG  24 22 
7 IHG  30 20 
8 IHG  27 25 
9 IHG  25 25 
10 IHG  32 33 
11 IHG  27 28 
12 IHG  25 26 
13 Control 33 33 
14 Control 30 30 
15 Control 35 33 
16 Control 34 29 
17 Control 34 33 
18 Control 31 32 
19 Control 35 34 
20 Control 36 36 
21 Control 34 34 
22 Control 22 21 
23 Control 28 27 
24 Control 27 25 
IHG, isometric handgrip; STAI-T, trait anxiety 
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Participant Baseline Characteristics 
One-Way ANOVA: Baseline Age Between-Group Differences 
1a. Age (Means) 
Group Mean SE N 
IHG 64.67 2.1 12 
Control 62.92 2.5 12 
 
1b. Age (All Effects) 
Univariate Tests of Significance for Age (Spreadsheet
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
97665.04 1 97665.04 1550.705 0.000000
18.38 1 18.38 0.292 0.594525
1385.58 22 62.98  
 
One-Way ANOVA: Baseline Height Between-Group Differences 
2a. Height (Means) 
Group Mean SE N 
IHG 169.12 2.6 12 
Control 168.28 2.8 12 
 
2b. Height (All Effects) 
Univariate Tests of Significance for Height (Spreadsheet
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
683019.1 1 683019.1 7837.688 0.000000
4.3 1 4.3 0.049 0.826239
1917.2 22 87.1  
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One-Way ANOVA: Baseline Weight Between-Group Differences 
3a. Weight (Means) 
Group Mean SE N 
IHG 77.19 3.7 12 
Control 83.05 5.3 12 
 
3b. Weight (All Effects) 
Univariate Tests of Significance for Weight (Spreadsheet
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
154044.8 1 154044.8 617.1350 0.000000
206.0 1 206.0 0.8251 0.373531
5491.5 22 249.6  
 
One-Way ANOVA: Baseline Body Mass Index Between-Group Differences 
4a. BMI (Means) 
Group Mean SE N 
IHG 26.99 1.2 12 
Control 29.40 1.8 12 
 
4b. BMI (All Effects) 
Univariate Tests of Significance for BMI (Spreadsheet
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
19057.23 1 19057.23 675.7724 0.000000
33.87 1 33.87 1.2011 0.284947
620.41 22 28.20  
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One-Way ANOVA: Baseline Systolic BP Between-Group Differences 
5a. Resting Systolic BP (Means) 
Group Mean SE N 
IHG 129.07 4.6 12 
Control 130.26 4.9 12 
 
5b. Resting Systolic BP (All Effects) 
Univariate Tests of Significance for SBP (Spreadsheet1
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
403522.7 1 403522.7 1486.983 0.000000
8.4 1 8.4 0.031 0.861725
5970.1 22 271.4  
 
One-Way ANOVA: Baseline Diastolic BP Between-Group Differences 
6a. Resting Diastolic BP (Means) 
Group Mean SE N 
IHG 71.57 2.6 12 
Control 73.46 3.5 12 
 
6b. Resting Diastolic BP (All Effects) 
Univariate Tests of Significance for DBP (Spreadsheet
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
126214.5 1 126214.5 1109.496 0.000000
21.4 1 21.4 0.188 0.668657
2502.7 22 113.8  
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One-Way ANOVA: Baseline Mean Arterial BP Between-Group Differences 
7a. Resting Mean Arterial BP (Means) 
Group Mean SE N 
IHG 90.74 3.1 12 
Control 92.28 3.7 12 
 
7b. Resting Mean Arterial BP (All Effects) 
Univariate Tests of Significance for MAP (Spreadsheet1
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
200988.2 1 200988.2 1439.687 0.000000
14.3 1 14.3 0.102 0.752043
3071.3 22 139.6  
 
One-Way ANOVA: Baseline Pulse Pressure Between-Group Differences 
8a. Resting Pulse Pressure (Means) 
Group Mean SE N 
IHG 57.50 3.2 12 
Control 56.80 2.8 12 
 
8b. Resting Pulse Pressure (All Effects) 
Univariate Tests of Significance for PP (Spreadsheet1
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
78381.86 1 78381.86 716.3533 0.000000
2.97 1 2.97 0.0272 0.870617
2407.19 22 109.42  
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One-Way ANOVA: Baseline HR Between-Group Differences 
9a. Resting HR (Means) 
Group Mean SE N 
IHG 67.84 3.3 12 
Control 66.67 2.1 12 
 
9b. Resting HR (All Effects) 
Univariate Tests of Significance for HR (Spreadsheet
Sigma-restricted parameterization
Effective hypothesis decomposition
Effect
SS Degr. of
Freedom
MS F p
Intercept
Group
Error
108556.4 1 108556.4 1201.113 0.000000
8.3 1 8.3 0.092 0.764748
1988.4 22 90.4  
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Effects of IHG Training on Resting Blood Pressure and Heart Rate 
Resting Systolic BP Pre- to Post-IHG Training Repeated Measures ANOVA 
1a. Resting Systolic BP (Means) 
Group Time Mean SE N 
IHG Pre- 129.07 4.6 12 
IHG Post- 121.11 4.6 12 
Control Pre- 130.26 4.9 12 
Control Post- 131.21 5.1 12 
 
1b. Resting Systolic BP (All Effects) 
 
1c. Resting Systolic BP (Tukey HSD Post-Hoc Test) 
Tukey HSD test; variable DV_1 (Spreadsheet1)
Approximate Probabilities for Post Hoc Tests
Error: Between; Within; Pooled MS = 279.09, df = 22.496
Cell No.
Group TIME {1}
129.07
{2}
121.11
{3}
130.26
{4}
131.21
1
2
3
4
1 BLSBP 0.000167
0.000167
0.998140 0.989086
1 W10SBP 0.547468 0.464904
2 BLSBP 0.998140 0.547468 0.786013
2 W10SBP 0.989086 0.464904 0.786013  
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Resting Diastolic BP Pre- to Post-IHG Training Repeated Measures ANOVA 
2a. Resting Diastolic BP (Means) 
Group Time Mean SE N 
IHG Pre- 71.57 2.6 12 
IHG Post- 67.23 2.5 12 
Control Pre- 73.46 3.5 12 
Control Post- 73.63 3.9 12 
 
2b. Resting Diastolic BP (All Effects) 
 
2c. Resting Diastolic BP (Tukey HSD Post-Hoc Test) 
Tukey HSD test; variable DV_1 (Spreadsheet1)
Approximate Probabilities for Post Hoc Tests
Error: Between; Within; Pooled MS = 121.33, df = 23.708
Cell No.
Group TIME {1}
71.574
{2}
67.287
{3}
73.463
{4}
73.630
1
2
3
4
1 BLDBP 0.010586
0.010586
0.974575 0.967627
1 W10DBP 0.527625 0.505519
2 BLDBP 0.974575 0.527625 0.999144
2 W10DBP 0.967627 0.505519 0.999144  
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Resting Mean Arterial BP Pre- to Post-IHG Training Repeated Measures ANOVA 
3a. Resting Mean Arterial BP (Means) 
Group Time Mean SE N 
IHG Pre- 90.74 3.1 12 
IHG Post- 85.23 3.0 12 
Control Pre- 92.28 3.7 12 
Control Post- 92.40 3.8 12 
 
3b. Resting Mean Arterial BP (All Effects) 
 
3c. Resting Mean Arterial BP (Tukey HSD Post-Hoc Test) 
Tukey HSD test; variable DV_1 (Spreadsheet1)
Approximate Probabilities for Post Hoc Tests
Error: Between; Within; Pooled MS = 139.51, df = 22.612
Cell No.
Group TIME {1}
90.741
{2}
85.228
{3}
92.284
{4}
92.395
1
2
3
4
1 BLMAP 0.000168
0.000168
0.988423 0.985813
1 W10MAP 0.475201 0.461922
2 BLMAP 0.988423 0.475201 0.999073
2 W10MAP 0.985813 0.461922 0.999073  
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Resting Pulse Pressure Pre- to Post-IHG Training Repeated Measures ANOVA 
4a. Resting Pulse Pressure (Means) 
Group Time Mean SE N 
IHG Pre- 57.50 3.2 12 
IHG Post- 53.82 3.0 12 
Control Pre- 56.80 2.8 12 
Control Post- 57.58 2.4 12 
 
4b. Resting Pulse Pressure (All Effects) 
 
4c. Resting Pulse Pressure (Tukey HSD Post-Hoc Test) 
Tukey HSD test; variable DV_1 (Spreadsheet1)
Approximate Probabilities for Post Hoc Tests
Error: Between; Within; Pooled MS = 99.573, df = 23.346
Cell No.
Group TIME {1}
57.500
{2}
53.824
{3}
56.796
{4}
57.583
1
2
3
4
1 BLPP 0.006444 0.998175 0.999997
1 W10PP 0.006444 0.884304 0.793068
2 BLPP 0.998175 0.884304 0.857127
2 W10PP 0.999997 0.793068 0.857127  
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Resting HR Pre- to Post-IHG Training Repeated Measures ANOVA 
5a. Resting HR (Means) 
Group Time Mean SE N 
IHG Pre- 67.84 3.3 12 
IHG Post- 67.77 3.1 12 
Control Pre- 66.67 2.1 12 
Control Post- 67.93 2.0 12 
 
5b. Resting HR (All Effects) 
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Cardiovascular Reactivity as a Predictor of IHG Training Effectiveness 
1a. Serial Subtraction Task Systolic BP Reactivity (IHG Training Group) 
SST Systolic BP Reactivity Dependent t-test 
Var1 – Baseline Systolic BP 
Var2 – SST Systolic BP 
 
1b. Serial Subtraction Task Diastolic BP Reactivity (IHG Training Group) 
SST Diastolic BP Reactivity Dependent t-test 
 
Var3 – Baseline Diastolic BP 
Var4 – SST Diastolic BP 
 
1c. Serial Subtraction Task HR Reactivity (IHG Training Group) 
SST HR Reactivity Dependent t-test 
 
Var5 – Baseline HR 
Var6 – SST HR 
 
 
 
 
166 
 
M.H.K Thesis – M. Badrov                                   Windsor – Applied Human Performance 
 
2a. Isometric Handgrip Task Systolic BP Reactivity (IHG Training Group) 
IHGT Systolic BP Reactivity Dependent t-test 
 
Var7 – Baseline Systolic BP 
Var8 – IHGT Systolic BP 
 
2b. Isometric Handgrip Task Diastolic BP Reactivity (IHG Training Group) 
IHGT Diastolic BP Reactivity Dependent t-test 
 
Var9 – Baseline Diastolic BP 
Var10 – IHGT Diastolic BP 
 
2c. Isometric Handgrip Task HR Reactivity (IHG Training Group) 
IHGT HR Reactivity Dependent t-test 
 
N
NewVar2 – IHGT HR 
 
ewVar1 – Baseline HR 
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3a. Cold-Pressor Task Systolic BP Reactivity (IHG Training Group) 
CPT Systolic BP Reactivity Dependent t-test 
 
NewVar3 – Baseline Systolic BP 
NewVar4 – CPT Systolic BP 
 
3b. Cold-Pressor Task Diastolic BP Reactivity (IHG Training Group) 
CPT Diastolic BP Reactivity Dependent t-test 
 
NewVar5 – Baseline Diastolic BP 
NewVar6 – CPT Diastolic BP 
 
3c. Cold-Pressor Task HR Reactivity (IHG Training Group) 
CPT HR Reactivity Dependent t-test 
 
N
NewVar8 – CPT HR 
 
ewVar7 – Baseline HR 
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1a. Serial Subtraction Task Systolic BP Reactivity (Control Group) 
SST Systolic BP Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
Var1
Var2
129.3333 16.41815
153.5000 17.60424 12 -24.1667 8.421353 -9.94089 11 0.000001
 
Var1 – Baseline Systolic BP 
Var2 – SST Systolic BP 
 
1b. Serial Subtraction Task Diastolic BP Reactivity (Control Group) 
SST Diastolic BP Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
Var3
Var4
74.05556 12.09878
85.66667 12.04034 12 -11.6111 2.748125 -14.6362 11 0.000000
 
Var3 – Baseline Diastolic BP 
Var4 – SST Diastolic BP 
 
1c. Serial Subtraction Task HR Reactivity (Control Group) 
SST HR Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
Var5
Var6
65.52778 6.763626
81.50000 9.317627 12 -15.9722 4.578073 -12.0857 11 0.000000
 
Var5 – Baseline HR BP 
Var6 – SST HR  
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2a. Isometric Handgrip Task Systolic BP Reactivity (Control Group) 
IHGT Systolic BP Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
Var7
Var8
129.8889 16.41405
162.1667 17.06050 12 -32.2778 12.83527 -8.71143 11 0.000003
 
Var7 – Baseline Systolic BP 
Var8 – IHGT Systolic BP 
 
2b. Isometric Handgrip Task Diastolic BP Reactivity (Control Group) 
IHGT Diastolic BP Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
Var9
Var10
73.13889 11.99702
85.75000 12.08399 12 -12.6111 3.093928 -14.1200 11 0.000000
 
Var9 – Baseline Diastolic BP 
Var10 – IHGT Diastolic BP 
 
2c. Isometric Handgrip Task HR Reactivity (Control Group) 
IHGT HR Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
NewVar1
NewVar2
67.02778 7.521630
82.50000 7.192167 12 -15.4722 4.820952 -11.1176 11 0.000000
 
NewVar1 – Baseline HR 
NewVar2 – IHGT HR 
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3a. Cold-Pressor Task Systolic BP Reactivity (Control Group) 
CPT Systolic BP Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
NewVar3
NewVar4
131.5556 17.88139
157.6667 18.78749 12 -26.1111 7.985256 -11.3273 11 0.000000
 
NewVar3 – Baseline Systolic BP 
NewVar4 – CPT Systolic BP 
 
3b. Cold-Pressor Task Diastolic BP Reactivity (Control Group) 
CPT Diastolic BP Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
NewVar5
NewVar6
73.19444 12.41900
85.25000 12.91317 12 -12.0556 6.079994 -6.86870 11 0.000027
 
NewVar5 – Baseline Diastolic BP 
NewVar6 – CPT Diastolic BP 
 
 
3c. Cold-Pressor Task HR Reactivity (Control Group) 
CPT HR Reactivity Dependent t-test 
T-test for Dependent Samples (Spreadsheet118)
Marked differences are significant at p < .05000
Variable
Mean Std.Dv. N Diff. Std.Dv.
Diff.
t df p
NewVar7
NewVar8
67.44444 8.007993
76.33333 9.604292 12 -8.88889 4.209977 -7.31406 11 0.000015
 
NewVar7 – Baseline HR 
NewVar8 – CPT HR 
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1a. SST SBP Reactivity vs. IHGT SBP Reactivity (IHG Training Group) 
SST vs. IHGT Systolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent 
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var1 vs.     Var2 26.91667 34.55556 -1.28034 22 0.213761
 
Var1 – SST Systolic BP 
Var2 – IHGT Systolic BP 
 
 
1b. SST SBP Reactivity vs. CPT SBP Reactivity (IHG Training Group) 
SST vs. CPT Systolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadsheet1
Note: Variables were treated as independent s
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var1 vs.     Var3 26.91667 30.55556 -0.532972 22 0.599396
 
Var1 – SST Systolic BP 
Var3 – CPT Systolic BP 
 
 
1c. IHGT SBP Reactivity vs. CPT SBP Reactivity (IHG Training Group) 
IHGT vs. CPT Systolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent 
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var2 vs.     Var3 34.55556 30.55556 0.553094 22 0.585776
 
Var2 – IHGT Systolic BP 
Var3 – CPT Systolic BP 
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2a. SST DBP Reactivity vs. IHGT DBP Reactivity (IHG Training Group) 
SST vs. IHGT Diastolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent 
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var4 vs.     Var5 11.41667 15.55556 -1.32118 22 0.200018
 
Var4 – SST Diastolic BP 
Var5 – IHGT Diastolic BP 
 
 
2b. SST DBP Reactivity vs. CPT DBP Reactivity (IHG Training Group) 
SST vs. CPT Diastolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent 
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var4 vs.     Var6 11.41667 14.97222 -1.10621 22 0.280586
 
Var4 – SST Diastolic BP 
Var6 – CPT Diastolic BP 
 
 
2c. IHGT DBP Reactivity vs. CPT DBP Reactivity (IHG Training Group) 
IHGT vs. CPT Diastolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent 
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var5 vs.     Var6 15.55556 14.97222 0.183209 22 0.856312
 
Var5 – IHGT Diastolic BP 
Var6 – CPT Diastolic BP 
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3a. SST HR Reactivity vs. IHGT HR Reactivity (IHG Training Group) 
SST vs. IHGT HR Reactivity Independent t-test 
T-test for Independent Samples (Spreadsheet1
Note: Variables were treated as independent s
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var7 vs.     Var8 14.05556 15.36111 -0.491080 22 0.628233
 
Var7 – SST HR 
Var8 – IHGT HR 
 
 
3b. SST HR Reactivity vs. CPT HR Reactivity (IHG Training Group) 
SST vs. CPT HR Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent 
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var7 vs.     Var9 14.05556 4.722222 4.785285 22 0.000089
 
Var7 – SST HR 
Var9 – CPT HR 
 
 
3c. IHGT HR Reactivity vs. CPT HR Reactivity (IHG Training Group) 
IHGT vs. CPT HR Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent 
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var8 vs.     Var9 15.36111 4.722222 4.955068 22 0.000059
 
Var8 – IHGT HR 
Var9 – CPT HR 
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1a. SST SBP Reactivity vs. IHGT SBP Reactivity (Control Group) 
SST vs. IHGT Systolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var1 vs.     Var2 24.16667 32.27778 -1.83031 22 0.080786
 
Var1 – SST Systolic BP 
Var2 – IHGT Systolic BP 
 
 
1b. SST SBP Reactivity vs. CPT SBP Reactivity (Control Group) 
SST vs. CPT Systolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent 
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var1 vs.     Var3 24.16667 26.11111 -0.580402 22 0.567542  
Var1 – SST Systolic BP 
Var3 – CPT Systolic BP 
 
 
1c. IHGT SBP Reactivity vs. CPT SBP Reactivity (Control Group) 
IHGT vs. CPT Systolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independent
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var2 vs.     Var3 32.27778 26.11111 1.413156 22 0.171603
 
Var2 – IHGT Systolic BP 
Var3 – CPT Systolic BP 
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2a. SST DBP Reactivity vs. IHGT DBP Reactivity (Control Group) 
SST vs. IHGT Diastolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadsheet
Note: Variables were treated as independent s
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var4 vs.     Var5 13.13889 14.27778 -0.865598 22 0.396052
 
Var4 – SST Diastolic BP 
Var5 – IHGT Diastolic BP 
 
 
2b. SST DBP Reactivity vs. CPT DBP Reactivity (Control Group) 
SST vs. CPT Diastolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadsheet
Note: Variables were treated as independent s
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var4 vs.     Var6 13.13889 13.80556 -0.449103 22 0.657750
 
Var4 – SST Diastolic BP 
Var6 – CPT Diastolic BP 
 
2c. IHGT DBP Reactivity vs. CPT DBP Reactivity (Control Group) 
IHGT vs. CPT Diastolic BP Reactivity Independent t-test 
T-test for Independent Samples (Spreadshee
Note: Variables were treated as independen
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var5 vs.     Var6 14.27778 13.80556 0.311136 22 0.758626
 
Var5 – IHGT Diastolic BP 
Var6 – CPT Diastolic BP 
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3a. SST HR Reactivity vs. IHGT HR Reactivity (Control Group) 
SST vs. IHGT HR Reactivity Independent t-test 
T-test for Independent Samples (Spreadshe
Note: Variables were treated as independen
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var7 vs.     Var8 15.97222 15.47222 0.260524 22 0.796883
 
Var7 – SST HR 
Var8 – IHGT HR 
 
3b. SST HR Reactivity vs. CPT HR Reactivity (Control Group) 
SST vs. CPT HR Reactivity Independent t-test 
T-test for Independent Samples (Spreadshe
Note: Variables were treated as independen
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var7 vs.     Var9 15.97222 8.888889 3.945210 22 0.000689
 
Var7 – SST HR 
Var9 – CPT HR 
 
3c. IHGT HR Reactivity vs. CPT HR Reactivity (Control Group) 
IHGT vs. CPT HR Reactivity Independent t-test 
T-test for Independent Samples (Spreadshe
Note: Variables were treated as independen
Group 1  vs. Group 2
Mean
Group 1
Mean
Group 2
t-value df p
Var8 vs.     Var9 15.47222 8.888889 3.563095 22 0.001739  
Var8 – IHGT HR 
Var9 – CPT HR 
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1a. Correlation Analysis (IHG Training Group) 
Correlations (Spreadsheet1)
Marked correlations are significant at p < .05000
N=12 (Casewise deletion of missing data)
Variable SSTSBP SSTDBP SSTHR IHGSBP IHGDBP IHGHR CPTSBP CPTDBP CPTHR
RSBP -.8248 -.6760 -.6273 -.6168 -.5205 -.7845 .3732 .3402 -.0315
p=.001 p=.016 p=.029 p=.033 p=.003p=.083 p=.232 p=.279 p=.923  
2a. Correlation Analysis (Control Group) 
Correlations (Spreadsheet6)
Marked correlations are significant at p < .05000
N=12 (Casewise deletion of missing data)
Variable SSTSBP SSTDBP SSTHR IHGSBP IHGDBP IHGHR CPTSBP CPTDBP CPTHR
SBP -.2101 -.2624 -.1311 .3675 -.3999 -.0001 .1676 -.3101 -.4567
p=.516 p=.419 p=.691 p=.241 p=.196 p=.999 p=.607 p=.327 p=.134  
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Cardiovascular Reactivity Following IHG Training 
SST Systolic BP Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
1a. SST Systolic BP Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 26.92 3.9 12 
IHG Post- 20.11 2.5 12 
Control Pre- 24.17 2.4 12 
Control Post- 25.28 2.8 12 
 
1b. SST Systolic BP Reactivity (All Effects) 
 
1c. SST Systolic BP Reactivity (Tukey HSD Post-Hoc Test) 
Tukey HSD test; variable DV_1 (Spreadsheet1)
Approximate Probabilities for Post Hoc Tests
Error: Between; Within; Pooled MS = 104.24, df = 27.501
Cell No.
Group TIME {1}
26.917
{2}
20.111
{3}
24.167
{4}
25.278
1
2
3
4
1 Var2 0.011734
0.011734
0.911253 0.979026
1 Var3 0.765802 0.607846
2 Var2 0.911253 0.765802 0.942472
2 Var3 0.979026 0.607846 0.942472  
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SST Diastolic BP Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
2a. SST Diastolic BP Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 11.42 2.2 12 
IHG Post- 9.22 1.5 12 
Control Pre- 13.03 1.2 12 
Control Post- 14.28 1.0 12 
 
2b. SST Diastolic BP Reactivity (All Effects) 
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SST HR Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
3a. SST HR Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 14.06 1.8 12 
IHG Post- 12.06 1.8 12 
Control Pre- 15.97 1.3 12 
Control Post- 14.89 1.8 12 
 
3b. SST HR Reactivity (All Effects) 
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IHGT Systolic BP Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
4a. IHGT Systolic BP Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 34.56 4.5 12 
IHG Post- 26.83 2.6 12 
Control Pre- 32.28 3.7 12 
Control Post- 34.00 4.0 12 
 
4b. IHGT Systolic BP Reactivity (All Effects) 
 
4c. IHGT Systolic BP Reactivity (Tukey HSD Post-Hoc Test) 
Tukey HSD test; variable DV_1 (CVSR-IHG Reactivity Spreadshee
Approximate Probabilities for Post Hoc Tests
Error: Between; Within; Pooled MS = 170.25, df = 30.815
Cell No.
Group TIME {1}
34.556
{2}
26.833
{3}
32.278
{4}
34.000
1
2
3
4
1 Var8 0.021978
0.021978
0.973357 0.999630
1 Var9 0.737988 0.542124
2 Var8 0.973357 0.737988 0.945703
2 Var9 0.999630 0.542124 0.945703  
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IHGT Diastolic BP Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
5a. IHGT Diastolic BP Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 15.56 2.2 12 
IHG Post- 14.39 1.6 12 
Control Pre- 14.28 1.0 12 
Control Post- 10.75 1.5 12 
 
5b. IHGT Diastolic BP Reactivity (All Effects) 
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IHGT HR Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
6a. IHGT HR Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 15.36 2.0 12 
IHG Post- 11.92 2.5 12 
Control Pre- 15.47 1.4 12 
Control Post- 14.81 1.4 12 
 
6b. IHGT HR Reactivity (All Effects) 
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CPT Systolic BP Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
7a. CPT Systolic BP Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 30.56 5.6 12 
IHG Post- 26.81 3.7 12 
Control Pre- 26.11 2.3 12 
Control Post- 24.19 1.9 12 
 
7b. CPT Systolic BP Reactivity (All Effects) 
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CPT Diastolic BP Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
8a. CPT Diastolic BP Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 14.97 2.3 12 
IHG Post- 13.61 1.2 12 
Control Pre- 13.81 1.2 12 
Control Post- 10.83 1.5 12 
 
8b. CPT Diastolic BP Reactivity (All Effects) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
186 
 
M.H.K Thesis – M. Badrov                                   Windsor – Applied Human Performance 
 
187 
 
CPT HR Reactivity Pre- to Post-IHG Training Repeated Measures ANOVA 
9a. CPT HR Reactivity (Means) 
Group Time Mean SE N 
IHG Pre- 4.39 1.1 12 
IHG Post- 4.72 0.8 12 
Control Pre- 8.89 1.2 12 
Control Post- 8.92 1.5 12 
 
9b. CPT HR Reactivity (All Effects) 
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Appendix C: University of Windsor Research Ethics Board Clearance 
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Appendix D: Windsor-Essex Community Health Centre Letter of Collaboration 
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Appendix E: Poster Advertisement 
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Do you have HIGH BLOOD 
PRESSURE? 
Be part of an important high blood pressure study: 
 
• e age of 18? Are you over th
Do you have high bl• ood pressure? 
 
If you answered YES, you may be eligible to take part in a research study  
conducted by Mark Badrov (MHK Candidate) and Dr. Cheri McGowan. 
 
If you are interested and would like more information please contact: 
Mark Badrov and/or Dr. Cheri McGowan  
at 519-253-3000 ext. 4979 (PACR Laboratory) or badrovm@uwindsor.ca 
 
*Study cleared by the University of Windsor Research Ethics Board 
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Appendix F: University of Windsor Website Advertisement 
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Attention all individuals with high blood pressure: 
You may be eligible to participate in an exciting 12-week study looking at the effects 
of a novel exercise. This exercise only takes 12-minutes, 3x/week and all you do is 
squeeze a handgrip. You have to be 18 years or older and have high blood pressure. 
If you are interested, please contact Mark Badrov at 519-253-3000 ext. 4979 and/or 
Dr. Cheri McGowan at 519-253-3000 ext. 2451. Email inquiries can be made to 
badrovm@uwindsor.ca. This study has been cleared by the University of Windsor 
Research Ethics Board. 
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Appendix G: Newspaper Advertisement 
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Attention all individuals with high blood pressure: 
You may be eligible to participate in an exciting 12-week study looking at the effects 
of a novel exercise. This exercise only takes 12-minutes, 3x/week and all you do is 
squeeze a handgrip. You have to be 18 years or older and have high blood pressure. 
If you are interested, please contact Mark Badrov at 519-253-3000 ext. 4979 and/or 
Dr. Cheri McGowan at 519-253-3000 ext. 2451. Email inquiries can be made to 
badrovm@uwindsor.ca. This study has been cleared by the University of Windsor 
Research Ethics Board. 
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Appendix H: Radio Advertisement 
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Attention all individuals with high blood pressure: 
You may be eligible to participate in an exciting 12-week study looking at the effects 
of a novel exercise. This exercise only takes 12-minutes, 3x/week and all you do is 
squeeze a handgrip. You have to be 18 years or older and have high blood pressure. 
If you are interested, please contact Mark Badrov at 519-253-3000 ext. 4979 and/or 
Dr. Cheri McGowan at 519-253-3000 ext. 2451. Email inquiries can be made to 
badrovm@uwindsor.ca. This study has been cleared by the University of Windsor 
Research Ethics Board. 
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Appendix I: Consent to Participate in Research Form 
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CONSENT TO PARTICIPATE IN RESEARCH 
Title of Study: Cardiovascular stress reactivity tasks as predictors of blood 
pressure reduction following isometric handgrip training in hypertensives. 
You are asked to participate in a research study conducted by Mark Badrov and Dr. 
Cheri McGowan from the Department of Kinesiology at the University of Windsor as a 
requirement of Mark Badrov’s master’s level thesis. 
If you have any questions or concerns about the research, please feel to contact Mark 
Badrov at 519-253-3000 ext. 4979 or via email at badrovm@uwindsor.ca; or Dr. 
Cheri McGowan at 519-253-3000 ext. 2451 or via email at mcgowanc@uwindsor.ca. 
PURPOSE OF THE STUDY 
 
The purpose of this study is to investigate whether individuals with greater blood 
pressure and heart rate responses to certain tasks experience greater blood pressure 
reductions following handgrip exercise. 
PROCEDURES 
 
If you volunteer to participate in this study, you will be asked to: 
Visit 1: 
You will meet with the study investigators in the Physical Activity and Cardiovascular 
Research (PACR) Laboratory (Room #240, Human Kinetics Building, University of 
Windsor, Windsor, Ontario, Canada) where you will receive a consent form and 
information sheet on the study. At this time, Mark Badrov and/or Dr. Cheri McGowan 
(study investigators) will explain all parts of the study. If you are still interested in 
participating in the study, you will be asked to sign the consent form and fill out a brief 
medical questionnaire. You will then have your blood pressure measured, similar to how 
it is taken at a doctor’s office. At this time, you will also arrange a date to visit the PACR 
Laboratory again to familiarize yourself with the equipment and the lab, and to have your 
resting blood pressure measured again. 
Visit 2: 
After agreeing to participate in the study, and if you are eligible, you will complete a 
familiarization session. First, you will have your resting blood pressure measured again, 
in the same manner as the first visit. If you are eligible, you will have to get approval 
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from your doctor to participate in the study. You will then practice all parts of the study 
including the math task, the task where you place your hand in a bucket of cold water, 
and the handgrip exercise. After you practice all of parts of the study, you will choose the 
dates to complete the three days of testing. All testing days will be separated by at least 
24 hours. These tests (described below) will include: 1) a short handgrip exercise, 2) a 
task where you place your hand in cold water, and 3) a math task. After the testing, you 
will be placed in either the exercise group or non-exercise group. 
Testing Days (Visits 3-5): 
You will complete all three testing days over a one week period in the PACR Laboratory. 
This will happen again after 10 weeks of handgrip training. You will be asked not to 
exercise hard or drink alcohol for 24 hours before each testing day, and to avoid caffeine 
for at least 12 hours before. All testing will take place at the same time of day, in a quiet, 
temperature-controlled room, following a light meal. On testing days, you will be asked to 
go to the washroom before testing, as a full bladder can increase your blood pressure. 
Visit 1: Short Handgrip Exercise (Approximately 45 minutes): 
You will arrive to the PACR Laboratory and fill out a questionnaire about your feelings. 
Your resting blood pressure will then be measured after 10 minutes of seated rest, which 
will involve placing a cuff around your upper right arm. Your blood pressure will be 
measured four times, with 2 minutes of rest between measures. Heart rate will be 
measured using three sticker electrodes that will be placed on your chest; they will 
measure your heart rate throughout the testing. Following this, you will perform a short 
handgrip exercise. This will involve a 2 minute squeeze, performed at 30% of your 
maximal squeeze strength. Heart rate and blood pressure will be measured during the 
task and for 20 minutes after. 
Visit 2: Cold Water Task (Approximately 45 minutes): 
At least 24 hours following your previous visit, you will return to the PACR Laboratory 
and fill out the same form. Your resting blood pressure and heart rate will then be 
measured in the same way as before. After this, you will complete the cold water task. 
During this task, you will place your hand in cold water for 2 minutes. Heart rate and 
blood pressure will be measured during the task and for 20-minutes after. 
Visit 3: Math Task (Approximately 45 minutes): 
At least 24 hours following your previous visit, you will return to the PACR Laboratory 
and fill out the same form. Your resting blood pressure and heart rate will then be 
measured in the same way as before. After this, you will perform the math task. During 
this task, you will look at a computer and will be asked to subtract a two digit number 
from the four digit number displayed and respond with your answer aloud. You will be 
shown 25 numbers in total and will have 5 seconds answer each one. Heart rate and 
blood pressure will be measured during the task and for 20 minutes after. 
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You will complete all three testing days again after the 10 weeks of exercise training or 
no training. 
Training Days for the Training Group (approx. 30 minutes): 
If you are randomly placed into the handgrip exercise group you will exercise 3 days per 
week for a total of 10 weeks. The handgrip exercise will involve four, 2-minute squeezes, 
switching hands with each squeeze, separated by 1 minute of rest. Squeezes will be 
performed at 30% of your hardest squeeze. One of your exercise sessions will be 
supervised in the PACR Laboratory and two will be done at home. Blood pressure and 
heart rate will be monitored before each session in the same manner described above. 
Training Days for the Non-Training Group (approx. 15 minutes): 
If you are randomly placed into the non-exercising group, you will visit the PACR 
Laboratory 1 day per week to have your resting blood pressure and heart rate measured 
in the same manner as described above, to ensure equal face time with the study 
investigators. 
POTENTIAL RISKS AND DISCOMFORTS 
 
If you are in the handgrip exercise group you may experience tendonitis or pain in your 
wrist; however, the risk of this is low if the exercise is performed properly. You may feel 
numbness and/or tingling in your arm during blood pressure measurement and/or a 
minor rash from the sticker electrode adhesive. The cold water task may result in 
numbness and/or tingling, as well as an uncomfortably cold sensation. To minimize this 
risk, we will place towels around your hand and the task will only last 2 minutes, (which 
is well at the bottom of the 2-10 minute range typically used). In addition, all study 
investigators have medical training and there is an emergency action plan if required. 
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
 
You will benefit from this study by having your blood pressure measured, recorded, and 
tracked for a 12 week period. You may also see a decrease in your resting blood 
pressure through the use of this new exercise.  
The results of this study will benefit the scientific community and society through the 
development of new therapies to prevent and/or reduce cardiovascular disease and 
hypertension. Furthermore, the study may provide early support for the use of the math 
task and/or the handgrip bout as a simple and effective tool to identify individuals with 
high blood pressure who will respond to handgrip training with a reduction in blood 
pressure, thus providing health-care professionals an alternative, yet effective, tool for 
the treatment of high blood pressure in this high risk population. 
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COMPENSATION FOR PARTICIPATION 
 
For participating in this study, you will be reimbursed for all parking costs and will receive 
a University of Windsor Kinesiology Research t-shirt. If you were assigned to the non-
exercising group, you will be given the opportunity to take part in the training following 
the completion of the study. 
CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential and will be disclosed only with your permission. 
To ensure confidentiality, you will be assigned an identification number. Your name will 
not be used in any publication or presentation, and you will be identifiable only by your 
identification number on all collection tools (electronic or otherwise). All paper and 
electronic data will be stored in the locked cabinet in the PACR Laboratory. Information 
stored on computers will be password-protected, and will be only available to the study’s 
investigators. All paper records (including medical questionnaires) will be shredded 
when the study is finished. 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS 
 
Participants will have the opportunity to obtain the results from the study on the 
University of Windsor’s Research Ethics Board (REB) website or via a hard copy when 
the study is finished. At any point throughout the study, you may request a copy of your 
heart rate and blood pressure data. 
Web address: http://www.uwindsor.ca/reb 
SUBSEQUENT USE OF DATA 
 
This data may be used in future studies. As data will be collected under the participant’s 
identification number, data used for ongoing studies will ensure the privacy of the 
participants.  
RIGHTS OF RESEARCH SUBJECTS 
 
You may withdraw your consent at any time and discontinue participation without 
penalty. If you have questions regarding your rights as a research subject, contact:  
Research Ethics Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4; 
Telephone: 519-253-3000, ext. 3948; e-mail:  ethics@uwindsor.ca 
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SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE 
 
I understand the information provided for the study “Cardiovascular stress reactivity 
tasks as predictors of blood pressure reduction following isometric handgrip 
training in hypertensives” as described herein.  My questions have been answered to 
my satisfaction, and I agree to participate in this study.  I have been given a copy of this 
form. 
______________________________________ 
Name of Subject 
______________________________________ _____________________ 
Signature of Subject      Date 
 
SIGNATURE OF INVESTIGATOR 
 
These are the terms under which I will conduct research. 
_____________________________________ ____________________ 
Signature of Investigator                 Date 
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Appendix J: Letter of Information for Consent to Participate in Research Form 
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LETTER OF INFORMATION FOR CONSENT TO PARTICIPATE IN RESEARCH 
Title of Study: Cardiovascular stress reactivity tasks as predictors of blood 
pressure reduction following isometric handgrip training in hypertensives. 
You are asked to participate in a research study conducted by Mark Badrov and Dr. 
Cheri McGowan from the Department of Kinesiology at the University of Windsor as a 
requirement of Mark Badrov’s master’s level thesis. 
If you have any questions or concerns about the research, please feel to contact Mark 
Badrov at 519-253-3000 ext. 4979 or via email at badrovm@uwindsor.ca; or Dr. 
Cheri McGowan at 519-253-3000 ext. 2451 or via email at mcgowanc@uwindsor.ca. 
PURPOSE OF THE STUDY 
 
The purpose of this study is to investigate whether individuals with greater blood 
pressure and heart rate responses to certain tasks experience greater blood pressure 
reductions following handgrip exercise. 
PROCEDURES 
 
If you volunteer to participate in this study, you will be asked to: 
Visit 1: 
You will meet with the study investigators in the Physical Activity and Cardiovascular 
Research (PACR) Laboratory (Room #240, Human Kinetics Building, University of 
Windsor, Windsor, Ontario, Canada) where you will receive a consent form and 
information sheet on the study. At this time, Mark Badrov and/or Dr. Cheri McGowan 
(study investigators) will explain all parts of the study. If you are still interested in 
participating in the study, you will be asked to sign the consent form and fill out a brief 
medical questionnaire. You will then have your blood pressure measured, similar to how 
it is taken at a doctor’s office. At this time, you will also arrange a date to visit the PACR 
Laboratory again to familiarize yourself with the equipment and the lab, and to have your 
resting blood pressure measured again. 
Visit 2: 
After agreeing to participate in the study, and if you are eligible, you will complete a 
familiarization session. First, you will have your resting blood pressure measured again, 
in the same manner as the first visit. If you are eligible, you will have to get approval 
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from your doctor to participate in the study. You will then practice all parts of the study 
including the math task, the task where you place your hand in a bucket of cold water, 
and the handgrip exercise. After you practice all of parts of the study, you will choose the 
dates to complete the three days of testing. All testing days will be separated by at least 
24 hours. These tests (described below) will include: 1) a short handgrip exercise, 2) a 
task where you place your hand in cold water, and 3) a math task. After the testing, you 
will be placed in either the exercise group or non-exercise group. 
Testing Days (Visits 3-5): 
You will complete all three testing days over a one week period in the PACR Laboratory. 
This will happen again after 10 weeks of handgrip training. You will be asked not to 
exercise hard or drink alcohol for 24 hours before each testing day, and to avoid caffeine 
for at least 12 hours before. All testing will take place at the same time of day, in a quiet, 
temperature-controlled room, following a light meal. On testing days, you will be asked to 
go to the washroom before testing, as a full bladder can increase your blood pressure. 
Visit 1: Short Handgrip Exercise (Approximately 45 minutes): 
You will arrive to the PACR Laboratory and fill out a questionnaire about your feelings. 
Your resting blood pressure will then be measured after 10 minutes of seated rest, which 
will involve placing a cuff around your upper right arm. Your blood pressure will be 
measured four times, with 2 minutes of rest between measures. Heart rate will be 
measured using three sticker electrodes that will be placed on your chest; they will 
measure your heart rate throughout the testing. Following this, you will perform a short 
handgrip exercise. This will involve a 2 minute squeeze, performed at 30% of your 
maximal squeeze strength. Heart rate and blood pressure will be measured during the 
task and for 20 minutes after. 
Visit 2: Cold Water Task (Approximately 45 minutes): 
At least 24 hours following your previous visit, you will return to the PACR Laboratory 
and fill out the same form. Your resting blood pressure and heart rate will then be 
measured in the same way as before. After this, you will complete the cold water task. 
During this task, you will place your hand in cold water for 2 minutes. Heart rate and 
blood pressure will be measured during the task and for 20-minutes after. 
Visit 3: Math Task (Approximately 45 minutes): 
At least 24 hours following your previous visit, you will return to the PACR Laboratory 
and fill out the same form. Your resting blood pressure and heart rate will then be 
measured in the same way as before. After this, you will perform the math task. During 
this task, you will look at a computer and will be asked to subtract a two digit number 
from the four digit number displayed and respond with your answer aloud. You will be 
shown 25 numbers in total and will have 5 seconds answer each one. Heart rate and 
blood pressure will be measured during the task and for 20 minutes after. 
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You will complete all three testing days again after the 10 weeks of exercise training or 
no training. 
Training Days for the Training Group (approx. 30 minutes): 
If you are randomly placed into the handgrip exercise group you will exercise 3 days per 
week for a total of 10 weeks. The handgrip exercise will involve four, 2-minute squeezes, 
switching hands with each squeeze, separated by 1 minute of rest. Squeezes will be 
performed at 30% of your hardest squeeze. One of your exercise sessions will be 
supervised in the PACR Laboratory and two will be done at home. Blood pressure and 
heart rate will be monitored before each session in the same manner described above. 
Training Days for the Non-Training Group (approx. 15 minutes): 
If you are randomly placed into the non-exercising group, you will visit the PACR 
Laboratory 1 day per week to have your resting blood pressure and heart rate measured 
in the same manner as described above, to ensure equal face time with the study 
investigators. 
POTENTIAL RISKS AND DISCOMFORTS 
 
If you are in the handgrip exercise group you may experience tendonitis or pain in your 
wrist; however, the risk of this is low if the exercise is performed properly. You may feel 
numbness and/or tingling in your arm during blood pressure measurement and/or a 
minor rash from the sticker electrode adhesive. The cold water task may result in 
numbness and/or tingling, as well as an uncomfortably cold sensation. To minimize this 
risk, we will place towels around your hand and the task will only last 2 minutes, (which 
is well at the bottom of the 2-10 minute range typically used). In addition, all study 
investigators have medical training and there is an emergency action plan if required. 
POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY 
 
You will benefit from this study by having your blood pressure measured, recorded, and 
tracked for a 12 week period. You may also see a decrease in your resting blood 
pressure through the use of this new exercise.  
The results of this study will benefit the scientific community and society through the 
development of new therapies to prevent and/or reduce cardiovascular disease and 
hypertension. Furthermore, the study may provide early support for the use of the math 
task and/or the handgrip bout as a simple and effective tool to identify individuals with 
high blood pressure who will respond to handgrip training with a reduction in blood 
pressure, thus providing health-care professionals an alternative, yet effective, tool for 
the treatment of high blood pressure in this high risk population. 
 
 
209 
 
M.H.K Thesis – M. Badrov  Windsor – Applied Human Performance 
 
 
COMPENSATION FOR PARTICIPATION 
 
For participating in this study, you will be reimbursed for all parking costs and will receive 
a University of Windsor Kinesiology Research t-shirt. If you were assigned to the non-
exercising group, you will be given the opportunity to take part in the training following 
the completion of the study. 
CONFIDENTIALITY 
 
Any information that is obtained in connection with this study and that can be identified 
with you will remain confidential and will be disclosed only with your permission. 
To ensure confidentiality, you will be assigned an identification number. Your name will 
not be used in any publication or presentation, and you will be identifiable only by your 
identification number on all collection tools (electronic or otherwise). All paper and 
electronic data will be stored in the locked cabinet in the PACR Laboratory. Information 
stored on computers will be password-protected, and will be only available to the study’s 
investigators. All paper records (including medical questionnaires) will be shredded 
when the study is finished. 
FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS 
 
Participants will have the opportunity to obtain the results from the study on the 
University of Windsor’s Research Ethics Board (REB) website or via a hard copy when 
the study is finished. At any point throughout the study, you may request a copy of your 
heart rate and blood pressure data. 
Web address: http://www.uwindsor.ca/reb 
SUBSEQUENT USE OF DATA 
 
This data may be used in future studies. As data will be collected under the participant’s 
identification number, data used for ongoing studies will ensure the privacy of the 
participants.  
RIGHTS OF RESEARCH SUBJECTS 
 
You may withdraw your consent at any time and discontinue participation without 
penalty. If you have questions regarding your rights as a research subject, contact:  
Research Ethics Coordinator, University of Windsor, Windsor, Ontario, N9B 3P4; 
Telephone: 519-253-3000, ext. 3948; e-mail:  ethics@uwindsor.ca 
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SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE 
 
I understand the information provided for the study “Cardiovascular stress reactivity 
tasks as predictors of blood pressure reduction following isometric handgrip 
training in hypertensives” as described herein.  My questions have been answered to 
my satisfaction, and I agree to participate in this study.  I have been given a copy of this 
form. 
______________________________________ 
Name of Subject 
______________________________________ _____________________ 
Signature of Subject      Date 
 
SIGNATURE OF INVESTIGATOR 
 
These are the terms under which I will conduct research. 
_____________________________________ ____________________ 
Signature of Investigator                 Date 
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Appendix K: Medical Questionnaire 
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Medical Questionnaire 
 
Last Name________________________________________   First Name____________________________________ 
Address______________________ City ________________ Province _______________ Sex (please circle):  M     F         
Height: ______________________ Weight: ______________________ Date of Birth___________________________     
Home Phone #   (           ) _______________________________________  Postal Code _________________________ 
                    
FOR EMERGENCY NOTIFY:  Name______________________ Relationship________________________________ 
Address_____________________________________________________ Phone______________________________ 
Family Doctor's Name____________________________ Date of Last Physical _______________________________ 
                                                                                                                               
Please Check Yes or No:                                                                                                                     Yes     No  
1. Have you ever been hospitalized? ---------------------------------------------------------------------------------------o       o 
          If yes, please specify? ___________________________________________________________ 
 Have you ever had surgery? ----------------------------------------------------------------------------------------------o        o 
         If yes, please specify_____________________________________________________________ 
2. Are you presently taking any medications or pills (including aspirin)? --------------------------------------------o        o 
         If yes, please specify? ___________________________________________________________ 
 Are you presently taking any vitamins or supplements?------------------------------------------------------------- o         o 
3. Do you have any allergies (medicine, food, bees or other stinging insects)?-------------------------------------  o         o 
         If yes, please specify?____________________________________________________________  
4. Have you ever passed out during or after exercise?-------------------------------------------------------------------  o       o 
 Have you ever been dizzy during or after exercise?-------------------------------------------------------------------  o       o 
 Have you ever had chest pain during or after exercise?--------------------------------------------------------------  o        o 
 Do you have high blood pressure?---------------------------------------------------------------------------------------  o       o 
If yes, are you being treated for this condition?_____________________________________________       
 Have you ever been told that you have a kidney problem? ---------------------------------------------------------- o       o 
 Have you ever been told that you have joint instability? ------------------------------------------------------------- o       o 
       Have you ever been told that you have a stomach problem? --------------------------------------------------------- o       o 
       Have you ever been told that you have a heart problem? ------------------------------------------------------------  o       o 
       Have you ever been told that you have a heart murmur? ------------------------------------------------------------- o       o 
 Do you have a machine that regulated your heart beat? -------------------------------------------------------------- o       o 
       Have you ever had racing of your heart or skipped heartbeats? ----------------------------------------------------- o       o 
 Has anyone in your family died of heart problems or a sudden death before age 50? --------------------------- o       o 
5. Do you have any skin problems (itching, rashes, acne)? ------------------------------------------------------------  o       o 
       If you get a cut, does it take you a long time to stop bleeding?------------------------------------------------------- o      o  
 If you experience a blow to a muscle, to you bruise easily? --------------------------------------------------------- o      o  
6. Do you have Diabetes? --------------------------------------------------------------------------------------------------- o       o 
7. Do you have Asthma or any other breathing problems? ------------------------------------------------------------  o       o 
                If yes, please specify?_______________________________________________________________  
8. Do you have any type of cardiovascular disease? -------------------------------------------------------------------- o       o 
         If yes, please specify?________________________________________________________________  
9. Have you had any other medical problems (infectious mononucleosis, etc.)? -------------------------------------o       o 
10. Have you had any medical problems since your last physical? ------------------------------------------------------o       o 
11. Do you smoke? -------------------------------------------------------------------------------------------------------------o       o 
Please explain any physical limitations that may prevent you from completing this study: 
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Appendix L: Physical Activity Readiness Medical Examination Questionnaire 
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Appendix M: Training Log 
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TRAINING LOG:    
Subject ID: _____________________________________________________________ 
Date 
What was 
your 
maximum 
contraction 
value? 
Did you 
complete 
two sets 
with each 
hand? 
 
Have you 
had any 
medication 
changes? If 
yes, please 
describe. 
Have you had 
any dietary 
changes? If 
yes, please 
describe. 
Have you had any 
physical activity 
changes? If yes, 
please describe. 
      
      
      
      
      
      
      
      
      
      
      
      
Please Note:  
- A change is diet is any abnormal addition or subtraction of calories or foods 
- A change in medication in any addition or subtraction of medications (i.e. any change)  
- A change in physical activity is the addition or subtraction of a structured physical activity program 
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Appendix N: Control Log 
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CONTROL LOG:    
Subject ID: _____________________________________________________________ 
Date 
 
Have you had any 
medication 
changes? If yes, 
please describe. 
Have you had any 
dietary changes? If 
yes, please describe. 
Have you had any physical 
activity changes? If yes, 
please describe. 
    
    
    
    
    
    
    
    
    
    
    
    
Please Note:  
- A change is diet is any abnormal addition or subtraction of calories or foods 
- A change in medication in any addition or subtraction of medications (i.e. any change)  
- A change in physical activity is the addition or subtraction of a structured physical activity program 
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Appendix O: Emergency Action Plan 
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EMERGENCY ACTION PLAN (EAP)  
FOR MEDICAL EMERGENCIES DURING EXERCISE TESTING 
 
STEP 1:   REMAIN CALM.   
CONTROL and ASSESS the situation. 
DESIGNATE a person to CALL and meet EMERGENCY PERSONNEL: 
 
Campus Police EXT. 4444              OR                911
(they will dispatch required authorities)   
 
OUR ADDRESS/DIRECTIONS: 
The University of Windsor 
Human Kinetics Building 
2555 College Ave. 
Main Entrance off College Ave. 
 
Room# 240 (uppermost floor) 
Go in through the main doors of the Human Kinetics 
 
STEP 2:   PERFORM all measures (CPR/First Aid) to ensure safety of subject. 
    ATTEND to subject until replaced by emergency personnel. 
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Appendix P: Cold-Pressor Task Action Plan 
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Cold-Pressor Task Action Plan 
Upon cessation of testing: 
1) t will remain in a seated position for an additional 5 minutes. Blood 
pressure and heart rate will be taken every minute to assess the return of these 
measures to baseline. 
Participan
 
 measure blood pressure and heart rate in the seated position 
2) Once blood pressure and heart rate have stabilized in the seated position and no 
symptom m 
• If the participant’s hand still remains cold the participant will be asked to 
e upright position 
3) Once baseline measures (blood pressure and heart rate) have been re-established 
and the
 
 
• The participant’s hand will be wrapped with towels and gently rubbed to
increase blood flow, which will speed up the warming of the extremity. 
• Continue to
until symptoms dissipate and/or blood pressure and heart rate have 
returned to baseline. 
 
s are present, help the participant into a standing position and allow the
to walk around with assistance from an investigator. Participants will remain 
upright for an additional 5 minutes. Blood pressure and heart rate will be taken 
every minute to assess the return of these measures to baseline. 
 
rub their hands together to generate warmth. 
• Continue to measure blood pressure and heart rate in th
until symptoms dissipate and/or blood pressure and heart rate have 
returned to baseline. 
 
 subject has been without symptoms for at least 10 minutes, they may 
leave the laboratory. 
 
 
 
 
226 
 
M.H.K Thesis – M. Badrov  Windsor – Applied Human Performance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix Q: Isometric Handgrip Exercise Device 
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(ZonaPLUS, Zona HEALTH, Boise, Idaho, USA) 
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ppendix R: Automated Brachial Artery Oscillometric Device 
 
 
 
 
 
 
A
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(Dinamap Carescape v100, Critikon, Tampa, Florida, USA) 
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